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Abstract 
 The ability to see faces is essential for successful social interactions and good quality 
of life. Age-related macular degeneration (AMD) is a progressive eye condition that damages 
central vision required to see faces clearly. This thesis aims to investigate potential means to 
improve quality of life in AMD, via a two-pronged approach. 
The first prong examines the importance of face recognition difficulties, using a 
qualitative study of the effects of poor face perception in AMD on social interactions and 
quality of life. Previous studies of the impact of AMD on quality of life have focussed on 
domains including reading, driving, and self-care. Paper 1 of the thesis presents the first in-
depth study of the quality-of-life impacts arising specifically from poor face perception. 
Results showed that, across all levels of vision loss (still driving through legally blind), AMD 
patients experience everyday problems with recognising who people are (face identity) and 
their emotions (facial expressions). These result in difficulties in social interactions, fear of 
offending others (e.g., appearing to ignore them deliberately), misinterpreting how others are 
feeling, and missing out in social situations. Patients also reported others did not understand 
their vision loss, and worried about appearing a fraud. These outcomes often contributed to 
social withdrawal and reduced confidence and quality of life. Paper 1 uses the study findings 
to develop new community resources (Faces and Social Life in AMD information sheet, 
conversation-starter, brochure for low-vision clinics), intended to improve patient and 
community understanding of how AMD affects face perception, and to provide practical tips 
for improving social interactions.  
The second prong focusses on improving face perception in AMD patients via image 
enhancement. The broad idea here is that, potentially, face images can be displayed to 
patients on screens or smart glasses after being digitally altered in ways that make them 
easier for patients to see and interpret. The specific image enhancement tested here is 
caricaturing, which involved exaggerating the shape information in the face image away 
from the average face (for face identity) or a neutral expression (for face expression). Paper 2 
demonstrates that caricaturing can improve perception of identity in AMD; this benefit was 
observed for all eyes tested with mild vision loss, and half of eyes tested with moderate-to-
severe vision loss. Paper 3 demonstrated that caricaturing can improve perception of facial 
expression in AMD, particularly for low-intensity expressions that are poorly recognised in 
their natural form, again across a wide range of vision loss. 
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Overall, this thesis demonstrates that poor face perception in AMD is an important 
contributor to patients’ reduced quality of life. With the aim of enhancing quality of life, I 
have developed resources to improve community understanding, plus demonstrated that 
caricaturing provides a useful image enhancement method in AMD. Future research should 
focus on: further evaluation of the helpfulness of the community resources (to patients, carers 
and orthoptists); testing whether combining image enhancement methods (e.g., caricaturing 
plus contrast manipulations) can further improve face perception; and engineering advances 
needed to implement accurate caricaturing for patients in real-time. 
 
Word count: 500 words (max. 500) 
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Chapter 1: Introduction  
 
1.1 Thesis aims and scope 
Age-related macular degeneration (AMD) is an eye condition that is characterised by 
the inability to see clearly using central vision due to damage to the retina (Khandhadia, 
Cipriani, Yates & Lotery, 2012; Lim, Mitchell, Seddon, Holz & Wong, 2012). Vision loss in 
AMD is associated with reduced ability to see faces (Barnes, De l’Aune, & Schuchard, 2011; 
Bullimore, Bailey, & Wacker, 1991; Boucart et al., 2008; Johnson, Woods-Fry & Wittich, 
2017; Taylor, Smith, Binns & Crabb, 2018) which is required for successful social 
interactions (Yardley, McDermott, Pisarski, Duchaine & Nakayama, 2008). 
The scope of this thesis is broad, incorporating multiple disciplines including 
psychology (both cognitive and clinical), ophthalmology and vision science. This 
multidisciplinary research has used a mixed-methods approach to: 1) investigate the 
importance of face recognition difficulties in AMD and how that impacts social interactions 
and quality of life, and 2) develop methods to improve quality of life by: i) understanding the 
effects of reduced face perception on social interactions and developing new community 
resources for AMD patients, family, friends, carers and health professionals, and ii) 
improving face perception via caricaturing, an image enhancement technique not used 
previously in AMD patients. 
 
1.2 Thesis structure  
This thesis has seven chapters. Chapter 2 introduces the thesis topic by providing a 
review of the background literature required to understand and interpret the research 
presented in the proceeding chapters. Chapter 2 is divided into four main sections, the first 
section provides an overview of what AMD is, how it is diagnosed and progresses. The 
second section reviews what is known about the impact of AMD on vision, face perception, 
social interactions, quality of life and psychological wellbeing. The third section considers 
the relationship between vision loss in AMD, everyday functioning and self-reported 
difficulties. The fourth section reviews how to potentially improve quality of life in AMD by: 
a) understanding the effects of reduced face perception on social interactions and 
disseminating this knowledge to AMD patients, family, friends, carers and health 
professionals, and b) using caricaturing, an image enhancement technology to improve face 
perception.  
9 
 
 Chapter 3 presents an in-depth qualitative study that examines the importance of 
impaired face perception on social interactions and quality of life in AMD. The findings from 
the qualitative study were used to develop new community resources, including the “Faces 
and Social Interaction in AMD” information sheet. The findings were also used to develop a 
proposed quantitative research tool titled “Face Perception and Social Interactions in AMD 
questionnaire” in Chapter 4. This tool could be used to address future research questions of 
scientific interest with AMD patients that can only be completed via quantitative information, 
although note the questionnaire’s validation and implementation is beyond the scope of this 
thesis. 
The importance of face recognition difficulties in AMD and how that impacts social 
interactions and quality of life is firmly established in the first part of this thesis, which 
provides support for the second part of this thesis that focuses on improving face perception 
in AMD via caricaturing. Chapter 5 includes the first experimental study that examines if 
caricaturing can improve face identity perception in AMD, and Chapter 6 investigates 
whether caricaturing can improve recognition of facial expressions in AMD.   
Finally, Chapter 7 presents a summary of the findings from this thesis and how they 
can be used to improve the quality of life of AMD patients. The future of image enhancement 
methods in AMD are discussed including their integration and application. Open questions 
that arose from this thesis are proposed to guide future research in this important and 
developing area.    
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1.3 Thesis format and publication details 
The qualitative study (Chapter 3) and experimental studies (Chapters 5 and 6) of this 
thesis have been prepared as individual manuscripts for journal publication. The text in the 
thesis chapters is identical to that submitted for publication, or about to be submitted, except 
for number formatting which is specific for this thesis. I am the first author for each of the 
article manuscripts, and the contributions of each author are indicated at the start of each 
chapter.  
Publication status details for the three chapters that have been or will be submitted to 
journals for publication are as follows: 
 
Chapter 3 
Lane, J., Rohan, E. M. F, Sabeti, F., Essex, R. W., Maddess, T., Dawel, A., Robbins, R. A., 
Barnes, N., He, X., & McKone, E. (submitted 4/7/2018). Impacts of impaired face 
perception on social interactions and quality of life in age-related macular 
degeneration: A qualitative study and new community resources. Submitted to PLoS 
One (under review). 
 
Chapter 5 
Lane, J., Rohan, E. M. F, Sabeti, F., Essex, R. W., Maddess, T., Barnes, N., He, X., Robbins,  
R. A., Gradden, T., & McKone, E. (2018). Improving face identity perception in age-
related macular degeneration via caricaturing. Scientific Reports, 8:15205. 
doi:10.1038/s41598-018-33543-3   
 
Chapter 6 
Lane, J., Mazlin, J., Irons, J., Rohan, E. M. F, Sabeti, F., Essex, R. W., Maddess, T.,  
 Robbins, R. A., Gradden, T., Dawel, A., Smithson, M., Barnes, N., He, X., Crookes,  
K., & McKone, E. (in preparation). Caricaturing improves recognition of low 
intensity facial expressions in age-related macular degeneration. To be submitted.  
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1.4 A note on referencing and Supplementary Materials sections 
 For the three papers of the thesis, the relevant chapter provides the complete 
manuscript for that paper in the submitted format, meeting the specific requirements of the 
target journal. Thus, each chapter presents the references for that chapter/paper at the end of 
the chapter, rather than the end of the whole thesis. Similarly, each chapter contains both the 
main-text of the manuscript plus the Supplementary Materials section submitted with the 
article. Finally, referencing style varies across chapters, based on whether the journal requires 
numbered or author-name referencing format. 
 
1.5 A note on patient data across studies  
 A total of 30 participants were included across the different studies for this research 
project. Some patients completed all of the studies across the research project, whereas other 
patients completed one study. The patient codes (P numbers) for each study were allocated 
based on specific criteria for that particular study e.g., in Chapter 3, P1 to P21 were ordered 
by best corrected visual acuity in the patients’ best eye. Therefore, the patient codes are 
independent for each study.  
A large proportion of the overall participants had wet AMD due to the majority of 
recruitment occurring in a clinical setting i.e., at a hospital where patients are being treated. 
Wet AMD is treatable, while dry AMD is currently not. Thus, wet AMD patients attend 
vision clinics much more regularly (for their treatment injections) and are thus more likely to 
be captured during recruitment. 
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Chapter 2: Literature review: AMD, the impact of AMD, the 
relationship between vision, everyday functioning and self-
reported difficulties, and how to potentially improve quality of 
life in AMD  
 
2.1 Chapter overview   
 This chapter provides an overview of AMD, face perception in AMD and the impact 
of poor face perception in AMD on social functioning and quality of life. It includes a review 
of qualitative research conducted with AMD patients as well as quantitative studies that have 
examined face perception and enhancement methods to improve face perception in AMD 
patients. The theoretical basis of the face enhancement method investigated in the 
experimental chapters of this thesis, caricaturing, is also reviewed. The main aim for the 
literature review is to provide a broad overview of the research areas that are most relevant to 
my research questions. It does not provide an exhaustive review but rather focuses on the 
literature relevant to my whole thesis. Each thesis chapter includes an introduction that is 
more refined and relevant to the research questions specific to that section of the thesis. 
 
2.2 What is AMD? 
2.2.1 AMD prevalence, types and central vision loss  
Age-related macular degeneration (AMD; also known as age-related maculopathy and 
age-related macular disease) is an eye condition most prevalent in people aged over 50 years 
that affects central vision and is the leading cause of irreversible visual impairment in 
Australia and the developed world (Bunting & Guymer, 2012; Khandhadia, Cipriani, Yates & 
Lotery, 2012; Mitchell & Bradley, 2006; Mitchell, Smith, Attebo & Wang, 1995; Wong et 
al., 2014). The prevalence of AMD is increasing due to the consistent growth of the ageing 
population and accounts for 8.7% of global blindness (Cimarolli, Boerner, Brennan-Ing, 
Reinhardt & Horowitz, 2011; Wong et al. 2014). Keel et al., (2017) found AMD to be the 
main cause of vision loss in 11.1% of nonindigenous Australians and 1.1% of indigenous 
Australians that participated in their study.  
AMD is a progressive, chronic disease in which the macula deteriorates either through 
the loss of retinal cells (known as geographic atrophy or “dry” AMD which accounts for 90% 
of all cases), or abnormal blood vessels and blood entering the retina (choroidal neovascular 
14 
 
or “wet” AMD) (Khandhadia et al., 2012; Singer, Amir, Herro, Porbandarwalla & Pollard, 
2012). The macula is the highest acuity area of the retina as it receives the greatest amount of 
incoming light allowing for fine detail and clear images to be seen (Harvey & Walker, 2014; 
Khandhadia et al. 2012; Singer et al., 2012). AMD can partially or completely damage the 
macula which in some patients can result in a central scotoma (i.e., visual field loss or blind-
spot) that forces patients to use their blurred peripheral vision to function. As the disease 
progresses, patients are often required to view their world using sections of their retina 
further in the periphery which become more blurred with greater eccentricity (Marmor & 
Marmor, 2010). Consequently, AMD progressively decreases the ability to see clearly which 
is essential for everyday tasks including reading, driving, self-care, and, importantly for this 
thesis, face recognition (Harvey & Walker 2014; Hooper, Jutai, Strong & Russell-Minda, 
2008; Owlsey & McGwin, 2008). 
 
2.2.2 Diagnosis and progression of AMD  
 Before describing the diagnosis and progression of AMD, it is important to recognise 
there are many changes that occur in the eye in normal ageing and whilst changes in structure 
and function lead to changes in vision, normal ageing does not inevitably lead to the 
development of AMD (Ehrlich et al., 2008; Owsley, 2011; Salvi & Currie, 2006). For 
example in normal ageing, vascular and structural changes that occur in the retina lead to a 
decline in visual function that includes decreased visual acuity and contrast sensitivity, a 
decline in visual field sensitivity and increased dark adaptation threshold (Elliott, Yang & 
Whitaker, 1995; Owsley 2011; Salvi & Currie 2006; Sjöstrand, Laatikainen, Hirvelä, Popovic 
& Jonsson, 2011). Although there are changes associated with normal ageing in the eye, it is 
the combination of these changes with a genetic predisposition and environmental risk factors 
(e.g., smoking and hypertension) that contribute to the development of AMD (AREDS, 2000; 
Ehrlich et al., 2008; Tomany et al., 2004).   
 The diagnosis and progression (described as levels or stages) of AMD are dependent 
on specific features of AMD that have been defined by The American Academy of 
Ophthalmology (AAO) Preferred Practice Pattern guidelines (2015) that correspond to the 
Age-Related Eye Disease Study (AREDS) Research Group classification system (AREDS, 
2001). AMD is associated with specific pathological changes that occur in the inner 
neurosensory layer and the outer retinal pigment epithelial cell layer (Khandhadia et al., 
2012). The presence of no AMD is characterised by no or few small drusen (yellow protein 
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and lipid deposits under the retina) <63 μm in diameter. Early AMD is characterised by a 
combination of multiple small drusen, few intermediate drusen 63-124 μm in diameter, or 
mild retinal pigment epithelial abnormalities. Patients with early AMD are at a low risk of 
progressing to advanced AMD after 5 years in either eye (AAO, 2015; AREDS, 2001). The 
progression to intermediate AMD is clinically distinctive because patients are at risk of 
progressing to advanced AMD. Intermediate AMD is characterised by any of the following: 
numerous intermediate drusen, at least one large drusen ≥ 125 μm in diameter, and 
geographic atrophy (i.e., an area of cell degeneration of the retinal pigment epithelial not in 
the central part of the macula). Finally, advanced AMD is the end-stage of AMD and is 
characterised by one or more of the following: geographic atrophy involving the foveal 
centre, neovascular maculopathy that includes choroidal neovascularisation (the growth of 
new blood vessels from the choroid into the sub-retinal pigment epithelium), serous and/or 
haemorrhagic detachment of the neurosensory retina or retinal pigment epithelial, retinal hard 
exudates (lipid deposits), sub-retinal pigment epithelial fibrovascular proliferation (growth of 
new blood vessels and fibrous tissues on the retina) and disciform scar (AAO, 2015; Boyer, 
Freund, Regillo, Levy & Garg, 2015; Hudson et al., 2006). End-stage AMD is defined as 
moderate (20/80+) to profound (20/600+) vision impairment and the loss of clear, central 
vision. AMD at this stage has a significant impact on everyday functioning, for example, 
reading, watching television, shopping and seeing faces (Boyer et al., 2015; Hudson et al., 
2006).  
 AMD patients are classified into stages as described above and are also grouped into 
vision loss categories (mild, moderate and severe) using best-corrected visual acuity (BCVA) 
cut-off values from the International Statistical Classification of Diseases and Related Health 
Problems 10th Revision (ICD-10; WHO, 2015). In this classification, mild vision loss refers 
to BCVA poorer than 6/6 (normal vision), down to 6/18; moderate refers to BCVA poorer 
than 6/18, down to 6/60; and severe refers to BCVA poorer than 6/60.  
 As indicated above, the diagnosis of AMD is complex and classified using multiple 
standardised systems. For this thesis a vision assessment was conducted by a qualified 
orthoptist under the review of an ophthalmologist to diagnose and classify AMD patients. 
The vision assessment assessed both eye structure and function to determine how the 
symptoms of AMD impacted each patients’ vision. One might assume AMD severity could 
be determined using a vision outcome measure (e.g., visual acuity) alone, however this would 
not suffice as good visual acuity can be retained even if AMD is present due to foveal sparing 
(i.e., not all of the fovea is damaged by AMD; Owsley, 2011).   
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2.3 The impact of AMD 
2.3.1 How does AMD affect vision? 
The impact of AMD on vision can be complex and unique to each individual patient. 
A commonly used depiction on macular degeneration websites includes an image of a 
person’s face with a black spot or scotoma in the centre of the image (see Figure 2.3.1A). 
More recently, the Macular Disease Foundation Australia website has also included images 
that demonstrate other visual phenomena associated with AMD including a loss of contrast 
sensitivity and distortions (see Figure 2.3.1B).  
However, recent research by Taylor, Edwards, Binns and Crabb (2018a) suggests that 
these depictions are not accurate (i.e., over-emphasising the presence of scotomas) or too 
simplistic as the description of visual experience from patients with dry AMD included blur, 
missing parts and distortions which are not depicted in the current AMD simulations. The 
impact of AMD on vision is variable depending on the type of AMD and at times unstable 
depending on disease progression. This complexity and variability in how AMD affects 
vision generally, and face perception specifically, has begun to be established in qualitative 
studies, which are comprehensively reviewed later in this literature review in section 2.3.8 
“Quality of Life and AMD”.  
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Figure 2.3.1 How AMD affects vision. A. Standard depiction of how AMD impacts vision on 
websites (https://ghr.nlm.nih.gov/art/large/age-related-macular-degeneration.png accessed 28 
March 2018). B. A more comprehensive depiction of how AMD impacts vision as shown in 
the Macular Degeneration Booklet (p.10), from the Macular Disease Foundation Australia 
website (https://www.mdfoundation.com.au/sites/default/files/MDBooklet_2017-
04_WEB.pdf accessed 28 March 2018).  
 
2.3.2 How does AMD impact face perception? 
A person’s face conveys a vast amount of information about who a person is, how 
they are feeling, whether they are engaged or interested, their attractiveness, gender, age and 
social status. This thesis will focus on face identity (being able to recognise who a person is 
to determine if they are familiar or unfamiliar), facial expression (to determine a person’s 
emotional state), eye gaze (where someone is looking indicating their attention and 
engagement), and facial cues to speech (using facial movements with verbal cues to interpret 
another person’s speech).  
B. 
A. 
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Before determining how face perception is impacted specifically in AMD, it is 
important to understand when reviewing face perception research, that face recognition 
ability changes across the lifespan and the changes seen in AMD are not part of normal 
ageing. In older adults without AMD, face identity recognition ability begins to decline at 
approximately 50 years and decreases steadily with age (Boutet & Faubert, 2006; Bowles et 
al., 2009; Norton, McBain & Chen, 2009). This decline in face processing has been shown in 
studies using the Cambridge Face Memory Test (CFMT; Duchaine & Nakayama, 2006) and 
the Cambridge Face Perception Test (CFPT; Duchaine, Germine, & Nakayama, 2007) where 
older adults (>50 years) are less accurate and slower to perceive faces with increasing age 
(Bowles et al., 2009). Less research has examined changes in face expression perception. 
Lott, Haegerstrom-Portnoy, Schneck and Brabyn (2005) tested both identity and expression 
perception in older adults without AMD (range 64-102 years) on a face recognition task 
where learned unfamiliar faces were viewed at varying distances and participants were asked 
to identify the person and the facial expression (happy, sad, angry or afraid). This study 
showed that face recognition performance (identity and expression) significantly decreased 
with increasing age and worsening visual acuity (Lott et al., 2005).  
 
2.3.3 How does AMD affect face identity and expression recognition? 
In addition to qualitative studies examining how AMD impacts face perception, a 
relatively small number of quantitative studies have conducted face identity and face 
expression recognition experiments with AMD patients. Here I will review all of the studies 
that have investigated identity and expression recognition in AMD patients compared to 
controls.  
Face identity perception was examined by Taylor, Smith, Binns and Crabb (2018b) in 
patients with dry AMD (visual acuity 6/30 or better), using a modified version of the CFMT 
(51 trials instead of 72 trials in the original version; Duchaine & Nakayama, 2006). They 
found that patients with mild and moderate dry AMD performed similarly to controls 
whereas the patients with advanced dry AMD had poor face recognition ability having 
identified significantly fewer faces than controls. Taylor et al. (2018b) conclude that patients 
with dry AMD may not have difficulties with face recognition until advanced stages of the 
disease. However, there was a lot of variation in the performance of patients with some 
advanced patients performing better than early and intermediate patients. As highlighted by 
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Taylor et al. (2018b) the variation in performance is likely related to the size of the lesion or 
scotoma and whether the patient had foveal sparing.   
Bullimore, Bailey and Wacker (1991) asked controls and AMD patients to learn faces 
and then name the identity and facial expression (happy, sad, angry and fear) at multiple 
viewing distances. When compared to controls, AMD patients in this study required a much 
closer viewing distance to reach a recognition threshold for both face identity and expression. 
Also, in some AMD patients, the decline in performance was largely due to difficulties in 
identity recognition, that is, AMD patients found it more difficult to recognise identity than 
expression whereas recognition thresholds were similar for identity and expression in 
controls (Bullimore et al., 1991).  
In another study, Barnes, De l’Aune and Schuchard (2011) used a face identity 
discrimination task (matching a target face against eight reference faces) in younger adults, 
older adults and AMD patients (who had significantly lower visual acuity and contrast 
sensitivity scores compared to the older adults). AMD patients overall were significantly less 
accurate and slower than older adults at face discrimination and their performance on the task 
decreased as their visual acuity and contrast sensitivity decreased (Barnes et al., 2011).  
When examining the impact of AMD on expression perception, Boucart et al. (2008) 
asked AMD patients with low visual acuity (mean 20/200) to detect whether a face had an 
expression or not, or to categorise an expression (from happy, angry or neutral). AMD 
patients performed better at the categorisation task than determining whether a face was 
expressive or not, whereas controls performed equally well on both tasks. When considering 
performance accuracy on the tasks, AMD patients performed significantly worse than healthy 
controls. Boucart et al. (2008) proposed that the reason AMD patients experienced many 
more false alarms compared to controls was due to the strategy they used to determine if a 
face was expressive or not, for example, they might have relied on the shape of the mouth to 
determine expression (i.e., categorising expressive faces with a closed mouth as neutral and 
open mouth as expressive). Finally, Johnson, Woods-Fry and Wittich (2017) examined 
expression detection and categorisation (happy, angry and neutral) and found AMD patients 
performed at a significantly lower accuracy level in both tasks when compared to controls.  
Not only do AMD patients show impaired face perception compared to controls they 
also exhibit differences in eye fixation patterns to faces. Seiple, Rosen and Garcia (2013) and 
Boucart et al., (2008) found AMD patients fixate significantly less on the internal features of 
the face (e.g., eyes and mouth) and significantly more on the external features of the face 
when compared to controls. Kumar and Chung (2014) found AMD patients showed higher 
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fixation instability than age-matched controls which included more microsaccades and slow 
drifts, making it more difficult to fixate on images. It is likely that these abnormalities in eye 
fixations contribute to reduced face perception in this population. 
In summary, multiple experimental studies, as described above, have indicated that 
AMD impairs the recognition of both face identity and facial expressions. The scores for 
AMD patients in face recognition tasks can be highly variable which is largely dependent on 
the severity of AMD, however overall AMD patients are slower to perceive faces and less 
accurate at recognising both face identity and facial expressions than age-matched controls.  
 
2.3.4 How does AMD affect eye gaze processing and facial cues to speech? 
As well as being able to see who a person is and their expressions, it is likely AMD 
patients have difficulty seeing eye gaze and facial cues to speech, however there is currently 
limited research in this area. Perception of others' eye gaze direction is needed to determine 
when someone is making eye contact with you versus attending to someone else in the room, 
and also for joint attention (i.e., shifting attention to follow the object of another person's 
gaze; Frischen, Bayliss, & Tipper, 2007). One relevant study (Sheldon, Quint, Hecht & 
Bowers, 2014) found that 16 patients with central vision loss due to bilateral central scotoma 
(including six AMD patients) used a wider mutual gaze range (i.e., larger eye gaze area when 
looking at another person; Gamer & Hecht, 2007) and showed significantly more variable 
gaze direction judgments than controls.  
 Processing of facial speech, namely mouth movements corresponding to the 
production of speech sounds, improves ability to follow conversations, particularly in noisy 
situations or where hearing is poor, by subconsciously affecting how a certain speech signal 
is perceived (e.g., as /b/ or as /g/, Schweinberger & Soukup, 1998; Walker, Bruce & 
O’Malley, 1995), and by explicitly supporting lip reading in the case of hearing-impaired 
older adults who have learned this skill (Gagné & Wittich, 2009). Concerning whether facial 
speech perception might be impaired in AMD, there is contradictory evidence: Legault, 
Gagné, Rhoualem and Anderson-Gosselin (2010) found in observers without AMD that 
audiovisual speech perception worsened when face stimuli were blurred using convex lenses 
to simulate a binocular visual acuity level of 6/30 and 6/60; but Wilson, Wilson, ten Hove, 
Paré, and Munhall (2008) claimed peripheral vision was sufficient to support most visual 
information in speech (based on four patients with central vision loss due to macula holes). 
There have been no previous studies which have examined effects of impaired eye gaze or 
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facial speech perception on social interactions in AMD. To examine how AMD impacts face 
perception, this thesis will ask AMD patients to discuss their experiences associated with eye 
gaze and facial cues to speech.  
 
2.3.5 How might AMD affect perception of other information that contributes 
to identity and emotion recognition? 
When face perception is reduced or impaired, the use of alternative non-face 
strategies are required to identify who a person is and their emotional state. In prosopagnosia, 
a condition where people are unable to recognise people by their faces and, in some cases, 
facial expressions either due to damage to, or abnormal development of the inferotemporal 
cortex and/or white matter connections (Behrmann, Avidan, Gao & Black, 2007; Biotti & 
Cook, 2016); people report using voice, hair, gait, clothing, other unique physical attributes 
and contextual cues to identify others (Kress & Daum, 2003; Yardley, McDermott, Pisarski, 
Duchaine & Nakayama, 2008). Non-face strategies for recognising a person’s emotional state 
include using tone of voice and body language (Biotti & Cook, 2016). In general these non-
face strategies can be helpful, however are not fool-proof, for example, when trying to use a 
person’s hair to identify them after they have had a haircut, or trying to discern a familiar 
voice or the affect of a voice in a crowded room (Biotti & Cook, 2016). 
It is expected that patients with low vision would use similar non-face strategies as 
those with prosopagnosia to recognise others and their emotional state. However, given the 
loss of clear, central vision in AMD, it is anticipated that AMD patients would use non-face 
cues that are large and easy to see (e.g., gait and hair) more than people with prosopagnosia 
who do not have vision loss. Previous research has not examined the non-face strategies used 
to recognise identity and expression perception in AMD. These will be examined by this 
thesis.   
 
2.3.6 The impact of poor face perception on social interactions  
Social interactions allow the transmission and decoding of information and mutual 
understanding between two people. Reduced ability to perceive faces in social situations can 
result in misinterpretation, confusion and harm (i.e., if threat is not detected; Jack & Schyns, 
2015). Much of the research on the association between poor face perception and social 
interactions has been conducted on people with prosopagnosia, autism spectrum disorder 
(ASD) and schizophrenia.  
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In prosopagnosia, Yardley et al. (2008) reported reduced face identity perception in 
people with this condition resulted in feelings of worry, guilt, failure and embarrassment 
when not recognising familiar people and avoidance of social situations. Studies on people 
with ASD report reduced social attention and deficits in processing face identity and 
expression when compared to controls, however the relationship between the social attention 
and face perception deficits in ASD are not clear (Chita-Tegmark, 2016; Nomi & Uddin, 
2015). Also, as the social content becomes more complex, for example as the number of 
people increases in a social situation, the social attention and face processing deficits seen in 
ASD worsen (Chita-Tegmark; Nomi & Uddin). Research in people with schizophrenia has 
shown this population have impaired emotion perception which may be associated with 
abnormal face scanning, that is, scanning the parts of the face that are not important for 
expression perception (Kohler, Walker, Martin, Healey, & Moberg, 2010) and impaired face 
identity perception (Megreya, 2016). These impairments can contribute to poor social 
functioning, social withdrawal and isolation (Wölwer et al., 2012).  
These examples highlight how impaired face perception in social interactions may be 
associated with many types of difficulties which can reduce a person’s ability to develop and 
maintain social relationships; all of which may contribute to psychological distress (Sato et 
al., 2017; Yardley et al., 2008). 
 
2.3.7 Social functioning and AMD  
Few studies have examined the impact of AMD on social interactions. Wang and 
Boerner (2008) examined how low vision impacts social relationships across various eye 
diseases including AMD. Participants reported problems making eye-contact and seeing 
visual cues, problems seeing facial expressions or the way people react and consequently not 
knowing how to respond to others, not being able to initiate or follow conversations, making 
errors when recognising others and worrying that they are offending others due to their poor 
face perception. Owsley et al., (2006) examined the emotional issues associated with AMD 
and reported their participants felt bothered when staying home from social events and 
inadequate when they avoid social functions because of their vision. Following an extensive 
literature review, no studies were found that specifically examined the impact of poor face 
perception on social interactions and quality of life (as defined in the next section) in AMD 
patients and this thesis will include the first qualitative study to examine this.  
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2.3.8 Quality of life and AMD 
The impact of AMD on quality of life (QoL) is difficult to examine due to multiple 
factors. Firstly, the loss of central vision in AMD impacts all areas of functioning (practical, 
social, behavioural, cognitive and psychological) which in-turn affects autonomy, 
independence and QoL (Finger, Fleckenstein, Holz & Scholl, 2008; Mitchell & Bradley, 
2006). Whilst there are many studies in the literature that claim to examine QoL in AMD 
patients, there are few that define what QoL is. Two broad definitions include: “Quality of 
life is how good or bad you feel your life to be” (McGee, O’Boyle, Hickey, O’Malley & 
Joyce, 1991, p. 2), and “An evaluation of all aspects of our lives” (Taylor, Hobby, Binns & 
Crabb, 2016, p. 2). When considering these broad and somewhat vague definitions of QoL, 
there are many potential domains of QoL which are highly interdependent, correlated and can 
maintain or exacerbate each other, making the examination of QoL complex. For example, 
vision loss in AMD is associated with increased functional disability, reduced social 
interactions and symptoms of depression which in-turn exacerbates psychological distress 
and increases functional disability (Cimarolli et al., 2016; Dawson, Mallen, Gouldstone, 
Yarham & Mansell, 2014).  
Second, AMD is heterogeneous disease and patients exhibit individual differences in 
symptoms and their effects. Such individual differences include the rate of progression and 
severity of the disease, whether the AMD is monocular or binocular, and the perceived 
importance associated with the vision loss. For example two patients with the same visual 
acuity and reading speed may have significantly different QoL outcomes because one patient 
had planned to comprehensively read once they retired, whereas the other patient did not 
enjoy reading prior to their diagnosis (Slakter & Stur, 2005).  
Third, researchers often claim to be measuring QoL, however they are not measuring 
QoL specifically, instead they have measured domains related to QoL including 
psychological wellbeing, functional status and vision-specific functional status (Mitchell & 
Bradley, 2006). For example, a study that examines the impact of AMD on mood is not 
measuring QoL (even though a reduction in mood can be associated with a reduction in 
QoL), and AMD patients with no reported psychological symptoms may report a severe 
reduction in their QoL due to AMD (Mitchell & Bradley, 2006). To measure how AMD 
impacts patients’ QoL most studies use patient reported outcome measures (that measure 
psychological wellbeing, health status, functional status, vision-specific functional status and 
vision-specific individualised quality of life), performance based studies (measuring stimulus 
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detection accuracy) and qualitative methods (asking AMD patients about their visual 
experiences) (Bennion, Shaw & Gibson, 2012; Finger et al., 2008; Mitchell & Bradley, 2006; 
Slakter & Stur, 2005; Taylor et al., 2016). This issue regarding the direct and specific 
measurement of QoL in AMD is important, however for the purpose of this review, both 
research that examines QoL directly and indirectly using domains that are related to QoL will 
be included. 
 
2.3.9 Measures used to examine QoL in AMD patients 
Despite the complications associated with measuring QoL (e.g., some tools measure 
constructs that are indirectly associated with QoL) described above, there are currently many 
measures used to examine the QoL in AMD patients; for a review of the vision-specific 
psychometric tools refer to Finger et al. (2008). One general QoL measure that is very widely 
used, has good to excellent psychometric properties, is cross-culturally valid and targets 
physical, psychological, social and environmental domains is the 26-item World Health 
Organisation’s WHOQOL-BREF quality of life measure (Skevington, Lotfy, O’Connell, & 
WHOQOL Group, 2004). Here I will review two measures that are used in this thesis and one 
that highlights the importance of including a face perception item when conducting QoL 
research with AMD patients. 
The most commonly used psychometric tool that measures vision-specific QoL in 
AMD is the National Eye Institute Visual Function Question (NEI-VFQ-25 item; Mangione 
et al., 2001). The NEI-VFQ is designed to measure vision-targeted health-related QoL across 
different eye conditions and has been extensively used with AMD patients. In general, 
average scores for visual functioning are worse in AMD patients compared to older adults 
and the scores worsen with increased severity of AMD (Finger et al., 2008; Mangione et al., 
2001; Taylor et al., 2016). Domains of the NEI-VFQ include general health and vision, 
activities, and vision-specific social functioning, mental health, difficulties with roles and 
dependency (Mangione et al., 2001). In regards to the research questions of this thesis, the 
NEI-FVQ has two questions related to face perception, one related to face identity: “Because 
of your eyesight, how much difficulty do you have recognizing people you know from across 
a room?” and one related to face expression: “Because of your eyesight, how much difficulty 
do you have seeing how people react to things you say?”. Questions related to social 
functioning in the NEI-VFQ include difficulty visiting people, going out to social activities 
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(e.g., movies or sporting events), staying at home, and worrying about doing things that will 
embarrass self or others because of their eyesight (Mangione et al., 2001). 
The NEI-VFQ measures vision-specific QoL which is a subset and not a complete 
measure of  QoL. To address this issue, Mitchell and Bradley (2004) designed the Macular 
Disease Quality of Life questionnaire (MacDQoL) which they report is the only measure that 
specifically and directly examines the QoL of AMD patients. The MacDQoL examines 23 
domain-specific items that include household tasks, leisure activities, self-confidence, 
financial situation and independence. The MacDQoL does not ask questions about face 
perception, however has four questions related to social functioning including how AMD has 
impacted their closest personal relationship, family life, friendships and social life, and the 
way people in general react to them (Mitchell & Bradley, 2004). One unique aspect of the 
MacDQoL that was highlighted by Slakter and Stur (2005) is this measure also asks 
respondents about the relative importance of each domain and weights the domain ratings.   
Finally, the last tool discussed here is the Impact of Vision Impairment questionnaire 
(IVI; Weih, Hassell & Keeffe, 2002). The IVI is a 32 item measure with five domains (leisure 
and work, consumer and social interactions, household and personal care, mobility and 
emotional reaction to vision loss) (Hassell, Lamoureux & Keefe, 2006). Hassell et al. (2006) 
tested the IVI in 106 AMD patients and the areas of greatest concern as measured by the IVI 
included reading, hobbies, worries about declining vision, shopping and falling. The IVI 
asked participants about their difficulty “recognising or meeting people” and it was ranked 
11th for the level of difficulty or concern of the 32 items and whilst the IVI is not used in this 
thesis, research using this measure has indicated reduced face perception does concern AMD 
patients.  
 In summary, the current measures used to examine QoL in AMD patients are limited 
as they often measure vision function or health status rather than QoL. To overcome this 
issue, Mitchell and Bradley (2004) developed the MacDQoL to specifically examine QoL in 
AMD patients. Whilst this measure does ask about social functioning, it does not ask about 
face perception – impairment of which has been shown to be of concern to AMD patients. 
The MacDQoL might therefore be missing a vital component to QoL in AMD. Alternatively, 
the NEI-VFQ asks two questions about face perception however the wording of the questions 
is too broad i.e., asking if they see “how people react to things you say” is likely to include 
reactions other than facial expressions.  
To conclude, there is extensive evidence that face perception is impaired in AMD 
(e.g., Barnes et al., 2011; Boucart et al., 2008; Bullimore et al., 1991). One study by Wang 
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and Boerner (2008) indicated impaired face perception in AMD can make social interactions 
difficult due to problems making eye-contact, seeing facial expressions and interpreting 
social interactions which can lead to withdrawal and feelings of inadequacy (Owsley et al., 
2006). As highlighted above, previous research has examined how AMD impacts QoL across 
multiple domains, however current QoL measures either ask no, or limited, poorly worded 
questions about face perception and social interactions (Mangione et al., 2001; Mitchell & 
Bradley, 2004). Also, no current measures include items that investigate the effects of 
impaired eye gaze and facial speech perception on social interactions in AMD, the non-face 
strategies used to recognise identity and expression perception by AMD patients, or how 
reduced face perception in AMD interacts with social functioning and QoL. This thesis aims 
to conduct the first comprehensive qualitative study on reduced face perception in AMD and 
the impact reduced face perception has on social interactions and QoL. The findings from this 
qualitative study will be used to develop a quantitative questionnaire for future research that 
will include items that comprehensively examine face perception in AMD and how impaired 
face perception impacts social interactions and QoL in AMD patients.  
 
2.3.10 Psychological wellbeing and AMD 
As highlighted previously, QoL research often includes the examination of the 
psychological impact of AMD, which is not a direct measure of QoL. Therefore, 
psychological wellbeing in AMD will be reviewed separately here.  
Multiple studies have examined the psychological impact of AMD. Early studies 
reported that AMD patients are up to two times more likely to be clinically depressed than 
older adults without AMD (Brody et al., 2001; Casten, Rovner, & Tasman, 2004). The 
reported prevalence rates of depression in patients with AMD has varied across studies 
(largely dependent on the methodological approach and comparison group used, refer to 
Zheng, Wu, Lin and Lin (2017) for a review), however the trend across studies indicates the 
symptoms of depression are more common in AMD patients than people without AMD, and 
the prevalence of depression increases with AMD severity level (Augustin et al., 2007; 
Dawson et al., 2014). 
Whilst the relationship between AMD and depression has been established, less is 
known about anxiety and AMD. Anxiety and depression have high rates of comorbidity and 
therefore it is important to consider the impact of both of these disorders on patient 
functioning, recovery and rehabilitation (Eramudugolla, Wood, & Anstey, 2013; Zbozinek et 
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al., 2012). Studies examining the prevalence of anxiety and depression in AMD patients have 
shown the relationship between anxiety and AMD is less robust when compared to the results 
for depression and AMD and overall, patients with AMD are not more likely to have 
symptoms of anxiety than people without AMD (Cimarolli et al., 2016; Dawson et al., 2014).  
The emotional impact of impaired vision due to AMD was examined by Owsley et al. 
(2006) who reported AMD patients experienced feelings of frustration, fear, sadness, 
inadequacy, gratitude and hope. Specific to face recognition, AMD patients reported feeling 
embarrassed and awkward when not being able to recognise people including their friends 
and family, which may lead to psychological distress (Owsley et al. 2006). The contribution 
of impaired face perception in AMD to symptoms of depression and anxiety has not been 
examined, largely due to the difficulty in isolating specific contributors to psychological 
distress (i.e., is low mow mood caused by poor face perception, reduced social interactions or 
their interaction, or due to grief associated with reduced vision and uncertainly of disease 
progression). This thesis is the first to specifically ask AMD patients about the impact of 
impaired face perception on their social interactions and quality of life whilst measuring 
patients’ visual function and psychological wellbeing (including depression and anxiety) to 
get a better understanding of the relationships between these factors.   
 
2.3.11 Treatment of depression and anxiety in AMD  
 Various treatment approaches have been developed, tested and evaluated in AMD 
patients that are aimed at reducing the psychological distress associated with this disease and 
interventions have demonstrated varied levels of effectiveness. For depression, interventions 
have included antidepressant medication (Brody et al., 2011 where an effect size of 0.67 was 
reported), behavioural activation (Rovner et al., 2014; effect size 0.32), problem solving 
treatment (PST; Nollett et al., 2016; effect size 0.19; Rovner, Casten, Hegel, Leiby, & 
Tasman, 2007) and stepped care; where evidence-based treatment is used and ‘stepped up’ 
from low to high intensity when lower intensity interventions are not effective (Seekles, van 
Straten, Beekman, van Marwijk, & Cuijpers, 2011; van der Aa et al., 2015; effect size 0.21).  
Less research has examined the treatment of anxiety in AMD, however treatment for 
anxiety is similar to depression with the implementation of stepped care and self-management 
programs (van der Aa et al., 2015; Cimarolli et al., 2016). The results from AMD-specific 
interventions for depression and anxiety have shown varied effect sizes and the longevity of a 
reduction of symptoms is limited (Nollett et al., 2016). To improve the longevity of treatment 
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gains, Nollett et al. (2016) recommended booster sessions for ongoing symptom reduction. 
Current best practice includes eye health professionals conducting a screen for depression and 
anxiety and referring the AMD patient to mental health professionals if required. Treatment 
can combine low vision rehabilitation with AMD-specific mental health programs (Augustin 
et al., 2007; Cimarolli et al., 2016).   
 
2.3.12 Psychological adjustment to chronic disease and AMD 
The way individuals are impacted by and adjust to chronic disease can be diverse 
depending on the condition, the rate of progression and level of patient support. de Ridder, 
Geenen, Kuijer and van Middendorp (2008) examined the impact of chronic diseases 
including diabetes, rheumatoid arthritis and cancer and reported, following diagnosis, a 
reduction in wellbeing may be associated with shock and grief. Following this initial period, 
patients can undergo psychological adjustment which can include acceptance of diagnosis, 
development of coping and self-management strategies, and time to re-calibrate expectations 
associated with quality of life (de Ridder et al., 2008). However, in some cases of chronic 
disease, as the condition progresses, a reduction of psychological adjustment can occur due to 
the decrease in effectiveness of previously established coping and self-management strategies 
and the reality of living with severe impairment (de Ridder et al., 2008). 
When examining adaptation and psychological adjustment to AMD, results are mixed. 
For example, Schilling, Wahl, Horowitz, Reinhart and Boerner (2011) found that AMD 
patients became less distressed as their chronic functional impairment increased during the 
progression of their vision loss. This adaptation enables AMD patients to be less reactive to 
their functional losses, which is protective for their psychological wellbeing (Schilling et al., 
2011). In contrast, Hassell et al., (2006) found participants did not adapt to their vision loss in 
AMD, and the longer the time with impaired vision, the greater the impact on QoL. 
Therefore, future research is required in examining psychological adjustment in AMD across 
the progression of the disease.  
In conclusion, Section 2.3 of this review highlights the impact AMD has on vision 
and many broad facets of a person’s life including face perception, social interactions, quality 
of life and psychological wellbeing, all of which can lead to a reduction in everyday 
functioning.  
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2.4 What is the relationship between vision loss in AMD, everyday 
functioning and self-reported difficulties?   
2.4.1 Relationship between visual function and performance in everyday tasks 
 As indicated throughout this review, AMD impacts most aspects of vision, including 
face perception as well as social interactions, quality of life and psychological wellbeing. The 
relationship between these factors is complex and often interdependent. Another 
complicating factor researchers have identified are the difficulties found in establishing a 
relationship between vision status and function status in patients with vision loss. For 
example, West et al. (2002) examined the relationship between tasks of everyday life (e.g., 
mobility tasks, daily living tasks, reading speed and face recognition) in a population-based 
study of 2520 adults aged 65 to 84 years as part of the Salisbury Eye Evaluation (SEE) 
Project. The number of AMD patients in this study was not specified, however 3.7% of 2520 
participants were classified as having a visual impairment (>6/12 to <6/60) and 0.83% were 
classified as legally blind (≥ 6/60) (Rubin et al., 1997; West et al., 2002). 
 In this study, participants’ best-corrected visual acuity (range 6/6 to 6/190) and 
contrast sensitivity were highly correlated (r = 0.81) where generally participants with good 
contrast sensitivity also had good visual acuity (West et al., 2002). The face identity task 
required that participants perform 15 trials of an odd-one-out task where they chose which of 
four faces differed (where the other three faces were identical). Results showed that as visual 
acuity decreased, face recognition performance decreased (West et al., 2002). However the 
relationship between visual functioning and task performance is not always as clear. Whilst 
the overall trend across the research is most AMD patients perform worse in tests of 
functional performance than controls, it is important to consider that a large variation in 
performance is often seen across AMD patients and at times patients with severe AMD may 
perform better than those with mild AMD (Barnes et al., 2011; Taylor et al., 2018b). Despite 
these complications, in general, functional performance in AMD patients decreases with 
disease progression and decreasing vision status (Alexander et al., 1988; Bullimore et al., 
1991; Cimarolli et al., 2016; Dawson et al., 2014; Mangione et al., 2001).  
 As well as investigating the relationship between visual function and performance in 
everyday tasks, West et al. (2002) wanted to use their findings to determine a cut-off score 
that defines disability based on patients’ task performance or measures of vision (visual 
acuity and contrast sensitivity). However, West et al., (2002) identified many factors other 
than those related to vision that can impact task performance (e.g., age, education, comorbid 
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conditions, task difficulty and length of time since onset) and due to these factors, a disability 
cut-off score is likely to lack reasonable sensitivity and specificity. This finding is important 
as it would be tempting to define visual disability in AMD and other eye conditions based on 
visual function or task performance, however the relationship between visual function and 
everyday function is not straightforward and as discussed previously, visual function may not 
be a good indicator of disease severity. Therefore, to comprehensively assess the impact of 
AMD and associated visual disability in an individual AMD patient, a comprehensive vision 
assessment that examines the structural damage to the retina is required.  
Another issue to consider when examining visual function and performance is the use 
in current research of multiple outcome measures to determine vision status. The most 
commonly used measure is visual acuity, however Taylor et al. (2018b) reported that contrast 
sensitivity may be a better predictor of real-world visual performance in AMD patients than 
visual acuity alone. Alexander et al. (1988) asked AMD patients to identify colours, products 
and faces and found when contrast sensitivity was controlled for, visual acuity made no 
difference to performance. Therefore, it is important to consider which outcome measures to 
use when examining the impact of AMD on quality of life and include outcome measures 
other than visual acuity including contrast sensitivity, glare sensitivity and size and 
characteristics of the scotoma as these outcomes contribute independently to deficits in 
everyday tasks (Slakter & Stur, 2005; West et al., 2002).  
 
2.4.2 Relationship between self-reported difficulties in face recognition and 
performance on a face recognition task 
As highlighted in the preceding section of this review, a positive relationship exists 
between vision status and functional status (i.e., as visual acuity worsens so does activities of 
daily living). In relation to face recognition performance, Taylor et al. (2018b) reported a 
strong association between worsening face recognition performance in the modified CFMT 
and contrast sensitivity in patients with dry AMD.  
Investigating face recognition difficulties in AMD and their impact on QoL is 
complicated by individuals’ lack of insight into their face recognition abilities. For example, 
Palermo et al. (2016) examined if adults have insight into their face recognition abilities 
using face performance tasks and self-report measures and found typical adults have modest 
insight into their ability to recognise faces, whereas people with congenital prosopagnosia 
overall have greater insight. In older adults with normal vision, Lott et al. (2005) reported a 
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low correlation between participants’ self-reported difficulties recognising faces (across a 
room and in dimly lit places) and function or performance in the face recognition tasks. 
In AMD patients, Tejeria, Harper, Artes and Dickinson (2002) reported low 
correlations (r = 0.13 for identity and r = 0.05 for expression) between self-reported difficulty 
in face perception (assessed by asking participants questions about face recognition e.g., “I 
have difficulty recognising familiar faces in the street”, and expression discrimination e.g., “I 
feel I sometimes miss something in conversations because I cannot see the expression in 
other people’s faces”) and face performance (using a famous face recognition task and a face 
expression difference task).  
It has been suggested that a lack of insight into face recognition ability may be due to 
a lack of testing for face perception during development and compensatory strategies can 
mask deficits in face recognition, particularly in prosopagnosia (Palermo et al., 2016). It 
would be anticipated that AMD patients would have greater insight into their impairment in 
seeing faces compared to prosopagnosia, because they were able to see faces before their 
diagnosis. However AMD patients are not particularly accurate when reporting their vision 
status or functional status using self-report measures (West et al., 2002). This may be because 
AMD is a progressive disease and patients might not notice their reduced ability to see faces 
over time, or as their face perception decreases across the disease progression, the strategies 
used to compensate for their reduced face perception increases.  
West et al. (2002) proposed that self-reported difficulties in face perception are often 
inaccurate as they rely on the individual’s assessment of their ability and their understanding 
of the task difficulty and their specific limitations. Also, Palermo et al. (2016) found that self-
report measures with multiple questions were better able to tap into insight than single-item 
questions. These issues are important and will be examined in this thesis with the aim of 
designing a standardised self-report quantitative measure that examines face perception in 
AMD patients that can be administered in conjunction with performance based measures in 
future research. 
 
2.5 How to potentially improve QoL in AMD 
2.5.1 Understanding the effects of poor face perception on social interactions 
and disseminating this knowledge  
 One potential factor that exacerbates the impact of poor face perception in AMD 
patients is the lack of understanding from others about the disease, however few studies have 
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examined this issue. In prosopagnosia, Yardley et al. (2008) proposed that the lack of 
awareness of prosopagnosia may contribute to the negative psychosocial consequences 
reported by people living with this condition (e.g., concerns about offending others, 
embarrassment, guilt and avoidance of social situations). It is expected that AMD patients 
would experience similar problems in social situations, however the negative outcomes might 
be reduced as AMD is more well-known to the general public than prosopagnosia. In 
Australia, it is reported that 80% of people aged 16 years or older and 92% of people aged 50 
years or older were aware of macular degeneration, and 73% of people understand that 
macular degeneration is a disease of the eyes (Heraghty & Cummins, 2012). These statistics 
indicate many Australians have heard of macular disease, but it does not indicate the general 
public understands how AMD impacts vision or how the vision loss associated with AMD 
impacts the patient. This lack of understanding of AMD by others has been indicated in 
qualitative studies. For example, Wong, Guymer, Hassell and Keefe (2004) reported that 
AMD patients described feeling like a fraud and despite telling others many times that they 
are legally blind, others didn’t seem to understand the magnitude of the vision loss associated 
with AMD, or believe that a person with AMD cannot see them. Wang and Boerner (2008) 
also found in low vision participants that others don’t understand that peripheral vision is 
intact allowing a person to walk around whilst fine vision is damaged affecting everyday 
tasks including reading, driving and face perception.  
 The lack of understanding of AMD is demonstrated by a study in the United States by 
Stein, Brown, Brown, Hollands and Sharma (2003) who asked AMD patients, members of 
the community and health professionals (including medical students and ophthalmologists) to 
answer a questionnaire, and the participants without AMD were asked to respond as if they 
had AMD. When the responses were compared between the three groups, members of the 
community and health professionals did not understand the significant impact of AMD and 
they greatly underestimated the negative impact of AMD on QoL. Stein et al. (2003) 
proposed that members of the community may not know how AMD affects vision (i.e., 
causes blurring and distortions in central vision) and how this affects everyday function. It 
would be expected that health professionals, particularly ophthalmologists, would understand 
this, however their responses indicated they did not understand how much quality of life is 
impacted in AMD patients as a consequence of their vision loss. Given these findings, it is 
unlikely the general public have a good understanding of how AMD impacts vision and 
people living with AMD.  
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 To increase awareness of AMD, macular disease organisations (e.g., the Macular 
Disease Foundation Australia (MDFA); https://www.mdfoundation.com.au) use different 
forms of media to provide AMD patients, family, friends, carers and the general public with 
information about AMD and how it impacts vision. These organisations provide information 
sheets on AMD including details regarding symptoms, causes, prevention, treatment and 
visual aids. These sheets are often placed in eye examination rooms to disseminate this 
information to people who may not use technology.  
 As well as providing general information on AMD, the emotional impact of sight loss 
is discussed in a handout by the UK Macular Society (https://www.macularsociety.org) that 
includes feeling like a fraud and the importance of seeking emotional support through AMD 
help-lines or support groups. Vision Australia (https://www.visionaustralia.org) describes 
difficulties associated with vision loss including other people not understanding and problems 
with social interactions including making eye contact, seeing facial expressions and 
recognising others. Limited strategies to manage poor face perception are proposed on Vision 
Australia’s website including telling others about your vision loss, ask people to address you 
by name, listening to tone of voice for emotion perception, listen to direction of voice for 
location of others, and looking above the mouth to simulate eye contact. However, this 
information does not discuss AMD directly and patients might expect face recognition 
problems only occur with severe vision loss (given this website is associated with low vision 
and blindness).  
Whilst there is information on websites and brochures about AMD, due to the limited 
amount of research conducted in this area, there is currently very limited information on 
macular disease websites specific to the impact of AMD on face perception, or the impact of 
reduced face perception on social interactions and quality of life. Given the poor 
understanding of AMD and the limited knowledge about poor face perception and its impact, 
this thesis will aim to use the findings of the qualitative study to develop resources for AMD 
patients, their family, friends, carers and health professionals to gain a better understanding of 
how AMD impacts face perception, the impact on social interactions and quality of life, and 
provide practical strategies to improve social interactions. If possible, these resources will be 
included on the Macular Disease Foundation Australia website, to gain the greatest 
opportunity to disseminate this knowledge and potentially improve the quality of life of 
AMD patients.  
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2.5.2 Use image enhancement technology to improve face perception 
It has been well established that AMD impairs the ability to recognise the identity of 
faces (Barnes et al., 2011; Bullimore, et al., 1991; Taylor et al., 2018b) and see facial 
expressions (Boucart et al., 2008; Johnson et al., 2017). To sustain and improve vision in 
patients with moderate to severe wet AMD, pharmacological treatments have been used with 
the most common being anti-vascular endothethial growth factor (anti-VEGF) drugs (e.g., 
ranibizumab or bevacizumab) (Vottonen, Kaarniranta, Pääkkönen & Tarkka, 2017; Ying et 
al., 2014; Ying et al., 2015). Whilst the use of pharmacological treatments is effective and 
likely to maintain patients’ ability to perceive faces, the focus of this thesis in on non-
pharmacological enhancement methods. 
The simplest method that has been used to improve face perception in AMD is 
magnification, that is, making the face larger. Tejeria et al. (2002) used a famous face 
recognition task with a telescopic device. In that study 86% of AMD patients saw a 
significant improvement in face identification. Tejeria et al. (2002) also used a face 
expression difference task in which AMD patients had to discriminate from four faces which 
expression was the odd one out (from happy, sad, surprise, sad and neutral) and 79% of 
participants showed a significant improvement in this task when using their telescopic device. 
Bullimore et al. (1991) asked AMD patients to learn faces and then name the identity and 
facial expression (happy, sad, angry and fear) and found face perception performance 
improved with decreasing viewing distance. Finally, Johnson et al. (2017) examined the 
impact of magnification on expression detection and recognition (happy, angry and neutral) 
in AMD patients and found that magnification did assist with emotion perception. Despite 
magnification being able to assist with face perception in AMD patients, the use of telescopic 
devices has not been adopted due to the devices being heavy and cumbersome to use (Lowe 
& Rubinstein, 2000; Tejeria et al., 2002). Also, Johnson et al. (2017) argued that 
magnification alone did not provide an increase in performance suitable for everyday use and 
other methods including contrast enhancement and shape-based image enhancement may be 
better suited to improving emotion perception in AMD patients than magnification alone.  
Using a different method to enhance face perception, Peli and colleagues (1989, 1991 
and 1994) increased the contrast of the medium and high-spatial frequency components of the 
face and in their studies reported spatial information between 4 and 8 cycles/face is most 
critical for face recognition. Using this manipulation with black and white images, AMD 
patients reported the famous faces were clearer, sharper and easier to see and 50% of their 
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participants showed significant improvement in face identity recognition (Peli, Goldstein, 
Young, Trempe & Buzney, 1991). More recent studies in adults with normal vision (Keil, 
2008; Keil, Lapedriza, Masip, & Vitria, 2008) suggest whilst optimal face identity processing 
occurs in a narrow spatial frequency band from 8 to 16 cycles per face, processing can occur 
when spatial information is suppressed, that is, when viewing conditions are not optimal as in 
AMD. Faces are still perceived in less than optimal conditions because the ability to 
recognise others incorporates information from high spatial frequencies, that provide 
information about shapes and contours within the face (rapid luminance variations in the 
internal features of the face e.g., eyes, nose and mouth), and low spatial frequencies, that 
provide information from slow luminance variations including that the object is a face and the 
external features (e.g., hair and face shape and size) (Boucart et al., 2008). Therefore, spatial 
frequency manipulations used by Peli et al., might be particularly useful in AMD patients as 
the damage to their retina contributes to a significant loss beyond that associated in normal 
ageing in both contrast sensitivity and high spatial frequency (Boucart et al., 2008; Owlsey, 
2011). However, there are no current real-world applications of spatial frequency 
manipulations specifically designed to assist with face perception. The use of glasses that 
utilises a spatial frequency manipulation could be developed, as shown by van Rheede et al., 
(2015) who developed a pair of residual vision glasses to assist low vision patients to move 
around their environment by manipulating the brightness of obstacles based on distance from 
the obstacle. Further development and application of spatial frequency manipulations to 
improve face perception in AMD patients is required. 
 More recent technological advances to improve vision in AMD patients include 
miniature telescopes implanted as intraocular devices in the eye (e.g., the implantable 
miniature telescope IMT; VisionCare Ophthalmic Technologies). Intraocular implants allow 
for improved eye and head movement and reduced vestibular effects compared to external 
visual aids (Singer et al., 2012). Boyer et al. (2015) tested an IMT on patients with dry AMD 
aged ≥55 years with moderate to severe central vision loss (i.e., bilateral best-corrected 
distance visual acuity (BCDVA) between 6/24 and 6/240). When assessed 60 months post 
implantation, 62% of participants tested maintained a clinically significant 2-line 
improvement in BCDVA (Boyer et al., 2015). The IMT has seen promising results, however 
is not suitable for patients with wet AMD or who have had cataract surgery and the implant 
does result in a loss of field of view and peripheral vision (Singer et al., 2012).  
 Finally, the OrCam MyEye 2.0 smart camera is a device attached to glasses that uses 
computer facial recognition software to verbally identify up to 100 people who have been 
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pre-programmed into its database (www.orcam.com/en/myeye2). Whilst this device would be 
incredibly useful with recognising those familiar to the person with vision loss, this 
technology is too expensive (between AUD$5000 to $10000) for many patients. It also does 
not improve the vision of the AMD patient as such, but rather provides a computer-generated 
solution to person perception.  
 
2.5.3 Mid-to-high level visual processing enhancements of faces 
 As indicated in Figure 2.5.3, there are multiple visual processing areas associated with 
face perception. Previous face enhancement methods using magnification and spatial 
frequency manipulations relied on improving processing of face images in early-stage, low-
level visual areas of the visual cortex (e.g., retina through to V1 and V2; Kanwisher & Dilks, 
2013). Theoretically face perception might also be improved by enhancements targeting 
higher level visual processing areas, however no studies have examined this in AMD 
patients. Here we investigated caricaturing, a method of image enhancement that targets mid-
to-high visual processing areas that code face-shape information (Duchaine & Yovel, 2015; 
Kayaert, Biederman, Op de Beeck, & Vogels, 2005; Pasupathy & Connor, 2001) as a 
potential means to enhance face perception in AMD patients.  
 
 
 
 
 
 
 
 
Figure 2.5.3 Some of the visual processing areas that respond to faces. Previous image 
enhancement techniques for improving face identity perception in AMD have targeted low 
level vision in early visual areas. Our caricaturing method is designed to tap potential for 
additional benefits from improving coding of face-shape information in mid- and high-level 
processing regions (Duchaine & Yovel, 2015; Kanwisher & Dilks, 2013; Kayaert, et al., 
2005; Pasupathy & Connor, 2001). Image based on Irons et al., 2014 and from Chapter 5. 
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2.5.4 Caricaturing of identity 
 Caricaturing is a method of image enhancement that exaggerates the unique shape 
information of an individual face away from an average face (Valentine, 1991). As depicted 
in Figure 2.5.4A, a natural unaltered (or veridical) face with a large chin and pointed nose 
when compared to the average face will have these aspects of their face exaggerated when 
their face is caricatured making the chin larger and nose more pointed. In practice, software is 
used to create an average face by morphing together numerous faces that have the same 
viewpoint, expression, sex, age and race as the target face. Multiple landmark points on key 
locations of the face are placed on both the target face and average face and the morphing 
procedure stretches and compresses the distances between the key locations to move the 
idiosyncratic shape aspects of the target face away from the average face (Valentine, 1991). 
Shifting the target face on the same direction away from the average face allows the 
caricatured face to be perceived as the same person, just a more exaggerated version of 
themselves that is easier to identify (Irons et al., 2014; Valentine, 1991; Valentine, 1999).  
The effect of caricaturing in the enhancement of face identity perception is explained 
by perceptual face space theory proposed by Valentine (1991). In this model (see Figure 
2.5.4B), individual faces are uniquely coded on a multidimensional perceptual face space 
based on the unique shape dimensions of each face and how the face differs from the 
perceptual norm. The dimensions of face space are unknown, but it is proposed that the 
average face, positioned at the centre of a person’s face space, is based on the diet of faces 
that an individual has experienced, particularly during their development, however face space 
can adapt when new faces (e.g., ethnicities) are introduced (Rhodes et al., 2005; Valentine, 
Lewis & Hills, 2016). Faces that are distinctive, or that ‘stand out in a crowd’ lie towards the 
periphery of face space and are likely to not be confused because they have no close 
neighbours on the face space dimensions, whereas faces that look similar (e.g., sisters) are 
more likely to be confused because of their close proximity in the face space framework 
(Valentine, 1991).  
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Figure 2.5.4 Caricaturing and perceptual face space. A. To make a caricature the veridical 
face is morphed away from a race/sex/age-matched average, such that all distinctive aspects 
of the face are exaggerated. In this individual, such aspects include the wide nose, the 
distance from nose to top lip, the thickness of eyebrows etc. Note that only shape, not colour 
(which would include lighting information, an unreliable cue to identity) is caricatured in our 
stimuli. (Face images reproduced from Irons et al., 2014). B. Explanation of caricaturing 
benefits in terms of a mental face space. Caricaturing is guaranteed to move any two faces 
further away from each other in this multidimensional space. Note dimensions coded on the 
axes remain unknown (but are derived from a participant’s everyday ‘diet’ of faces, and code 
for both local attributes such as lip thickness and global attributes such as width of the face). 
Images from Irons et al., 2014 and Chapter 5.  
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As shown in Figure 2.5.4B, if you take two faces, caricaturing exaggerates the shape 
information in each face moving it away from the average face and further into the periphery 
of face space which makes two faces appear more dissimilar than when they were 
uncaricatured. As well as making the two faces more dissimilar to each other, caricaturing 
makes each face more distinctive and easier to recognise as there is lower exemplar density 
with fewer confusable neighbours when faces are placed further into the periphery (Valentine 
et al., 2016).  
The use of caricaturing has been well established in normal vision and research in 
young adults has demonstrated that caricatured famous faces and unfamiliar faces are 
recognised faster and with better accuracy than the unaltered (veridical) face (Benson & 
Perrett, 1991; Chang, Levine & Benson, 2002; Lee, Byatt & Rhodes, 2000; Valentine, 1999). 
However, the caricature advantage is not seen across all conditions. For example, Rhodes, 
Brennan and Carey (1987) did not show a caricature advantage with veridical line drawings 
in a goodness of likeness task. In another study, participants were asked to select a face that 
looked ‘best-like’ themselves or a close friend, and selected an anti-caricatured face (Allen, 
Brady & Tredoux, 2009).  
Caricature effects have not previously been investigated in AMD. However one 
previous study has explored the effect of caricaturing in simulated AMD. Irons et al. (2014) 
simulated in young adults different severities of vision loss due to AMD using a blur 
manipulation and reported a caricature advantage, that is, faces were perceived as more 
dissimilar in a rating task comparing two faces, and in memory tasks recognition of faces was 
significantly better when they were caricatured compared to when they were unaltered. More 
recently, Dawel et al., (in press) showed caricaturing can improve identity processing across 
many settings including in high resolution images, at multiple blur levels simulating central 
vision loss, own-race faces, other-race faces, young adult observers and older adult observers 
(aged 64-86 years i.e., the age-range relevant for AMD). Therefore, previous research 
indicates caricaturing improves face identity recognition using three different tasks including 
simultaneous perception (dissimilarity ratings to faces compared in pairs), old-new 
recognition memory, and face-name learning in young and older adults (Dawel et al. (in 
press); Irons et al., 2014). It is expected given these findings that caricaturing will enhance 
face identity perception in AMD patients, which will be examined for the first time in this 
thesis.   
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2.5.5 Caricaturing of expression 
As well as enhancing the perception of face identity, caricaturing has also been shown 
to improve the perception of facial expressions. Expression caricaturing, like identity 
caricaturing uses morphing software however instead of exaggerating the distinctive identity 
information in a face, expression caricaturing holds identity information constant and 
exaggerates the physical differences between the original (veridical) expression and a neutral 
expression of the same face (described as the reference face). The general procedure used to 
caricature expressions across studies (e.g., Benson, Campbell, Harris, Frank & Tovee, 1999; 
Calder, Young, Rowland & Perrett, 1997; Irons et al., 2014) is to place multiple landmark 
points on the anatomical landmarks of the neutral reference face (e.g., eyes, nose, mouth, 
hairline etc.). The same landmark points are then placed on the veridical expressive face with 
the addition of landmark points that are unique to each specific expression e.g., wrinkle and 
smile lines around the mouth and eyes for a happy expression. The additional landmark 
points from the expressive face are then matched onto the same location on the neutral face. 
Caricatures are then extracted using morphing software where the differences in shape 
information between the landmark points on the neutral and expressive face are exaggerated 
(expanded or contracted). For example, 100% caricaturing indicates a doubling of the 
differences between veridical and neutral landmark point locations. Figure 2.5.5 shows a 
neutral expression, veridical happy expression and the caricatured happy expression (80% 
caricature level).  
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Figure 2.5.5 Example of caricaturing a happy expression. Neutral and veridical images are 
from McLellan database (McLellan et al., 2010). Image from Chapter 6.  
  
In normal adult observers, caricaturing has been shown to improve expression 
recognition accuracy, speed up expression naming time and increase the perceived intensity 
of expressions in younger adults (Benson et al., 1999; Calder et al., 1997; Calder et al., 2000; 
Leppänen, Kauppinen, Peltola, & Hietanen, 2007), and older adults (mean age approximately 
64 years; Kumfor et al., 2011; Kumfor, Irish, Hodges & Piguet, 2013). The effect of 
caricaturing expressions has also been examined in special populations. For example, 
caricaturing improved performance accuracy in expression perception (particularly for anger, 
disgust, sadness and fear) in patients with frontotemporal dementia (Kumfor et al., 2011) and 
increased accuracy and reduced identification speed in an emotion-matching task in children 
with Down Syndrome (Cebula, Wishart, Willis & Pitcairn, 2017). This thesis will be the first 
to examine if caricaturing enhances expression perception in AMD patients.  
In summary, section 2.5 indicates there are a number of potential image enhancement 
technologies available to improve face perception and potentially improve quality of life in 
AMD patients. However, currently used methods have practical, financial and eligibility 
constraints e.g., IMT can only be transplanted in patients with dry AMD. Until now, 
technologies have only targeted low-level visual processing areas in face perception which 
have limited application i.e., you can only magnify a face so much before it falls outside the 
useful range of vision and before it looks distorted.  
Following from Irons et al. (2014) who demonstrated the feasibility of caricaturing in 
patients with low vision, and Dawel et al. (in press) who demonstrated that older adults can 
A. Example of expression caricaturing: 
Neutral expression Veridical expression 
uncaricatured, original photo 
Caricatured expression 
80% strength 
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perceive the caricature advantage in face identity, this PhD research will be the first to 
examine if caricaturing enhances face identity perception in AMD patients. Following studies 
that have used caricaturing to enhance face expression perception in both younger (e.g., 
Benson et al., 1999; Calder et al., 2000) and older adults (Kumfor et al., 2011, 2013) this 
thesis will also conduct the first experimental study to examine if caricaturing improves 
expression perception in people living with AMD.  
 
2.6 Summary and links to the present thesis 
This review has highlighted the broad impact AMD has across multiple domains 
including vision, face perception (focusing on face identity and face expression), social 
interactions, quality of life and psychological wellbeing. Not only is the impact of AMD 
wide-reaching, it is also complex due to relationships between vision status, everyday 
functioning and self-reporting difficulties.   
With the aim of improving the quality of life in AMD patients, this thesis will 
specifically address two key issues. It will for the first time in AMD, examine the importance 
of reduced face perception on social interactions and quality of life. The findings from this 
qualitative study will be used to develop new community resources for AMD patients and 
their family, friends, carers and health professionals, to provide better awareness and 
understanding of poor face perception in AMD.   
Once the importance of face perception has been established in the first part of this 
thesis, the second part will aim to improve quality of life in AMD patients by enhancing face 
perception (for both identity perception and expression recognition) via caricaturing. 
Previous enhancement methods in AMD patients including magnification and spatial 
frequency manipulations have showed minimal benefits due to limitations associated with the 
effectiveness and practicality of these techniques (Johnson et al., 2017; Peli et al., 1989, 
1991, 1994; Tejeria et al., 2002). This thesis will conduct the first experimental studies to 
examine if caricaturing enhances face perception in AMD patients.  
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Chapter 3: Impacts of impaired face perception on social 
interactions and quality of life in age-related macular 
degeneration: A qualitative study and new community resources  
 
3.1 Chapter overview   
The purpose of this chapter is twofold. First, it is the first study to comprehensively 
examine via a qualitative approach how impaired face perception impacts social interactions 
and quality of life in AMD. The second purpose of Chapter 3 was to use the findings from the 
qualitative study to develop new community resources to potentially improve awareness, 
understanding, social interactions and quality of life for people living with AMD.   
 
3.2 Publication status  
This manuscript has been submitted as follows: 
 
Lane, J., Rohan, E. M. F, Sabeti, F., Essex, R. W., Maddess, T., Dawel, A., Robbins, R. A., 
Barnes, N., He, X., & McKone, E. Impacts of impaired face perception on social 
interactions and quality of life in age-related macular degeneration: A qualitative 
study and new community resources. Submitted to PLoS One (under review).  
 
3.3 Author contributions  
 Lane and McKone proposed the project with contributions from Barnes and He. 
 Lane and McKone prepared the ethics documentation and obtained ethics approval. 
 Lane recruited all patients with the assistance of Essex, the Macular Disease 
Foundation Australia and ABC radio.  
 Lane and McKone developed the qualitative interviews. 
 Lane administered quantitative measures.  
 Lane conducted and transcribed all interviews.  
 Lane, McKone, Dawel and Robbins performed preliminary data coding with final 
coding by Lane and McKone. 
 Rohan performed all vision assessments and consulted with Essex, Sabeti and 
Maddess regarding diagnosis. 
 Lane and McKone performed data extraction and statistical analyses.  
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 Lane drafted the manuscript. 
 Lane and McKone together refined the paper, with detailed editing provided by 
McKone and general content comments and editing by Maddess, Essex, Sabeti, 
Rohan, He, Dawel and Robbins.  
 For the community resources, Mr Rob Cummins and Anthony Lehner from the 
Macular Disease Foundation Australia provided feedback on content and formatting.  
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3.4 Submitted manuscript: Impacts of impaired face perception on social 
interactions and quality of life in age-related macular degeneration: A 
qualitative study and new community resources  
 
3.4.1 Abstract 
Aims: Previous studies and community information about everyday difficulties in age-related 
macular degeneration (AMD) have focussed on domains such as reading and driving. Here, 
we provide the first in-depth examination of how impaired face perception impacts social 
interactions and quality of life in AMD. We also develop a Faces and Social Life in AMD 
brochure and information sheet, plus accompanying conversation starter, aimed at AMD 
patients and those who interact with them (family, friends, nursing home staff).  
Method: Semi-structured face-to-face interviews were conducted with 21 AMD patients 
covering the full range from mild vision loss to legally blind. Thematic analysis was used to 
explore the range of patient experiences.   
Results: Patients reported faces appeared blurred and/or distorted. They described recurrent 
failures to recognise others' identity, facial expressions and emotional states, plus failures of 
alternative non-face strategies (e.g., hairstyle, voice). They reported failures to follow social 
nuances (e.g., to pick up that someone was joking), and feelings of missing out ('I can't join 
in'). Concern about offending others (e.g., by unintentionally ignoring them) was common, as 
were concerns of appearing fraudulent ('Other people don't understand'). Many reported 
social disengagement. Many reported specifically face-perception-related reductions in social 
life, confidence, and quality of life. All effects were observed even with only mild vision 
loss. Patients endorsed the value of our Faces and Social Life in AMD Information Sheet, 
developed from the interview results, and supported future technological assistance (digital 
image enhancement).  
Conclusion: Poor face perception in AMD is an important domain contributing to impaired 
social interactions and quality of life. This domain should be directly assessed in quantitative 
quality of life measures, and in resources designed to improve community understanding. The 
identity-related social difficulties mirror those in prosopagnosia, of cortical rather than retinal 
origin, implying findings may generalise to all low-vision disorders.  
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3.4.2 Introduction 
 Age-related macular degeneration (AMD) is a progressive disease that causes central 
vision loss and reduced visual acuity [1]. AMD impairs many aspects of everyday 
functioning and independent life, such as ability to drive, read, and cook for oneself [2-3]. 
Previous research into reduced quality of life in AMD has focussed primarily on these areas 
of everyday function, without considering specifically the effects of poor face perception [4-
9]. For example, the major quantitative questionnaire designed to assess macular-
degeneration-related change in quality of life (the MacDQoL) [10] has no questions about 
face perception while including questions targeting multiple other domains (e.g., ability to 
engage in hobbies, self-care, or shopping); and its questions related to interactions with other 
people do not disentangle problems caused by face perception difficulties from problems 
caused by other aspects of AMD (e.g., inability to maintain a social life outside the home due 
to loss of driver's license). Similarly, the websites of national and international macular 
disease support organisations, to which patients may be referred by medical staff, provide 
information sheets and videos that focus on issues such as driving, reading and maintaining 
independence. These websites commonly show an image of a social scene with a central face 
blotted out by a black blob to illustrate the (supposed) effects of AMD on vision (e.g., 
https://ghr.nlm.nih.gov/art/large/age-related-macular-degeneration.png, accessed 28 March 
2018), yet overlook the intricacies of potential difficulties with face perception and resulting 
problems with social interactions. These sites also do not address when in the course of 
macular disease progression a patient might begin to experience face-related social 
difficulties (e.g., in early stage AMD with mild vision loss, or only in late stage AMD with 
severe vision loss). 
 The implicit assumption in these previous approaches is that face perception problems 
in AMD are of relatively minor importance to patients' everyday lives. The present study was 
designed to provide the first evaluation of whether this assumption is true, via an in-depth 
exploration of the types of face-related experiences patients report in a qualitative interview. 
 There are several reasons to believe that, in fact, the functional importance of face 
perception problems in AMD might be high. First, it is well established that AMD impairs 
the ability to recognise the identity of faces and to see facial expressions, both in self-reports 
and formal laboratory testing [11-15]. Problems are particularly likely for faces seen small or 
in the distance, although can also occur even when the face is near (e.g., sized as during a 
natural conversation with an individual 1-2 metres away; e.g., [14,15]). 
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 Second, there is strong evidence that poor face identity recognition is associated with 
negative psychosocial outcomes. Across the normal population range of young adults, poorer 
face identity recognition ability is correlated with increased social anxiety [16]. In 
prosopagnosia — a disorder in which face identity recognition is clinically impaired but at 
the brain rather than retinal level — social interactions, confidence, and quality of life can be 
severely affected. In a qualitative study of these effects, Yardley et al. [17] found all 25 
participants described recurrent and at times traumatic social interaction difficulties, 
including: common failures to recognise family members, close friends, and work colleagues, 
which contributed to concerns about offending others, plus feelings of embarrassment, guilt 
and failure; particular social difficulties in groups due to not knowing who everyone was; 
resulting fear of and sometimes avoidance of social situations; dependence on others to help 
identify people; and long-term consequences that included a small social circle, damaged 
personal relationships (e.g., due to unintentionally ignoring a friend in the street), and 
reduced self-confidence. In low vision, there are no detailed studies of AMD patients, 
although the literature does contain a handful of quotes, from patients with a mix of eye 
diseases, suggesting similar face-identity-related social problems might occur (e.g., feeling 
embarrassed when not recognising others) [6,8].   
 Third, accurate face expression recognition is also important for normal social 
interactions. People use others’ facial expressions to judge how they are feeling (e.g., happy, 
angry), the intended meaning of their words (e.g., if they are serious or making a joke), 
whether they are engaged by the conversation or bored, and, ultimately, to decide how to 
respond [18]. Expressions also play a broader role in sending social signals (e.g., that a child 
genuinely needs help when displaying genuine sadness, or is merely pretending when 
displaying posed sadness), and misperceptions of such signals can lead to inappropriate social 
responses [19]. In low vision, again there are no previous studies that have examined 
expression-related social difficulties in any detail, in AMD or any vision disorders.  
 The present study explores the psychosocial impact of face perception difficulties in 
AMD, focussing primarily on problems arising from identity and expression recognition 
failures. We ask whether AMD patients might suffer the same identity-related difficulties in 
social interactions as seen in prosopagnosia. We also explore whether expression perception 
difficulties might result in additional problems, such as misinterpretations in social 
interactions. We also ask patients specifically about the importance of face perception to 
them, and explore whether face perception problems in particular — rather than all the other 
difficulties of living with AMD — impact their confidence, willingness to engage socially, 
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and quality of life. Other topics we address in briefer form include: how faces appear to 
people with AMD (surprisingly, not a question that appears to have been previously 
investigated); whether patients attempt to use alternative non-face-based strategies for 
recognising people and emotions (e.g., voice, gait, body shape, hairstyle) and whether these 
are effective; problems with eye gaze and with facial cues to speech; and patient views on the 
potential value of technological help for improving face perception (e.g., smart glasses that 
could enhance face images to make them easier to recognise). Finally, we explore the 
questions of whether patients feel people around them understand their face-related vision 
difficulties, as relevant to the potential need for, and content of, community resources 
specifically focusing on face-related social difficulties.  
 Given the lack of any previous detailed information from AMD patients on how face 
perception affects their social interactions and quality of life, the appropriate methodology for 
a first investigation is qualitative, not quantitative. (Indeed, creating a valid quantitative 
measure to assess frequency and severity of problems cannot be done without first 
discovering the types of problems that patients experience [20]). We used interviews that 
were semi-structured and open ended. Questions were partly a priori (e.g., designed to 
examine similarity to previous findings concerning social effects of poor face identity 
recognition in prosopagnosia) but the study was also to a large extent exploratory. Thus, 
interviews included a mix of: questions asked directly of all patients; follow-up questions 
asked of some patients and not others depending on their previous responses; and 
spontaneous comments from patients.  
 Overall, our aim was to capture the range of experiences reported by AMD patients 
concerning the type and impact of their face recognition difficulties in everyday life. A key 
aspect of this was selecting patients to cover a wide range of vision loss — from very mild 
(e.g., still driving) to severe (legally blind) — to allow us to capture any phenomena that 
might be reported only by individuals at one end of this range. For example, perhaps it might 
be that only people with moderate or severe vision loss due to AMD report face perception 
problems that are bad enough to impact their social interactions and quality of life. Or, it 
might be that only people with mild vision loss report that others fail to understand their 
problems seeing faces.  
 We also included some standard quantitative questionnaires. These allowed us to 
more completely describe the sample (e.g., their depression and anxiety levels), and to allow 
replication of expected findings, including that self-reported everyday visual function should 
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decrease with worsening visual acuity [13,21] and that AMD should be associated with a 
reduction in quality of life on the MacDQoL [22]).   
 In the second part of this article, we use the interview results to develop a community-
targeted Faces and Social Life in AMD Information Sheet. A good understanding by others 
can potentially improve patients' quality of life by, for example, increasing empathy for the 
person living with AMD, allowing others to provide suitable practical help to assist social 
interactions, and decreasing the likelihood of others taking offence (e.g., if the person with 
AMD appears to ignore them or misunderstands their social cues). The information sheet is 
designed for AMD patients, family members, friends, and carers including, for example, 
nursing home staff. The wording style is aimed at the general public, that is, suitable for 
readers without medical or scientific expertise. It may also be of some value to medical 
professionals (e.g. ophthalmologists who wish to better understand the patient experience) or 
clinical psychologists and counsellors (e.g., if treating a person with AMD for depression or 
anxiety associated with social withdrawal). To accompany the information sheet, we provide 
a Conversation Starter, that guides family/friends/carers through a series of face perception 
questions they can ask the person living with AMD, to gain a better understanding of that 
particular person's day-to-day social experiences, and how the carer can best help them. 
Finally, we also provide a 1-page brochure, suitable to be given to patients in vision clinics 
(e.g., by orthoptists), which include large-print information on a few key points and the web 
addresses at which the patient or family can find the Information Sheet and Conversation 
Starter. These new community materials are made available in Supplement S1.  
 
3.4.3 Method 
3.4.3.1 Participants 
Participants were N = 21 AMD patients (all Caucasian; 16 female, 5 male; age M = 
83.5 years, SD = 7.3, range = 66 to 92). To be eligible to participate, patients had to: (a) be 
diagnosed by a qualified ophthalmologist as having AMD in both eyes and no other eye 
diseases (to ensure any vision-related problems were attributable specifically to AMD; note 
non-visually significant lens opacity was permitted); and (b) not have dementia (patients who 
disclosed a diagnosis of dementia during recruitment were not invited to participate, and all 
tested participants demonstrated normal levels of cognitive functioning during interview). 
Additionally, (c) patients had to report, on initial contact, experiencing difficulties seeing 
faces in their everyday life: while all patients with moderate and severe vision loss would be 
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expected to experience face perception problems [11-15], early-stage AMD patients might 
not and, it is necessary for patients to report face perception problems to then interview them 
about the effects of those problems on social interactions and quality of life (i.e., patients not 
yet experiencing face problems would add no data concerning our major aims).  
Participants were recruited until (a) we had covered a wide range of severity of vision 
loss from mild to legally blind (Table 1), and (b) saturation was reached in the qualitative 
interview results (i.e., no new experience types were being reported, the standard criterion for 
sufficient sample size in qualitative research, e.g., [23,34]). Patients were recruited through 
advertisement or individual approach from author JL, via: The Canberra Hospital Eye Clinic; 
a private ophthalmologist’s clinical rooms; local radio interview discussing the study; or 
letter from the Macular Disease Foundation Australia to AMD patients living in the Canberra 
region.  
Concerning demographics, the sample was generally middle-class and financially 
secure. For the 20 patients willing to answer financial questions, none disagreed with the 
statements “I have enough to pay my household bills” and “I have enough to pay for 
household repairs or help needed in the house”; only 4 disagreed with “I can afford to buy 
what I want”; 6 agreed with “I cannot afford to do things I would enjoy”. Regarding highest 
education level, 7 had a university qualification, 7 another tertiary qualification (e.g., 
certificate or apprenticeship), 5 secondary school and 2 primary school. Eighteen patients 
resided in their own house (8 still with a spouse), and 3 in assisted accommodation (e.g., 
nursing home). All reported regular contact and support from others (e.g., spouse, adult 
children, grandchildren, carers). Three participants were still driving.  
Most patients were tested across three sessions, lasting up to 2 hours each. They were 
not paid, beyond reimbursement of travel to the university. The research was conducted in 
accordance with the Declaration of Helsinki. Ethics approval was obtained from the Human 
Research Ethics Committees of Australian Capital Territory (ACT) Health (protocol 
ETH.10.13.291) and Australian National University (protocol 2013/386). Participants' written 
consent was obtained, following explanation of the study and possible consequences; this 
included specific consent for the qualitative interviews to be audio recorded, and for 
publication of de-identified quotes. 
 
3.4.3.2 Acuity, and criteria for mild, moderate and severe vision loss categories 
 Best Corrected Visual Acuity (BCVA) was measured by a qualified orthoptist using a 
retro-illuminated LogMAR chart mounted on a stand conforming to the ETDRS standard 
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format [25]. Vision loss categories were defined using BCVA cut-off values from the 
International Statistical Classification of Diseases and Related Health Problems 10th Revision 
[26]. Mild vision loss refers to BCVA poorer than 6/6 (normal vision), down to 6/18. 
Moderate refers to BCVA poorer than 6/18, down to 6/60. Severe refers to BCVA poorer 
than 6/60. To give concrete interpretation to the acuity values, in Australia, a standard driving 
licence requires BCVA better than 6/12, and 6/60 is legal blindness.  
 Patients were ranked (Table 1) and grouped based on best-eye visual acuity. This was 
on the grounds that AMD can affect the two eyes to different extents (in our sample, 
correlation between acuity in the two eyes was only r = .28), and it is functional acuity in the 
best eye which is likely to be the primary determiner of how well the patient can see faces in 
everyday life. This is because the brain preferentially attends to input from the eye providing 
the higher-quality input and tends to ignore input from an eye providing lower-resolution 
input; see evidence from amblyopia [27], or after laser surgery where the two eyes are given 
different corrections for close and far viewing [28]. Supplement S2 provides: detailed 
information about both eyes (including BCVA, low contrast visual acuity LCVA, AMD type 
and stage); details of full vision assessments; and evidence that best-eye BCVA was indeed 
the most appropriate measure on which to rank patients' everyday vision ability.  
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Table 1. Individual patient details, with patients ordered by acuity (BCVA) in their best 
eye1. 
Patient code & 
vision loss 
category 
Age  
in years 
Sex 2 Best Eye     Best Eye Visual Acuity 
BCVA                 LCVA  
Best Eye 
Diagnosis 
Mild  
(<6/6 to 6/18) 
      
P1 85 F R 6/7.5 6/15 Dry AMD 
P2 91 (93) 3 F L 6/9.5 6/19 Wet AMD 
P3 86 F R 6/12 6/30 Dry AMD 
P4 70 F R 6/12 6/19 Wet AMD 
P5 78 (78) F L 6/15 6/38 Wet AMD 
P6 87 F R 6/15 6/30 Wet AMD 
P7 86 F L 6/15 6/60 Dry AMD 
P8 86 F R 6/15 6/60 Early AMD 
Moderate 
(<6/18 to 6/60) 
      
P9 4 73 F R 6/19 6/30 Wet AMD 
P10 79 M R 6/19 6/48 Dry AMD 
P11 88 M L 6/19 6/48 Wet AMD 
P12 92 F L 6/24 6/38 Early AMD 
P13 66 (68) F L 6/24 6/60 Wet AMD 
P14 82 M R 6/38 6/48 Wet AMD 
P15 84 F L 6/38 6/60 Wet AMD 
P16 78 M L 6/60 6/95 Dry AMD 
Severe (<6/60)       
P17 4 89 F R <6/60 5 – Wet AMD 
P18 82 F R 6/75 6/150 Dry AMD 
P19 92 (94) F L 6/75 6/120 Wet AMD   
P20 90 M L 6/75 6/190 Wet AMD 
P21 91 F L 6/190 <6/240 6 End-stage AMD 
Notes:  
1 Additional vision testing data, plus information for the other eye, in Supplement S2 (Table S1).  
2 Codes:  M = male, F = female; L = left eye (i.e., OS, ocular sinister), R = right eye (i.e., OD, oculus dextrus); 
BCVA = Best Corrected Visual Acuity (high contrast letter stimuli), LCVA = Low Contrast Visual Acuity; "<" 
= worse than. 
3 For the 4 participants with more than 6 months between interviews, age value in brackets gives the age at time 
of second interview. Table S1 provides acuity results on repeat test at time of second interview. None of the 4 
participants' vision had degraded sufficiently to change them into a more severe vision loss category. 
4 Participants P9 and P17 did not do the second interview due to ill health.   
5 P17 did not have a vision assessment at the ANU and her visual acuity (BCVA only) was reported by her 
ophthalmologist. For correlations (Table 2) her BCVA value was entered as 6/60 or logMAR +1.0. 
6 LCVA listed as <6/240 indicates the patient could not read all letters on the largest line of the LCVA chart.  
 
3.4.3.3 Quantitative questionnaires: Everyday visual function, and psychological wellbeing  
 Overall level of everyday visual function was assessed using the National Eye 
Institute Visual Functioning Questionnaire (NEI-VFQ-25; Interviewer Administered Format 
plus appendix [21]). State (i.e., current) level of depression and anxiety were assessed using 
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scales validated for elderly participants: the Geriatric Depression Scale-15; GDS-15 [29], and 
the Geriatric Anxiety Inventory; GAI [30]. AMD-related change in quality of life was 
assessed using the Macular Degeneration Quality of Life Questionnaire; MacDQoL [10], this 
instrument uses patients' ratings across multiple domains (e.g., ability to engage in hobbies, 
household tasks, travel outside the house, shopping, perform self-care) of how their life 
would change if they did not have AMD (but everything else in their life remained the same) 
multiplied by their rating of the importance of that domain to them. All questionnaires were 
administered verbally.  
 
3.4.3.4 Qualitative interviews  
Interviews were one-on-one. They were conducted at the ANU, the patient's place of 
residence, or (in a few cases) on the telephone. Each patient took part in one, or both, of two 
interviews, each lasting 30-45 minutes. 
To explore the range of patient experiences, Interview 1 (all 21 patients) was semi-
structured and open ended. The initial questions asked directly of all patients are listed in 
Supplement S3. Supplement S4 gives examples of participants’ very different responses to a 
given initial question, and the corresponding variation in follow-up questions. Topics 
addressed were those described in the Introduction.  
Interview 2 (19 patients, see Table 1) was primarily concerned with obtaining patient 
feedback on material for potential inclusion in our Faces and Social Life in AMD Information 
Sheet. We drafted a list of possible facts and statements, based on findings after testing most 
patients on Interview 1. We then asked patients in Interview 2 whether they did or did not 
endorse each fact/statement as useful to include in the Information Sheet, and to provide 
comments as needed (e.g., where they thought clarification or qualification was needed). In 
some cases, Interview 2 also revealed additional patient experiences, and/or included 
additional follow-up and clarification questions arising from their Interview 1 responses. 
Time delay between Interviews 1 and 2 ranged from same-day testing up to 2 years; vision 
assessment was repeated for the 4 patients with longer than 6 months delay (with none having 
moved to a more severe vision loss category across the delay; see Supplementary Table S1). 
 
3.4.3.5 Interview data coding 
 Interviews were transcribed verbatim, combined across Interviews 1 and 2, and 
entered into NVivo software (QSR International Pty Ltd, Version 10, 2015) to assist with 
data collation. Patient experiences from the transcripts were coded into themes [31], using a 
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mix of a bottom-up (inductive) and top-down (theoretical) approaches. For bottom-up 
analysis, three authors independently read 6 interviews (3 from Interview 1 and 3 from 
Interview 2) from patients spread across the three AMD severity levels, and extracted 
emergent themes relevant to the present research questions (i.e., content related to face 
perception and/or its effect on social interactions and quality of life); coding strategies 
between authors were reviewed, and themes chosen were based on consensus negotiation 
[32]. Themes were also redefined (e.g., two sub-themes combined), and additional themes 
were developed, in a top-down manner, to ensure adequate coverage of all the specific topics 
we wished to address (e.g., emotion perception; technology preferences), and to allow 
comparison to previous findings in the literature (e.g., whether AMD patients experience the 
same types of identity-related social-interaction problems reported in prosopagnosia). JL then 
coded the interview transcripts from each patient into the final themes, including whether the 
patient had experienced that type of phenomenon or not, together with the piece/s of quoted 
text relevant to that experience. EM cross-checked the coding, with discrepancies resolved 
via negotiation. In addition to the initial coding of full interview transcripts to themes, 
multiple text search queries were conducted for each theme to avoid missing any data.     
 
3.4.4 Results 
3.4.4.1 Quantitative measures of visual function and psychological wellbeing 
 Table 2 presents sample-descriptive results for quantitative scales, including across 
our full patient sample, and subgroup means for patients with mild, moderate and severe 
vision loss (ICD-10 criteria [26] as used in Table 1). Table 2 also shows correlations with 
acuity (best-eye BCVA from Table 1, converted to logMAR; note higher logMAR scores 
indicate poorer vision).  
 As expected, Table 2 demonstrates impairment in self-reported everyday visual 
function. All individual patients reported meaningful everyday impairment on the NEI-FVQ 
(highest score = 66 where 100 is no impairment). Self-reported NEI-VFQ function correlated 
significantly with objective vision level, with function worsening with worsening acuity 
(significant negative correlation with BCVA). We also found impairments specifically on the 
two NEI-VFQ items that are relevant to face perception (Question A6 ‘because of your 
eyesight, how much difficulty do you have recognizing people you know from across a 
room?’; and Question 11 ‘because of your eyesight, how much difficulty do you have seeing 
how people react to things you say?’). Mean scores for both items were well below the no 
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impairment level, and every patient indicated impairment on the identity and/or the 
expression question (i.e., the highest scores of 100 indicated in the range data in Table 2 
came from different patients). Both face-relevant items showed correlations with objective 
acuity that were in the predicted direction, significantly so in the case of the face-identity-
related item (Question A6).  
 For psychological wellbeing measures, Table 2 shows worsening acuity correlated 
significantly with increasing anxiety. Depression did not correlate linearly with worsening 
acuity (a finding consistent with evidence of psychological adjustment to chronic disease 
[33]). Results for the MacDQoL showed a sizeable AMD-associated reduction in quality of 
life on average (i.e., mean score of –3.9 where 0 is no impact), with a close-to-significant 
correlation between worsening acuity and greater AMD-associated reduction. Note there are 
no face-related-item data provided for the MacDQoL in Table 2 because the measure 
includes no items from the face domain.   
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Table 2. Patient results and comparison values for quantitative questionnaires. 
Measure Scale comparison values All patients 
N=21 
M(SD)[range] 
Correlation 
with acuity 
(best-eye 
BCVA) (r) 7 
Means for vision loss 
subgroups 8 
Mild      Mod    Severe 
 n=8        n=8       n=5 
Everyday Visual Function 
   NEI-VFQ-25 (full scale) 1  
 
100 = no difficulty 
0 = maximum difficulty 
 
46.9(12.1) 
[22.2-69.8] 
 
–.47* 
 
50.0 
 
48.4 
 
39.5 
   Item A6 (face identity) 2 100 = no difficulty 
0 = maximum difficulty 
32.1(26.4) 
[0-100] 
–.58** 43.8 34.4 10.0 
   Item Q11 (expression) 3 100 = no difficulty 
0 = maximum difficulty 
55.6(32.7) 
[0-100] 
–.37 66.7 59.4 31.3 
Depression (GDS-15) 4 
 
0-4 = normal  
5-9 = mild depression 
10-15 = moderate to severe  
             depression  
4.5(2.7) 
[1-10] 
+.12 4.8 3.9 5.2 
Anxiety (GAI) 5 0 = minimum anxiety level 
≥ 11 indicates Generalised      
   Anxiety Disorder  
3.5(4.4) 
[0-14] 
+.45* 2.3 2.6 6.8 
Quality of Life (MacDQoL)  
AMD-related change 6 
+3 = improved QoL 
0 = no impact of AMD 
–9 = maximum reduction 
-3.9(1.7) 
[-0.8-(-6.6)] 
–.41† -3.7 -3.1 -5.4 
Notes:  
1 Composite score on NEI-VFQ-25 (National Eye Institute 25-Item Visual Functioning Questionnaire 
Interviewer Administered Format plus Appendix) is the average of the vision-targeted subscale scores, 
excluding the general health rating question [21]. 
2 NEI-VFQ-25 Item A6 = ‘Because of your eyesight, how much difficulty do you have recognizing people you 
know from across a room?’,  
3 NEI-VFQ-25 Item Q11 = ‘Because of your eyesight, how much difficulty do you have seeing how people react 
to things you say?’ For this question N = 18 as three patients did not answer (P6 and P18 said they did not know 
and P7 said it depends on distance). 
4 Cut-offs from [34], GDS [29].  
5 Cut-off to identify Generalised Anxiety Disorder in older adults from [30].  
6 MacDQoL [10] measures macular-degeneration-associated change in quality of life (QoL), assessed across 23 
domains. Scores are weighted impact score, calculated by multiplying patients' rating for AMD-change (–3 = 
maximum reduction in ability in that domain to +1 = improvement) by their rating of importance of that domain 
to them (0 to 3), and averaging across the 23 items (or fewer if a domain did not apply to patient, e.g., work). 
7 Correlation directions (with acuity expressed as logMAR) are such that worsening visual acuity is associated 
with worse everyday visual function (negative r), increasing anxiety and depression (positive r), and poorer 
quality of life (negative r). For comparison of correlation to zero (two-tailed): ** = p<.01; * = p<.05; † = p<.07 
8 Mild, moderate and severe vision loss groups, defined by best eye high-contrast visual acuity (BCVA, Table 1) 
using ICD-10 criteria [26] (see Method). 
 
3.4.4.2 Qualitative experience of AMD patients  
To illustrate the range of experiences patients reported in the interviews, we use a mix 
of quotes (from which irrelevant information has been removed, and any names changed) and 
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tables containing the percentage of patients reporting certain experiences. These percentages 
are minimum values in many cases (marked with a '+' in Tables 3-7); this is because, in a 
semi-structured interview procedure, not all patients are necessarily asked directly about all 
experience types, meaning additional participants within our sample may have endorsed the 
experience if explicitly asked about it. Our reason for reporting concrete numbers at all — 
which is unusual in a qualitative interview study — is to provide information on whether a 
given difficulty was reported, say, only by patients with severe vision loss, or also reported 
by patients with mild vision loss.  
 
3.4.4.3 Difficulties seeing faces, facial appearance, and variability in face perception 
Table 3 collates reports of difficulties seeing faces. Results show that all patients, 
regardless of their residual visual acuity, reported their vision loss had made it harder to see 
faces. Problems were described as particularly acute at longer distances (e.g., across a room; 
also see the NEI-VFQ results in Table 2), but nearly half of patients reported having 
problems seeing faces clearly even at conversational distances (1-2 metres), including three 
mild patients.   
Concerning how faces appear visually to people with AMD, Table 3 shows three-
quarters of patients spontaneously mentioned one or more ways in which faces no longer 
looked normal. The most common aspect mentioned was that faces appeared blurred (or 
equivalent terms such as ‘unclear’, or ‘low-definition’). This blur meant that patients could 
not always see internal features clearly. For example, one patient described the interviewer, 
sitting less than 2 metres away, as having ‘two holes for the eyes’ (P1; mild). Additionally, 
nearly a third of patients mentioned seeing shape distortions and missing parts in the face. 
The nature of these varied: one patient said ‘The distortion is quite bad … on one side the 
mouth goes up and the eyes keep disappearing … or looks blurred and moving a bit’ (P2; 
mild); another said the ‘features are kind of deformed, jumbled ... it’s as if the face were on a 
piece of sheeting or something and somebody grabbed it from behind and pulled it like that 
[simulating a sheet being grabbed] and it just went all scrunched up’ (P9; moderate); another 
said ‘I can see the right hand side of you … not the left’ (P19; severe). One third of patients 
also reported other general visual disturbances (e.g., black flecks, lights and floaters) that 
would impact on the appearance of faces. Three patients mentioned seeing a black blob in the 
centre of their vision (a common illustration of the supposed perceptual effects of AMD; see 
Discussion), while one patient (P18; severe) specifically said they did not experience a black 
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blob in the centre, instead describing their experience as like ‘looking through a screen’ or 
‘looking through black tulle’. 
Table 3 also shows that many patients mentioned variability and inconsistency in how 
well they could see faces. Lighting was reported as a relevant factor by most (e.g., one 
example was that it was harder to recognise faces with the light behind them). Eleven patients 
said they prefer strong lighting, with faces harder to see in lower light levels. Three said the 
opposite, namely that they are light sensitive and prefer low lighting. Two said their light 
preference varies, i.e., sometimes they require strong light and other times they are light 
sensitive. One of these latter patients commented ‘This is one of my husband’s big bug bears, 
because he just can’t understand why one minute I want light and the next minute I don’t’ 
(P13; moderate). Some patients identified other factors associated with variability in how 
well they can see faces, including time of day (e.g., improvement as the day goes on), and 
treatment phase (i.e., pre/post injection if being treated with ranibizumab for Wet AMD). One 
patient said: ‘Sometimes I can see, sometimes I can’t’ (P19; severe). 
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Table 3. Difficulties seeing faces in AMD, how faces appear to patients, and problems 
with face identity and expression recognition. 
 % of Patients Reporting this Experience  
('+' indicates minimum value, i.e., not all patients 
asked directly about the experience) 
Description of Experience   Mild 1 
  (n=8) 
Moderate 
(n=8) 
  Severe 
  (n=5) 
  Total 
  (N=21) 
Difficult to see faces     
AMD has made it harder to see faces  100 100 100 100 
Unable to see faces properly even at close 
  (conversational) distances (e.g., 1-2 metres) 
  38+   50+   60+   48+ 
Faces are hard to see on TV  50  88  80  71 
How faces appear     
Faces appear abnormal in some way:   50+   100+   80+   76+ 
  - Faces appear blurred   50+   88+   80+   71+ 
  - Faces appear distorted/have missing parts   13+   38+   40+   29+ 
  - Other experiences (e.g. central black blob; black flecks)   25+   25+   60+   33+ 
Variability in seeing faces   88+   88+   80+   86+ 
Impacted by lighting   88+   88+   60+   81+ 
Other factors (e.g., varies with time of day)   50+   50+   60+   52+ 
Specific problems with facial identity & expression     
Problems recognising facial expressions 100 100 100 100 
Problems recognising face identity 100 100 100 100 
  - failing to recognise people you know (false negatives)   88+   88+   100   91+ 
  - ‘recognising’ people you don’t know (false positives)   50+   88+   80+   71+ 
Notes:   
1 Mild, moderate and severe vision loss groups, defined by best eye high-contrast visual acuity (BCVA, Table 1) 
using ICD-10 criteria [26] (see Method). 
 
3.4.4.4 Difficulties with face identity and expression recognition 
Table 3 shows that all patients reported their difficulties seeing faces resulted in 
problems recognising both face identity (who other people are) and facial expression. 
Importantly, the problems were not limited to those with moderate and severe vision loss, but 
also occurred in mild vision loss.  
For facial identity, both false negatives and positives were common. Almost all 
patients had experienced problems recognising people they know (false negatives). This 
included reports of failing to recognise good friends and close family members. Problems 
occurred even with mild vision loss, for example ‘I have had it happen, it’s very 
embarrassing ... the other day I didn’t even recognise my son ... within a yard or two of me 
and I didn’t recognise him, he said “Mum, it’s David!”’ (P2; mild). In general, patients with 
more severe vision loss reported such failures occurring more frequently. When asked ‘Do 
you find that you fail to recognise people you know?’, responses included ‘Oh all the time 
(P18; severe)’, and ‘I would pass people by in the street that I know very well. It’s very 
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embarrassing ... they’ve said to me “hey Mary how are you?”  ... I would not have a clue ... I 
don’t mean to be rude but I just can’t see them’ (P21; severe). 
Many patients also reported falsely ‘recognising’ people they did not actually know 
(false positives), such as approaching a person to say hello thinking they were a friend, only 
to find they were a stranger. When asked ‘Have you said hello to someone thinking it was 
someone you knew, and it actually wasn’t?’ example responses included ‘Yes and it’s not 
them at all. It’s someone totally different, yes, that becomes a bit embarrassing’ (P19; 
severe), and ‘Yes [laughs] … Someone I knew very well, I went up and started having a 
conversation with them and they looked at me blankly. And you know when I was closer: 
“yeah, you’re not who I thought you were”. I apologised to them, but what they thought, I 
don’t know’ (P14; moderate). These experiences of false positives and negatives in everyday 
life closely match quotes describing identity-related failures in prosopagnosia [17,35].  
Turning to facial expressions, comments suggested expression perception was even 
more severely affected by AMD, earlier in the progression of the disease, than identity 
recognition. When asked: Has AMD impacted your ability to see a person’s facial 
expressions? example responses were: ‘Yes, I think that was one of the first things that went, 
not actually see the expression’ (P5; mild), and ‘As far as expressions go, that’s something 
that’s gone’ (P16; moderate), and ‘Well you don’t get facial expressions with this disease’ 
(P18; severe). 
 
3.4.4.5 Alternative non-face-based strategies, and their effectiveness 
Problems identifying faces and recognising facial expressions would not have serious 
implications for social interactions if AMD patients were able to use other strategies to 
successfully recognise people and their emotions. However, this was commonly not the case.  
Table 4 lists various alternative strategies that patients reported trying to use (not 
necessarily successfully). For identity recognition, the most common visual strategy 
mentioned was using body shape/size followed by walk/gait, hair/hairstyle and clothing. 
Patients also reported two nonvisual strategies, voice recognition and context. Context was 
identified as both a help ‘When it’s a normal meeting it’s not so bad because most of them sit 
on the same tables’ (P20; severe) and a hindrance (when people are seen out of their usual 
context or when the patient was expecting someone else). Most patients reported using 
multiple strategies simultaneously, for example ‘I look at the way people are walking … 
mainly their gait and their general appearance … maybe for the women I look at their hair … 
their hairstyles … their size and behaviour … and then of course if they speak it’s voice 
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recognition’ (P18; severe). These identity-related strategies were identical to those that 
prosopagnosics report trying to use [17,35,36].  For expression, the two main strategies 
reported for trying to understand other people's feelings and emotions were using body 
language (e.g., a sad or angry posture) and voice: ‘The tone of voice gives them away. Mostly 
it’s reflected in people’s voices whether they are in a happy mood or a grumpy mood’ (P11; 
moderate). A strategy used by many patients, relevant to both identity and expression, was 
proximity, i.e., moving closer to others, or waiting for others to approach to try to improve 
the clarity of the face. Overall, these alternative strategies involved either looking at visual 
information that survives low resolution vision relatively well (e.g., because the body is 
larger than the face, or because determining hair colour and length requires only coarse 
spatial information), or using nonvisual information (auditory cues, context). 
 
Table 4. Alternative strategies that AMD patients try to use, and their effectiveness. 
 % of Patients Reporting this Strategy  
('+' indicates minimum value, i.e., not all 
patients asked directly about the strategy) 
Description of Strategy Mild  
(n=8) 
Moderate 
(n=8) 
Severe 
(n=5) 
Total 
(N=21) 
Identity recognition (visual strategies):     
  Body shape/size   38+   75+   80+   62+ 
  Walk/gait   38+   63+   20+   43+ 
  Hair (colour, length, hairstyle)   13+   50+   60+   38+ 
  Clothing   25+   38+   20+   29+ 
Identity recognition (nonvisual strategies):     
  Voice 100   75+ 100   91+ 
  Context (expecting certain people in certain    
                 locations) 
  50+   25+ 100   52+ 
Expression/emotion recognition:     
  Body language   25+   38+   20+   29+ 
  Auditory cues to emotion (e.g., tone of voice,  
                 hearing laughter or crying) 
100   63+ 100   86+ 
Affecting both identity and expression:      
  Proximity (e.g., wait for person to come closer so  
                    patient can see their face more clearly) 
  63+ 100   40+   71+ 
Effectiveness of these strategies:     
  My strategies don't always work   25+   62+   80+   52+ 
Reliance on other people     
  Others help (e.g., tell me who is approaching)    75+   88+ 100   86+ 
 
Importantly, patients reported that the non-face-based strategies they tried were often 
ineffective. Table 4 shows half the patients reported their suite of strategies failed: for 
example, ‘I can make some terrible mistakes … [my strategies] help, they are certainly not 
fool-proof’ (P11; moderate), and ‘I’m not sure that [my strategies] are very effective at all’ 
(P1; mild). Moreover, even when patients initially described their strategies as ‘effective’, 
further interview responses revealed patients generally meant the strategies worked ‘most of 
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the time’ or ‘in some contexts’ (e.g., for close family members). Patients also reported factors 
that can impair the effectiveness of their strategies; these factors included crowds, how often 
they see the person (i.e., level of familiarity), and the fact that some strategies are unreliable 
due to changes in the environment. Environmental changes included a participant who 
misidentified her own husband because he had recently lost weight and his body shape had 
changed (P13; moderate), and another who said ‘One of the ladies at church had long curly 
hair and she got it all chopped off and I didn’t have a clue who she was until she spoke’ (P14; 
moderate). Finally, the effectiveness of alternative strategies appears to decrease (Table 4) as 
AMD severity level increased. This may be because visual cues that survive mild loss of 
visual acuity well (e.g., body shape) become too blurred to be useful in moderate-to-severe 
AMD. 
The failure of AMD patients' alternative strategies meant they often reported being 
reliant on other people for assistance. In total, 86% of patients reported others helped 
sometimes, by naming the person aloud (e.g., ‘here comes Bill’ or ‘James is sitting at the 
back of the room with his wife’) or describing emotions (e.g., ‘Mary looks sad today’ or ‘Jan 
was smiling when she said that Mum’). Additionally, however, 7 patients reported that they 
would appreciate more help of this kind. 
 
3.4.4.6 Difficulties with, and changes to, social interactions 
Table 5 collates patient responses concerning the ways in which their face perception 
problems alter their immediate social interactions.  
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Table 5. Difficulties with, and changes to, social interactions arising from poor face 
perception. 
 % of Patients Reporting or Endorsing 
this Experience  
('+' indicates minimum value, i.e., not all 
patients asked directly about the 
experience) 
Description of Experience   Mild 
  (n=8) 
Mod 
(n=8) 
 Severe 
  (n=5) 
  Total 
  (N=21) 
Identity domain     
- "Some people with AMD may appear disengaged, this may be 
because they cannot see who is in a room." (N=15)  
100 100 100 100 
 
- When I don't recognise others, I worry they will think I’m rude or 
unfriendly  
  50+   63+   60+   57+ 
- To avoid false recognition of someone I don't actually know, I am 
cautious / hesitant / noncommittal (e.g., I don't say people's names, 
wait for them to speak first) 
  38+   25+   80+   43+ 
- To try to avoid giving offence to people I know by ignoring them, 
I'm indiscriminately friendly (e.g., I smile at everyone) 
  25+   25+    0+   19+ 
Expression domain     
- "People with AMD may be unable to see a person’s facial 
expressions i.e., whether someone looks happy, sad or bored. 
Because they cannot see facial expressions, they might miss social 
cues. For example, someone might be looking bored but the person 
with AMD can’t see this so they keep on talking, or a person might 
be just having a joke and is smiling when they say something, but 
the person with AMD takes it seriously." (N=16)  
  86 100 100   94 
 
- Patient gave specific example/s of above from their own 
experience 
  38+   50+   20+   38+ 
Face perception domains in combination     
- Social interactions are slowed or take more mental effort   63+   50+   80+   62+ 
- Particular difficulty in groups   38+   25+   40+    33+ 
Responses to mistakes     
-  I apologise   63+   38+   60+   52+ 
-  I explain I have vision loss (or wear a vision impaired badge)   88+   88+ 100   90+ 
-  I use humour (laugh it off)   25+   63+   60+    48+ 
-  I sometimes let it go/pretend there is no problem   75+   88+ 100   86+ 
-  I sometimes feel bad (embarrassed, frustrated, sad, upset)   100 100 100 100 
-  I worry what other people think of me and how they judge me   63+   88+   60+   71+ 
-  Others usually respond positively to my mistakes (e.g., humour, 
kindness, helpful) 
  50+   50+   60+   52+ 
-  Others can get angry/upset when I make mistakes   38+   25+   20+   29+ 
-  I sometimes can't tell how others respond (because I can't see 
their expressions) 
  50+   63+   40+   52+ 
Notes: For the two statements listed in quotes, a subset of patients (N=15, and N=16) were read these 
statements, as part of the pre-testing phase for the patient information sheet (within Interview 2), and asked 
whether they agreed with them. 
 
Identity recognition. In the identity domain, the social-interaction impacts reported by 
AMD patients were strikingly similar to those reported in prosopagnosia [17,35,36].  
First, patients experienced difficulties and disengagement in social situations, due to 
not knowing who was present. P16 (moderate) said: ‘I walk around the block and past the 
club. A lot of the times I walk in and see who’s in there. If anyone speaks to me I stop, have a 
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yarn to them for a while. But if nobody speaks to me I don’t stay, I just walk out again’. P17 
(severe) said: ‘I walk into the room of a morning and they’re all sitting there waiting to do 
yoga and I think “why can’t I see them?” ... someone might call out “Oh, hi Jenny” well, I 
don’t know where they are’. P12 (moderate) noted the need to rely on others to achieve social 
engagement: ‘the younger ones ... I was really pleased because they came looking for me to 
speak to me, whereas I wouldn’t have found them’. Concerning disengagement due to not 
knowing who was in the room (Table 5), P4 (mild) said ‘that sort of puts it in a nutshell 
actually’. 
Second, many patients were concerned about embarrassing themselves and/or 
offending others, and often changed their behaviour in attempts to avoid negative social 
interactions. To avoid the embarrassment of false-positive recognitions (i.e., saying hello to 
someone they did not know), many patients mentioned becoming more cautious, hesitant or 
noncommittal, and avoiding using names. P17 (severe) said ‘I wait until I am spoken to’. P9 
(moderate) said poor face recognition has made her ‘a bit more careful … a bit more 
tentative’. P18 (severe) said ‘I try now to discipline myself not to identify, not to say “oh this 
is my friend Jan”… I say non-committal things like “Hello how are you?”, not “I don’t 
believe we’ve met”’. 
 Concerning false negatives (i.e., failing to recognise familiar people), patients were 
very concerned about the impact on others. Most worried about appearing rude, unfriendly, or 
standoffish. P14 (moderate) said ‘I know I walk past people and ignore them because I don’t 
recognise them … I am sure that I upset people ... What they think of me I don’t know, it 
worries me’. P8 (mild) said others probably think she’s ‘snobby’. P15 (moderate) said she 
feels ‘embarrassed [about] cutting them dead [i.e., appearing to deliberately ignore them] or 
whatever they think’. P5 (mild) said ‘If you go out and you meet someone and have a 
conversation with them, and then the next time you meet them you don’t even recognise them, 
I imagine it would be unpleasant for the person ... you were getting on famously and then 
next time you wouldn’t recognise them. I would think I would hurt people’s feelings’. Two 
participants described situations where they directly knew they had offended another person. 
In the most extreme case, P18 (severe) reported ‘I go to craft on Sundays and this lady came 
in. She would usually come and talk to us, and then go over there and read the paper … 
Anyhow, on this occasion she didn’t come over and I didn’t know she was there ... I went over 
and got a glass of water and when I walked past her to come back she yelled, “You don’t 
even speak to me!”. She frightened the life out of me, I didn’t even know she was there, and I 
said to her, I am so sorry I didn’t even see you there because I’m vision impaired, you know 
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that. And anyhow, there was a bit of a discussion ... I was crying and I said I didn’t mean to 
ignore you’. 
As a way of dealing with concerns about failing to recognise familiar people, a few 
patients took the strategy of being indiscriminately friendly (e.g., smile at everyone) to avoid 
potentially offending anyone. For example, P8 (mild) said ‘I just smile at people because I 
think, well [laughs], I might know them’ and P13 (moderate) said ‘I just smile at everybody. 
There are probably people down the street who think “I wonder who that mad woman is who 
is smiling at me?” … [but] it is just easier … then you don’t offend anybody, and if you smile 
at someone and they do know you and they want to stop and speak to you then they will’. This 
contrasted with the tendency of most participants to be more cautious in their dealings with 
other people (to avoid false positives).  
This pattern is similar to that reported in prosopagnosia, where Yardley et al. [17] also 
found that in most participants the tendency is to become more cautious towards other 
people, while in a smaller subset the tendency is the opposite. Also note that patients' 
emotional responses to making mistakes in general varied: while all reported feeling bad 
about mistakes in some way (Table 5), not all patients reported they specifically felt 
embarrassed (replicating results in [15]). Example quotes included: ‘I don’t know about 
embarrassment, but it can be frustrating’ (P20; severe); ‘I haven’t felt the embarrassment one 
but the frustration is definitely there’ (P4; mild); ‘No, I don’t find embarrassment’ (P19; 
severe); and ‘Well, no I would never feel embarrassed’ (P18; severe).   
Expression perception. Other types of social difficulties reported by AMD patients 
can be related to problems specifically in expression perception. This includes failures to 
correctly understand others’ emotions, failures to understand what specific event had elicited 
an emotion, failures to pick up on whether others were joking or serious, inability to tell when 
others wished to speak to them or had got bored with their conversation and it was time to 
change topic, and/or worrying about whether they might be making these types of mistakes. 
Fifteen patients endorsed a statement describing that these types of problems can occur in 
AMD (Table 5), and eight gave examples. P9 (moderate) said ‘It can be a bit embarrassing if 
you don’t pick up correctly [that someone is sad], and just be happy and jolly, and that might 
not be appropriate at all’.  P5 (mild) said ‘With one doctor, I said to my daughter when we 
came out “Boy, he was a bit cranky wasn’t he, did I do something to upset him?” she said 
“No, he was just making a few jokes to try and break the ice”. But I thought, to me he 
sounded as if he was cranky and I couldn’t work it out. But my daughter said “No he was 
smiling”’.  
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One patient (P13; moderate) emphasised the normal social cues that had been lost 
with AMD: ‘[normally] if you’ve wounded someone’s feelings you can actually see, “oh I’ve 
hurt her” or “I shouldn’t’ve said that” or “I shouldn’t have said it the way I said it”. ... [Or] 
you can actually see that they are enjoying the conversation. ... whereas if you can’t see their 
face, you don’t have a clue’. Similarly, another said ‘I would never speak to anybody first 
now whereas I used to always, because I find if you speak to someone most times they’ll 
speak back to you, but I haven’t yet to learn to tell by their voice whether they're pleased that 
you are speaking to them or not so I don’t do it anymore’ (P5; mild).  
Inability to see rapid dynamic changes in expression also resulted in failures to 
understand what specific event had elicited an emotion. For example, P16 (moderate) said ‘If 
I am talking to people and someone there is laughing and carrying on, I know they are as 
happy as buggery [i.e., very happy], but I can’t see their face to see what, you know to see 
when their face changed’.  
 Multiple domains: slowing, difficulty in groups, eye gaze and facial speech. Other 
social difficulties reported by patients can arise from a combination of face perception 
problems across the domains of identity, expression, eye gaze and/or facial speech. 
Thirteen patients reported social interactions had become slower or required more 
mental effort. This could arise from many specific factors, for example: taking longer to 
realise who people are; the increased cognitive load of needing to remember who is sitting 
where in a group; having to 'work out' what caused someone to laugh rather than perceiving 
this directly. P11 (moderate) said his impaired face perception meant ‘I don’t interact 
quickly, I am now much slower in making decisions when talking to them’. P13 (moderate) 
said that during conversations ‘Sometimes when someone says something to you, you have to 
click your brain in to register what they are saying … I’m concentrating so hard on their face 
that sometimes words just go away’.   
Additionally, a third of participants raised the issue that social interactions can be 
particularly difficult in crowds or groups. For example, P20 (severe) said he found 
conversations hard to follow in groups, and P4 (mild) said ‘[Social situations] are very 
difficult particularly in a crowded room if you are at a function’. Theoretically, this finding is 
consistent with the fact that group situations pose the most challenging setting for face 
perception. That is, to fully engage in a group social interaction, one needs to be able to: 
rapidly identify all members of the group; pick up immediately on rapid changes of 
expression or emotion and what events these were in response to; use eye gaze cues to pick 
up on social signals such as when it might be your turn to speak or when the group's attention 
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has shifted elsewhere [37]; and potentially use facial speech cues to help understand what 
others are saying (particularly in a noisy environment [38]).  
Specifically concerning eye gaze and facial speech, Table 6 shows approximately half 
our patients mentioned problems relevant to these domains. For eye gaze, quotes suggested 
problems were particularly prevalent in group situations. For example, P16 (moderate) said 
‘If I’m sitting around talking to anyone in a circle or anything, I can’t see their eyes’ and P20 
(severe) said ‘Looking at someone at the other side of the table … I can’t see if they are 
looking at me [as opposed to someone else at the table]’. For using facial motion to help 
understand speech, P17 (severe) said ‘I can’t see the mouth at all, no way’, and P2 (mild) 
who had been trained in lip reading following partial hearing loss said her face-to-face 
conversations are ‘tied up with my lip reading, so very difficult’. 
 
Table 6. Other face problems: Eye gaze and facial speech. 
 % of Patients Reporting this Experience  
('+' indicates minimum value, i.e., not all 
patients asked directly about the experience) 
Description of Experience   Mild 
  (n=8) 
Moderate 
(n=8) 
  Severe 
  (n=5) 
  Total 
  (N=21) 
Problems with eye gaze 
  e.g., can't make eye contact; can't see where other people  
  are looking; can't see eyes 
  50+   38+   80+   52+ 
Problems with facial speech 
  e.g., AMD has made it harder to follow face-to-face  
  conversations but not phone conversations (ruling out a  
  hearing loss origin); can't lip read anymore (for patients  
  with previous lip-reading skill); can't see mouth 
  38+   63+   40+   48+ 
 
Responses to mistakes. Social interactions were also altered by the need to respond to 
mistakes. Where patients made explicit mistakes that were obvious to the person affected by 
the error (e.g., failing to recognise a familiar person, saying hello to a stranger, or failing to 
realise someone is upset), patients employed a variety of strategies for social repair. As 
shown in Table 5, they routinely apologise. Depending on the circumstances, patients 
sometimes explain they have vision loss — ‘I’m sorry my eyesight’s bad’ (P15; moderate), or 
‘I have macular degeneration, I am having a bit of a problem with recognising faces’ (P10; 
moderate) — although also note two of our patients chose not to disclose their vision loss 
beyond close family. Patients sometimes use humour to laugh off their mistakes: ‘[with] 
some of the people I know really well, I can joke about it with them’ (P14; moderate). Patients 
sometimes attribute their mistake to another source (e.g., pretending they had a memory 
failure), particularly with people they don't know well, or where the patient does not disclose 
81 
 
or does not wish to spend the time on a detailed conversation explaining AMD. On other 
occasions, patients report trying to ignore their mistakes and just get on with it without 
making a social repair attempt: ‘I just try to look as though I know what I am doing’ (P8; 
mild), and ‘There is nothing you can do about it, you just go with it’ (P12; moderate). 
Patients also reported experiencing a variety of responses to their mistakes from 
others. Overall, patients reported that others were commonly helpful and kind. For example, 
‘Nobody takes offence, they just give a little chuckle’ (P21; severe), ‘[Others] do the best that 
they can to help me’ (P12; moderate), and ‘Most people are very considerate and tolerant’ 
(P14; moderate). However, more than a quarter mentioned having experienced occasions on 
which others got angry and upset. Importantly, half also said there were occasions where they 
had no idea how the other person felt (e.g., because they could not see their expression); this 
is relevant to validity of one item on the MacDQoL [10] (see Discussion). 
Despite using often-successful social repair mechanisms, AMD patients reported that 
a number of negative emotions remained associated with making mistakes. As Table 5 
shows, many mentioned feelings of embarrassment, frustration or sadness. Many also 
reported worrying what others think of them and how they judge them (e.g., being perceived 
as rude, or stupid).  
Severity of vision loss. An important observation (Table 5, plus example quotes 
above) is that the social difficulties, and changed social behaviour, in AMD were not limited 
to those with severe vision loss, but were also experienced by patients even with only mild 
vision loss. 
 
3.4.4.7 Longer-term impact on patients’ social life, confidence, and quality of life 
 Table 7 summarises information about the longer-term effects of poor face perception 
on patients' social life, confidence, and quality of life. Negative impacts were common. 
Missing out. Concerning the quality of social life, three-quarters of our patients 
reported examples of missing out on the full quality of social experiences available to people 
with normal vision. Three said that due to their poor face perception they ‘can’t join in’ in 
social interactions (P15, P16, P19; moderate and severe), and even P1 with very mild vision 
loss (best-eye BCVA acuity of 6/7.5) said ‘you’re not with the rest of the crowd’ and ‘You’re 
not getting out of a conversation perhaps what you would normally get out’. In examples that 
patients found particularly upsetting: P18 (severe) said ‘I sat there [at a social function] for 
fully two hours not knowing who the people at the table were, and that was pretty 
distressing’; and P12 (moderate) said ‘At things like funerals where you know a lot of people 
82 
 
and you don’t recognise them … it’s disappointing afterwards when you hear that someone 
was there that you would have liked to have seen’. 
 
Table 7. Impact of reduced face perception on social life, confidence, and quality of life; 
plus lack of understanding by other people. 
 % of patients reporting experience or 
responding ‘yes’ 
Description of Experience Mild 
(n=8) 
Moderate 
(n=8) 
Severe 
(n=5) 
Total 
(N=21) 
Social life: missing out and withdrawal     
- Missing out (e.g., can't join in with the jokes;  
  didn't realise my old friend was at the funeral) 
  63+   75+ 100   76+ 
- I disengage/isolate/withdraw in social situations   63+   38+ 100   62+ 
- I am less willing to have social interactions due to my  
  reduced face perception 
 63  25  60  48 
Face-specific effects on reduced confidence, quality of life     
- Problems seeing faces has reduced my confidence  75  38  80  62 
- Problems seeing faces has reduced my quality of life  75  63 100  76 
Other people don't understand     
- Other people don't understand how AMD impacts my vision   75+   50+   80+   76+ 
- I worry other people think I'm faking it   50+   25+   40+   38+ 
 
Five participants mentioned missing out when watching TV or movies, for example 
when watching a drama programme they lose track of who’s who and so cannot follow the 
story properly (P12; moderate), or because in a panel show ‘Sometimes I find it hard to follow 
the interchange’ (P10; moderate). 
Social withdrawal, passivity. Many patients reported that the social difficulties, and/or 
the decreased enjoyment to be obtained from social settings, had led to an increased tendency 
to withdraw or isolate themselves, and to become more socially passive. This could occur 
within an individual social situation: for example, P19 (severe) said ‘[when you make a 
mistake recognising others] you want to go back and put yourself in a corner or in your room 
somewhere away’. It also resulted in half of patients agreeing that poor face perception had 
contributed to them being less willing overall to have social interactions than before they had 
AMD (Table 7). For example, P20 (severe) said ‘I'm less interactive’. P5 (mild) said ‘I'm 
more passive, definitely less interactive and tend to stay in the background. ... I don’t 
socialise anymore [with new people]’. P4 (mild) said ‘If I am going somewhere where there 
is going to be lots of people I sometimes don’t want to go’. P16 (moderate) said ‘You become 
a sort of a loner’. And P18 (severe) said ‘I'm more mousey now … I go up [to the social 
area] and sit down quietly, whereas one time I would have been the president [laughs] … I 
think it’s made me more introverted’.   
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Face-specific effects on confidence and quality of life. Recall that, while it is well 
established that AMD lowers confidence and quality of life [5,34]; also Table 2 in present 
sample), our novel question here is whether patients experience reductions that they see as 
specifically associated with their poor face perception, as opposed to the many other 
difficulties they experience in AMD. Table 7 shows that, when asked directly whether 
problems seeing faces had reduced their confidence, more than half of patients agreed. When 
asked directly whether problems seeing faces had reduced their quality of life, more than 
three quarters of patients agreed.  
Effects on quality of life included, in some cases, strong feelings of loss. For example, 
P17 (severe) said ‘It’s very important [to be able to see other people’s faces] I want to see 
them and it’s very distressing that I can’t … I want to see them’. And P8 (mild) who had 
previously worked assisting a politician said ‘I always prided myself, it was one of my best 
things when I was working for a politician, is that I could recognise all the people who came 
in to talk, I would say “this is so and so”... It used to be my pride, I could recognise people 
and give him the name … [now I can't do that anymore] it feels as though it’s not me’. 
 
3.4.4.8 Resilience 
In addition to the difficulties described above, it should be noted that most patients 
revealed examples of resilience, some degree of coming to terms with their face problems, 
and/or determination to fight against social isolation. Quotes include: ‘[not being able to see 
facial expressions] used to make me feel upset ... it was as if I’d lost something, lost a person 
sort of, but I’ve kind of got used to it now ... You either get up and go or you sit in your chair 
and die and I think I’d rather get up and go’ (P5; mild); ‘I think it [social withdrawal] could 
happen to people but I don’t let it happen to me ... I imagine that AMD could [make me more 
passive] and maybe it will get me that way eventually, at the moment I am still fighting it’ 
(P2; mild); ‘I’ve got on with life the best I can’ (P14; moderate); ‘Unless you sort of make an 
effort [socially], you could have a very miserable life, and I’m just not prepared to have a 
very miserable life’ (P13; moderate). 
 
3.4.4.9 'Other people don't understand'  
 Table 7 shows that most patients felt others did not understand how AMD affects their 
vision, and how hard it was for them to see faces clearly. In some cases, this occurred even 
when the other person was well aware of the AMD: ‘They know what I am like, at that minute 
they just forget’ (P16; moderate), and ‘They don’t realise [my vision’s] deteriorated yet’ (P8; 
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mild). In some cases, it reflected the other person having difficulty understanding that AMD 
can affect fine vision as needed for face recognition, but without externally-visible damage to 
the eyes, and without impairing coarse vision as needed to walk around. For example: ‘A 
couple of people have specifically said to me, in appearance, you don’t look as though you 
are having problems with your vision, your eyes look perfectly normal’ (P5; mild), and ‘I 
have lots of friends and family even who say to me “well how can you see that and you can’t 
see something else?”’ (P13; moderate).  
 This lack of understanding resulted in more than a third of patients raising concern 
that others think they are 'faking it'. For example: ‘I think she [my carer] thought I was just 
putting it on a bit you know’ (P8; mild), and ‘He [my son] had been a bit doubtful I think 
about it, but that [my failure to recognise him] has quite convinced him now that faces are 
distorted for me’ (P2; mild). This problem was not limited to patients with only mild vision 
loss, where others might perhaps be expected to be least appreciative of AMD difficulties 
(e.g., because the patient can still navigate well around the environment). Examples from 
moderate vision loss included: ‘sometimes you sort of think they’re doubting that you even 
have a problem’ (P13; moderate); and ‘I feel like a fraud [when I need to ask for help]’ (P9; 
moderate). Even patients who were legally blind worried that others didn't believe they had a 
real problem seeing faces: ‘I do think people think you are faking it a bit’ (P18; severe).  
 
3.4.4.10 Relative importance to patients of faces versus other aspects of vision loss, and of 
facial identity versus expression 
 Three questions addressed how important patients perceived their face problems to be, 
including relative to the many other visual domains affected by AMD (e.g., ability to read, 
drive, or cook). At the very beginning of Interview 1, we asked an open-ended question — 
‘Which areas or tasks have been made harder because of your AMD?’ — to record how many 
patients would spontaneously mention face perception difficulties as amongst their most 
important everyday problems: 38% did so (3 mild, 4 moderate, 1 severe). This compared to 
81% mentioning reading and 62% hobbies (e.g., knitting, sewing, crosswords and writing) as 
the two most common topics raised, and to rather smaller percentages for some domains 
included in the MacDQoL [10] (e.g., only 5% for enjoying meals and 14% for shopping; see 
Supplement S5 for detail). Later we asked directly for ratings of importance. In the identity 
section of Interview 1, in response to ‘How important is seeing other people's faces to you?’ 
15 patients indicated High/Very High, 5 said Medium, and only 1 said Low. In the expression 
section, in response to ‘How important is it for you to be able to see another person's facial 
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expressions?’, 16 patients indicated High/Very High, 4 said Medium, and only 1 said Low (a 
different participant from the person who chose Low for identity). Together, results of these 
three questions indicate that face perception is of high importance to most AMD patients, and 
also of no lesser importance than several domains currently included in the MacDQoL [10].  
 We also asked patients which was more important to them, recognising facial identity 
or recognising facial expressions: 67% said it is more important to be able to recognise who a 
person is (i.e., identity); 24% reported the two are equally important; and 10% said it is more 
important to see a person’s facial expressions. 
 
3.4.4.11 Patients’ views on possible technological help 
Our results so far indicate that technology that could improve patients' face perception 
and recognition would have the potential to improve their social interactions and quality of 
life. Our qualitative interviews thus addressed patients' willingness to try various types of 
future technological assistance. Most patients (71%) said they would be willing to use 
computer facial recognition software that could say aloud the name of other people in the 
environment. While a commercial product offering this service is available (for 100 learned 
faces [40]), note the named-by-computer approach has some disadvantages compared to 
improving a participant's own perception: naming aloud may interfere with hearing an 
approaching person speak, and is also only useful only for identity recognition (a running 
verbal commentary on dynamic aspects of faces like expressions or eye gaze would not be 
suitable for patients). We thus also asked about image enhancement, which has the potential 
to improve perception of all aspects of faces. We explained that, in image enhancement, 
patients would view faces on computers, tablets, or smart glasses [41,42] with the faces 
digitally altered in ways that have been reported to improve low-resolution face perception 
(e.g., making the face larger [15,43]; increasing the contrast of medium and high spatial 
frequencies [44,45]; or caricaturing the face, i.e., exaggerating its appearance away from the 
average to make identification easier [46-48]). Participants were on the whole very positive 
about trying image enhancement technology if and when it became available, particularly on 
TV and/or computer screens (90% support; e.g., one patient mentioned this would be useful 
when skyping his family), and via smart glasses (90% support). Only one patient (P16) was 
not interested in any type of electronic device, saying technology ‘left me behind’. Several 
patients noted that hand-held screens (e.g., phones, tablet computers) would not be valuable 
because they needed their hands available for balance, carrying things, and in some patients 
for using a mobility walker; thus, a hands-free option such as smart glasses was preferred. 
86 
 
Several participants highlighted potential concerns regarding the weight of smart glasses on 
the face, and the likely expense of the technology (even in our largely middle-class sample).  
 
3.4.4.12 Development of information sheet, conversation starter and brochure 
 In Interview 2, all but one participant asked indicated that an information sheet 
concerning the effects of AMD on face perception and social interactions would be useful. 
Responses from Interview 1 were used to draft potential points for inclusion in the 
information sheet (see Method). The final version contained concepts that were directly 
endorsed by patients for inclusion (for details, see Supplement S6), plus some additional 
points widely raised by patients (Tables 3-7) which we had not included in the draft but 
emerged as important themes once we had the full data set to analyse. Feedback on a final 
draft was also obtained from the Macular Disease Foundation Australia (via their Research 
Officer and Medical Affairs Manager), concerning appropriate formatting and language for 
macular degeneration patients. 
Our final community resource materials are in Supplement S1. The content of the 
Faces and Social Life in AMD Information Sheet highlights the core issues arising from the 
patient interviews: how faces might look to people with AMD; how early in disease 
progression problems could potentially arise; the types of social problems patients might 
experience that result from difficulty seeing faces; that individual experiences can be highly 
variable; and that the patient's experiences are genuine and normal for AMD. The sheet also 
aims to help others around the patient (e.g., family members, friends, carers, nursing home 
staff) appreciate compassionately why a patient may sometimes appear to behave in a 
socially odd manner (including appearing rude or unfriendly); to understand why they may 
have become more passive or disengaged in social settings; and to provide suggestions for 
how others might be able to help in concrete terms (e.g., by naming people as they approach). 
To give greatest accessibility to vision impaired patients (as advised by Macular Disease 
Foundation Australia), the information sheet has been prepared in large font, all plain text (no 
italics), and maximum contrast (plain black text on white background). 
Our accompanying Conversation Starter has questions for others to ask the individual 
person living with AMD. These are aimed at enabling AMD patients to describe in detail to 
family, friends and carers (e.g., nursing home staff) their own individual experiences in 
seeing faces, the impact this is having on their social interactions and social life, and what 
they would like other people to do to help. Finally, we provide a tri-fold 1-page brochure that 
can be given to patients at vision clinics, or picked up by family members, containing 
87 
 
directions to finding the information sheet and conversation-starter online; the brochure and 
information sheet are provided in both A4 and US-letter paper sizes. 
 
3.4.5 Discussion 
This study found that poor face perception in AMD impacts patients' psychosocial 
functioning in multiple ways. Concerning failures of identity recognition, patients with AMD 
revealed the same social interaction difficulties previously reported in prosopagnosia 
[17,35,36]. These included: failures to recognise even highly familiar people (e.g. family 
members); false recognitions of unfamiliar people; common feelings of embarrassment or 
frustration about these errors; concerns about offending others; and resulting changes in 
social behaviour, with most patients becoming more cautious around others to avoid making 
false positive identifications, and a few taking the opposite approach of being friendly to 
everyone to avoid false negatives. In addition to these identity-related problems, AMD 
patients experienced further difficulties associated with their problems perceiving facial 
expression and eye gaze. This included not being able to tell when others were joking, 
failures to be able to read others' emotional states, and inability to tell when others were 
making eye contact. There was also some evidence suggesting problems with facial speech. 
Taken together, the problems perceiving multiple aspects of face information resulted in 
patients commonly feeling they could not fully join in, or were not part of the group. Many 
reported social withdrawal or reduced enthusiasm for social events. Confidence and quality 
of life were reduced and, crucially, patients attributed at least some of this reduction 
specifically to face perception problems. On explicit ratings of importance, most patients 
rated face perception as high. Finally, psychosocial problems were seen even in patients with 
only mild vision loss, and patients commonly reported that others did not understand their 
face perception problems, and that they sometimes worried about being seen as a fraud.  
Overall, these results argue that the importance of face perception difficulties to 
everyday life in AMD is higher than has been implicitly assumed in previous approaches, 
including quality of life research and in community information websites.  
We now discuss a number of specific outcomes of our study in more detail, including 
open questions and limitations of the study where relevant. 
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3.4.5.1 Implications for the current Quality of Life instrument for macular degeneration 
(MacDQoL) 
A key implication of our findings is that problems with face perception in AMD 
contribute to social difficulties and reduced quality of life, independently of all of the other 
functional visual problems that occur in AMD (i.e., inability to drive, engage in hobbies, 
remain independent, etc.). This argues the MacDQoL [10] would benefit from adding a 
specific item about face recognition.  
The MacDQoL is the only quantitative questionnaire designed specifically to measure 
change in Quality of Life due to macular degeneration. It is widely used [44], is available in 
14 languages (https://www.healthpsychologyresearch.com/information/currently-available-
translated-questionnaires/MacDQoL-macular-disease-dependent-quality), has good 
reliability, and has been validated overall (e.g., scores correlate with level of vision loss; 
[21,45]. However, its 23 items include no questions addressing the domain of face 
perception. Additionally, while it does include questions relevant to social relationships with 
others ('closest personal relationships'; 'family life'; 'friendships and social life'), these 
questions do not mention faces, and patient responses could equally be related to other non-
face difficulties: for example, a patient's personal relationship with their spouse may be 
negatively impacted by the fact they can no longer contribute to household tasks; or a 
patient's friendships and social life may be reduced due to loss of driver's licence. Wording 
for a face-domain question for the MacDQoL could be along the general lines of asking the 
patient how much better they could see other people's faces (e.g., recognising who they are, 
or what they are feeling) if they did not have macular degeneration, and then following up 
with the usual MacDQoL question structure by asking participants how important seeing 
other people's faces is to them. (Unfortunately, we cannot suggest here precise wording that 
would match the MacDQoL format, because the questionnaire and its precise format is 
copyright).  
Our present study also revealed a problem with one of the existing items on the 
MacDQoL [10]. Q15 asks patients about how much better other people would react to them if 
they did not have macular degeneration (with choice between 5 "amount" options ranging 
from very much better to worse). However, consistent with evidence that AMD patients often 
cannot see how others react to them, due to poor facial expression perception, 7 of our 21 
patients said they could not answer this question — indeed, one said "How do I know?". The 
inability to see how others react is a well-established aspect of vision loss of multiple types 
(e.g., as reflected in the NEI-VFQ’s inclusion of the item 'Because of your eyesight, how 
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much difficulty do you have seeing how people react to things you say?'), further arguing that 
asking patients about how much macular degeneration has affected how others react is not a 
useful wording.   
In sum, our present results argue the MacDQoL could be improved in validity by (a) 
adding a question about quality of life in the domain of seeing faces, and (b) removing or 
rewording Q15. 
 
3.4.5.2 Improving community and patient information about AMD   
 Concerning community information about AMD, our interview results have revealed 
two key findings: poor face perception in AMD is qualitatively related to many difficulties in 
social interaction; and patients commonly feel that others don't understand these difficulties. 
This argues that one way to improve patients' quality of life is to improve community 
understanding of face-related social difficulties in AMD.  
 Our Faces and Social Life in AMD Information Sheet (and accompanying 
conversation stater and brochure) provides a much higher level of detail concerning face 
perception and social interaction difficulties than previously-available public material. For 
example, beyond noting that faces can be hard to see, macular disease organisations including 
the Macular Society (https://www.macularsociety.org/), the American Macular Degeneration 
Foundation (https://www.macular.org/), and the Macular Disease Foundation Australia 
(https://www.mdfoundation.com.au) have previously given no information about how this 
can affect social interactions. Vision Australia, which deals with all vision disorders 
including total blindness (http://www.visionaustralia.org), has an information page briefly 
explaining that vision loss can result in difficulties with social interactions due to poor face 
perception. This page mentions problems seeing facial expressions and maintaining eye 
contact, but does not mention facial identity. As the present results show, problems with 
identity recognition can have very important negative impacts on social interactions and 
social life (also see [17,35] in prosopagnosia). Additionally, the Vision Australia page does 
not refer to macular degeneration specifically, nor explain that AMD patients might 
sometimes experience face-related social interaction problems even when their vision is still 
otherwise quite good (e.g., good enough to drive). 
 Our hope is that our new community materials will help others around the patient 
(e.g., family members, friends, carers, nursing home staff) appreciate compassionately why a 
person living with AMD may sometimes appear to behave in a socially odd or changed 
manner (including appearing rude, unfriendly, or unusually passive), and to help to assist 
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with maintaining social engagement in practical ways (e.g., by naming people as they 
approach). 
 
3.4.5.3 Qualitative results provide a basis for future development of a quantitative 
questionnaire  
 An important limitation of the present study is that we have not aimed to examine the 
frequency or severity with which different types of face perception and social interaction 
difficulties occur. There are many research questions of scientific interest that can be 
addressed only with access to such quantitative information. For example, these include: (a) 
in multiple regression, how much of the decreased quality of life in AMD is uniquely related 
to face perception and social interaction problems over and above, say, the contributions from 
other aspects of vision loss (e.g., loss of ability to read or drive) or general age-related 
difficulties (e.g., other health problems, death of spouse or old friends; (b) whether a potential 
intervention (e.g., psychological treatments for social anxiety; advice to disclose AMD-
related face problems to others; technology to improve face perception) produces a 
significant improvement in social interaction and quality of life by comparing pre- versus 
post-intervention scores; (c) whether certain face perception or social interaction difficulties 
might be more severe in certain ophthalmological states (e.g., wet versus dry AMD) or 
perceptual states (e.g., the patient experiences blur-plus-distortions in the face, or only blur); 
and (d) the extent to which AMD patients have insight into their precise level of deficit (i.e., 
by correlating quantitative self-report of everyday face problems with lab-based measures of 
face ability), noting that insight is limited in normal vision [51,52] but perhaps may be better 
in patients given the potential benefit of internal comparison to their earlier abilities before 
AMD. 
 Development of a validated quantitative questionnaire to measure face-related social 
interaction difficulties is beyond the scope of the present study. Importantly, however, the 
qualitative analysis presented provides a crucial first step towards this end, by providing 
evidence on the types of face perception and psychosocial difficulties experienced by AMD 
patients. This detailed understanding of the types of experiences that can occur is an essential 
step towards developing a valid quantitative measure. Research that creates quantitative self-
report measures without prior qualitative understanding can result in validity problems. For 
example, in the 8-item self-report questionnaire [15] developed to supposedly assess AMD 
patients' insight into their level of face recognition difficulties, four items do not actually ask 
simply about perceived disability in face perception/recognition per se: two ask about 
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emotional responses to mistakes; and two ask about alternative strategies and wrongly 
assume that the only alternative strategy is voice.  
 Our qualitative results indicate that important domains to assess quantitatively, 
depending on the specific interests of the researcher, could include: frequency with which 
everyday face recognition problems are experienced (including identity, expression, eye gaze, 
and facial speech); degree of success or failure of alternative strategies to recognise people 
and their emotions other than by their face; frequency and severity of various types of social 
interaction difficulties related to impaired face perception; severity of negative emotional 
response to making errors (noting our participants varied on this, with some highly 
embarrassed and trying to avoid errors at all costs, and others more inclined to shrug off 
many of their mistakes); and severity of face-related impacts on social functioning, 
confidence, and quality of life. Potentially, items for a formal questionnaire could be based 
on the experience categories in Tables 3-7 and/or include rating-response versions of 
questions included in our Conversation Starter (Supplement S1).  
 To fully develop a quantitative self-report questionnaire from the present results 
would require large-sample testing to determine psychometric properties for any proposed 
instrument, including reliability (e.g., Cronbach's alpha, test-retest), factor structure, and 
convergent and divergent validity. For example, there may be separate factors for severity of 
face perception problems and severity of negative emotional responses to those problems; if 
so, we would expect face perception to correlate most strongly with acuity and lab-based face 
tests, while emotional response might correlate less with acuity and more with personality 
attributes.  
 
3.4.5.4 How widespread might social-interaction problems be in patients with only mild 
vision loss? 
 A potentially surprising finding from the present study was the consistent reports of 
face-related social interaction difficulties even in AMD patients with mild vision loss. While 
it may of course be the case that these occur quantitatively less frequently than in patients 
with more severe vision loss (an issue which requires development of a quantitative 
questionnaire to evaluate), qualitatively the problems were the same as in the moderate and 
severe vision loss categories. In terms of face identity failures, perhaps the most striking was 
our second mildest patient, who despite having visual acuity of 6/9.5 (best-eye BCVA), 
reported recently failing to recognise her own son standing next to her. Concerning 
expressions, a patient with acuity 6/15 said expressions were ‘one of the first things that 
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went’. In terms of social interaction effects of poor face perception, even our best-acuity 
patient (acuity 6/7.5) said ‘you’re not with the rest of the crowd … you’re not getting out of a 
conversation perhaps what you would normally get out’.  
Noting that we specifically recruited AMD patients who reported on initial phone 
contact that they experienced face recognition problems in everyday life, an open question is 
how widely spread face-related social interaction difficulties will be amongst mild vision loss 
patients. Predictions vary depending on the possible cause. 
First, predicting that social problems in mild-vision-loss AMD patients would be 
common, is a potential role for low-contrast visual acuity. Low- and high-contrast acuity are 
highly correlated (r = .93 in our sample) but absolute acuity performance is always poorer for 
low contrast than high contrast stimuli (see lower LCVA than BCVA for patients in Table 1; 
also for normal-vision observers [53,54]. Acuity for static, high contrast letter stimuli is not 
fully reflective of performance in real-world viewing conditions [55,56]. Faces, in particular, 
are dynamic stimuli seen in changing conditions of lighting and contrast, and also 
intrinsically contain much low contrast information, such as the shape of the boundary 
between the nose and the cheeks for face identity, or the presence of frown lines in the 
forehead for expression. Thus, the BCVA measure, and the ICD-10 [26] categories based on 
it, is likely to underestimate the absolute degree of functional vision loss relevant to 
perceiving faces. The greater absolute vision loss implied by LCVA suggests social 
interaction difficulties would likely be widespread in other 'mild' patients. 
Alternatively, predicting that social problems in mild-vision-loss AMD patients may 
be more restricted is the idea that there may be something special about mild patients who 
experience face perception problems often enough to noticeably impact their social 
interactions. One hypothesis is that there is something specific about the pattern of retinal 
damage in our patients that account for face perception difficulties severe enough to cause 
social interaction problems (e.g., perhaps such patients tend to have their relatively-well-
preserved acuity supported by a single small region of preserved retina within the fovea, 
rather than by peripheral vision); note that, while we have detailed retinal data for our 
patients (Supplement S2), we cannot yet evaluate this idea empirically because we did not 
recruit mild-vision-loss patients without any face problems for the present study. Another 
hypothesis is that there might be an effect of the other eye for our patients. While other-eye 
acuity did not predict functional vision levels across our full sample (e.g., on the NEI-VFQ; 
see Supplement S2), it is of some note that of our 7 mild vision loss patients, 6 had severe 
vision loss in the other eye (i.e., BCVA worse than 6/60; see Supplementary Table S1). Thus, 
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it cannot be ruled out, for example, that while typically patients preferentially use input from 
their best eye and ignore input from the poorer eye [27,28], our particular mild patients might 
be more likely than average to experience breakthroughs into attention from the poorer eye, 
and that these impair ability to perceive faces (e.g., if the severely-impaired other eye sends 
input suggesting unexpected movement in the face, such as a distortion or a part disappearing 
or reappearing, noting that movement attracts attention).  
 
3.4.5.5 Are negative consequences of poor face identity recognition due to having a disease 
not known to the general public?  
In addition to the major issues arising from our study discussed above, a number of 
brief points arise concerning a variety of topics. 
Yardley et al. [17] hypothesised that, in prosopagnosia, low public awareness of the 
disorder at the time may have been a major contributor to feelings of embarrassment, guilt, 
and failure. Awareness of AMD in Australia is very high (in 2011, 80% of people aged over 
15, and 92% of people aged 50+ years were aware of macular degeneration, and 73% 
understood it is a disease of the eyes [57]). Despite this, we still found feelings of 
embarrassment, guilt, and concerns about being perceived as a fraud (also see [9]). It thus 
seems that the critical variable here is not public awareness of the medical condition per se. 
Instead, it may be that AMD is an invisible condition (noting experiences of being treated as 
fraudulent or exaggerating are reported in other medical conditions not easily visible to 
others, e.g., endometriosis [58,59]), and/or that others do not have sufficient information to 
understand the specific ways that AMD actually affects vision (i.e., that it impairs fine vision 
tasks far more than coarse-vision tasks). This argues improving the patient experience 
requires increasing understanding of the detailed symptoms of AMD, rather than merely its 
existence. 
 
3.4.5.6 How faces appear to patients with AMD: Blurred, distorted, and often not the 
central black blob of traditional illustrations   
Surprisingly, no previous study seems to have asked AMD patients in any 
detail what faces look like to them. Taylor et al. [60] recently provided the first 
detailed self-reports about visual appearance in (dry) AMD, covering visual 
experience in general rather than specifically faces. Across 29 patients with 
geographic atrophy, the most highly reported descriptors were blur (45%), missing 
parts of the image (34%) and distortions (24%). For faces, our present results agree 
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in broad terms, with blur the most common phenomenon reported (71%) and reports 
of distortions and/or missing parts of the face the next most common (29%; patients 
with dry and wet AMD). Also in agreement with Taylor et al. [60], we found 
considerable heterogeneity in reported appearance across different patients.  
These results are important because they indicate that the most common 
illustration of how the world is supposed to appear to patients with AMD is 
inappropriate (e.g., National Eye Institute, NEI, https://nei.nih.gov/health/examples; 
also [61]). The NEI illustration would often be viewed by newly-diagnosed patients 
wondering what to expect as their AMD progresses, and shows a black or grey blob 
completely hiding faces located at central vision. However, in [60], only 2 of 21 
patients said this type of image reflected a good depiction of their vision. Here, only 
3 of our 21 patients spontaneously mentioned seeing a blob in their central vision, 
and one patient explicitly said she did not, and overall it was striking how many 
more patients reported blur as a key feature of their visual experience than a central 
blob. More broadly, patients felt that others didn't understand how faces looked to 
them, and also how variable this was (e.g., with lighting). Our Faces and Social Life 
in AMD  
Information Sheet provides a more accurate description of the range, and variability, 
of facial experience that patients might experience. This may be useful for medical 
staff explaining AMD to newly-diagnosed patients (e.g., orthoptists), for patients 
themselves, and also for family, friends and nurses to better understand why faces 
are so difficult for patients with  
AMD.   
Finally, the reports of variability have important implications for the design 
of labbased tests to assess objective face processing ability. Patients report that how 
well they see faces can vary substantially across lighting conditions, and across time 
(e.g., time of day, pre- vs. post- treatment with ranibizumab). This argues that, to 
obtain an accurate objective score for lab-based face ability, it may be important to 
test the patient on several different occasions, at different times of day, and with 
different lighting conditions on the faces.  
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3.4.5.7 Alternative strategies and importance of faces to successful real-world person 
recognition   
The present study is the first in low vision to investigate the success or 
otherwise of non-face-based strategies for recognising others and their emotions. The 
key findings were that AMD patients report that, in everyday life, they attempt to use 
a wide range of alternative strategies (hairstyle, body shape, gait, voice, context) but 
these non-face-based strategies commonly fail. Specifically, we found that body 
language and tone of voice are not sufficiently strong cues to emotional state to fully 
enable normal social interactions. We also found that cues such as body shape, gait, 
and hairstyle are not sufficiently strong or reliable cues to identity to enable accurate 
recognition of who people are. This latter result is of some interest given occasional 
claims by vision science researchers that hairstyle is sufficient to support identity 
recognition (e.g., based on findings such as [62]). Also, the reliance of AMD 
patients’ on body cues to recognise a person far away is similar to participants with 
normal vision. That is, when far away, controls use the body to recognise others, but 
when in close proximity, they only use face information [63].  
Our present results, in contrast, confirm previous findings from 
prosopagnosia (e.g., [17,35,36,64]), and also from low-resolution images (security 
camera video of walking people with faces covered [65]), that the ability to 
accurately perceive face information is crucial to reliable person recognition in 
everyday life, with other cues offering only partially useful information.   
  
3.4.5.8 Generalisation to other low-vision conditions   
  Finally, our results are relevant to low-vision conditions beyond macular 
degeneration. As with AMD, studies discussing effects of other types of vision loss 
on social interactions, social life, and quality of life have not disentangled, in any 
detail, effects specifically related to face perception problems (e.g., [8,66,67]). The 
details of how faces appear to patients with different disorders will vary (e.g., see 
description of patient visual experience in glaucoma [68]). However, all vision 
disorders producing low visual acuity will result in problems seeing faces clearly. 
There is no reason to think that the types of difficulties in social interactions we 
have reported here are in any way related to the specific type of retinal damage that 
occurs in macular degeneration. Indeed, the (identity-related) social interaction 
difficulties in AMD closely mirror those present in prosopagnosia, where face 
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recognition problems do not originate in the eye at all, but rather in the brain. Thus, 
it is highly likely that any eye disorder resulting in low vision will produce 
qualitatively similar social difficulties to those revealed in AMD, together with the 
same concomitant effects of missing out socially, tendency to social withdrawal, 
reduced confidence, and reduced quality of life specifically associated with face 
perception difficulties.   
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3.4.8 Supporting/Supplementary Information  
Supplement S1: New community resources (Faces and Social Life in AMD Brochure). 
 
Supplement S1 to S7 are in the same document 
Supplement S1: New community resources (Faces and Social Life in AMD Information 
Sheet and Conversation Starter). 
Supplement S2: Full vision assessment information, including rationale for ranking 
patients' functional vision based on best-eye BCVA (Includes Table S1 and Table S2). 
Supplement S3: Interview 1 initial questions. 
Supplement  S4: Interview 1 example of different follow-up questions to initial questions, 
arising from different patient responses. 
Supplement S5: Relative importance of face perception domain compared to domains 
currently included in MacDQoL (Includes Table S3 and S4). 
Supplement S6: Interview 2 results for patient endorsement of content included in Faces 
and Social Life in AMD Information Sheet (Includes Table S5). 
Supplement S7: References for supplementary materials S2-S7. 
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3.4.8.1 Supplement S1: New community resources  
Included on pp 3-8 are our new: 
 • Faces and Social Life in Age-related Macular Degeneration Information Sheet 
 • Faces and Social Life in Age-related Macular Degeneration: A Conversation Starter 
 
If this paper is accepted for publication, the full web address for an appropriate ANU website 
will be included on the brochure (the brochure is in a separate Supplement S1 document). 
Note the brochure will be formatted in both A4 and US-letter paper sizes.  
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Faces and Social Life in Age-related Macular 
Degeneration 
 
An information sheet for people living with AMD,  
and their family, friends and carers  
 
AMD can make it hard to see faces which may lead to 
some common mistakes: 
Everyone is different, but depending on lighting and distance, faces can 
look blurred or distorted.  Because faces can be hard to see: 
 
You might not recognise people you know: 
 The other day I didn’t even recognise my son … he was within a 
yard or two of me and I didn’t recognise him. 
 I pass by people in the street that I know very well.  
 
You might accidentally say hello to someone you don’t know: 
 I went up to someone I knew very well and started having a 
conversation with them. They looked at me blankly, and I realised 
they were not who I thought they were. It was very embarrassing! 
 I am more careful now and wait for others to speak first.  
 
You might use other information to help but it doesn't always work: 
 I look at the way people are walking, their size, their hairstyles … 
and then of course if they speak it’s voice recognition. 
 I can make some terrible mistakes, the other information helps but 
it is certainly not fool-proof. 
 
You might not see facial expressions: 
 You can't see if you’ve wounded someone’s feelings, so you don't 
realise ‘oh I’ve hurt her, I shouldn’t have said that’. 
 I thought my doctor was upset with me and I couldn’t work it out, 
but my daughter said he was having a joke just to crack the ice.  
 
You might find crowds hard: 
 I find social situations very difficult particularly in a crowded room  
 I find crowds uninteresting … if I can’t see and can’t place people 
then it’s a bit of a waste for me.  
 
Sometimes, these problems can start when your vision loss is quite mild.  
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People don’t understand how AMD impacts my 
vision: 
 It’s difficult, they forget I have AMD. 
 They don’t realise my vision has deteriorated.  
 I worry people think I am faking. They say ‘your eyes look 
perfectly normal’.  
 They wonder why I can’t recognise people but I can walk around ok 
 
Other people might think I'm rude or unfriendly: 
 
Many people with AMD worry that others think they are ignoring them 
on purpose. 
 People are mostly kind about mistakes (they help or laugh it off), 
but sometimes they do take offence: When I walked past Jenny and 
didn't recognise her, she yelled ‘you don’t even speak to me!’   
 
Face problems can make social situations difficult: 
 
Some people with AMD may appear passive or disengaged because they 
cannot see who is in a room.  
 My old friend Tony was at the funeral and I would have loved to 
talk to him, but sadly I had no idea he was there.  
 I sat there [at a social function] for fully two hours not knowing 
who the people at the table were, and that was pretty distressing. 
 I find social situations can be a bit tricky when you can’t see what 
other people are feeling.  
 You can’t feel completely part of what’s going on.  
 
Some people withdraw or lose confidence: 
 I don’t socialise anymore … I would think I would hurt people’s 
feelings … they thought you were getting on famously and then 
next time you don't recognise them … it’s easier not to put yourself 
in that situation. 
 I am more mousey now ... I go up to the social area and sit down 
quietly, whereas one time I would have been the president. 
 
Most people want to keep a good social life:     
 I don't give up! 
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Tips for people living with AMD 
 
• Being open about having AMD can help in social situations and avoid 
offending others, e.g., say ‘I’m sorry my eyesight’s bad but come a bit 
closer, onto my right side, and I'll be able to see you better’.   
 
• If you tell others about your vision loss, most people will respond 
positively if you make a mistake and are happy to laugh it off. This will 
help avoid feelings of frustration or embarrassment.  You might need to 
remind people though, because they can forget. 
 
How can family, friends and carers help? 
 
• When you approach someone with AMD it is good to introduce 
yourself: ‘Hi Mary, it’s Karen from next door’. 
 
 
• In a group conversation, say the name of the person you are talking to 
because people with AMD can't see who you are looking at: ‘John, who 
do you think will win the football this weekend?’ 
 
 
• If the person with AMD wants help with recognising others, you could 
tell them who is in a room: ‘John is in the back of the room with his 
wife’, and say people's names as they approach: ‘Hi Bob’. 
 
• For facial expressions, you could say: ‘Jill is looking sad today’ or ‘the 
doctor had a big smile on his face when he said that, he's having a joke’. 
 
• Understand that the person with AMD is not faking it. It is normal for 
them to sometimes be able to see faces and sometimes not. It is also 
normal in AMD to have some peripheral vision (to walk around) but 
reduced fine vision (e.g. have problems reading, seeing faces, cooking).  
 
• Everyone with AMD is different. Ask them to tell you how their vision 
is affected. To get you going, see our Conversation Starter questions 
that you can work through together.  You can ask if they have 
problems seeing faces, if they make mistakes, at what distance and under 
what lighting conditions, how this affects their social interactions and 
confidence, and what they would like you to do (or not do) to help.  
 
 
 
This Information Sheet is based on a study by researchers at the Australian National University 
Research School of Psychology, funded by the Australian Research Council. Quotes are adapted 
versions of actual quotes from AMD patients interviewed for that study. Version 25 June 2018. 
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Faces and Social Life in Age-related Macular Degeneration: 
A Conversation Starter 
 
The information sheet Faces and Social Life in AMD describes some of the difficulties with 
faces and social interactions that can be experienced by some people living with AMD.  
Not everyone experiences the same problems. Also, the problems they experience may 
change as their eyesight changes. 
The following questions are designed to start a conversation between a person with AMD and 
their family, friends, and carers (e.g., nursing home staff).  
The aim is to share information about this person's individual experiences in seeing faces, the 
impact this is having on their interactions and social life, and what they would like other people 
to do to help.  
 
 
Questions can be read out loud by the family member, friend, or carer. 
 
Seeing faces 
 
• Do you have problems seeing faces? 
- How often?  Just sometimes, or almost always? 
 
• Can you see people's faces OK if they are close by? For example, if you stand or sit next to 
them and are having a conversation?  
 [Move to a conversational distance, i.e., 1-1.5 metres apart]  
- What does my face look like to you now?  
- Is my face clear or blurred? 
- Can you see my facial features clearly? e.g., my eyes, nose, lips? 
- Can you see who I am? 
- Can you see when I change my expressions? [make a sad then happy face] 
- Can you see where I'm looking? [shift eyes to left then right] 
 
• Can you see people's faces OK if they are further away, like on the other side of the room? 
 [Move to the other side of the room]  
- What does my face look like to you now?  
- Is my face clear or blurred? 
- Can you see my facial features clearly? e.g., my eyes, nose, lips? 
- Can you see who I am? 
- Can you see when I change my expressions? [make a sad then happy face] 
- Can you see where I'm looking? [shift eyes to left then right] 
  
• What lighting makes it easier or harder for you to see faces? 
- Do you like strong light? Or weak light? 
 
• Are there other things that make it easier or harder to see faces sometimes?  
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Social interactions 
 
• Do you sometimes make mistakes recognising people because you can't see their face  
  clearly?  
- Have you failed to recognise someone you know, like walking straight past a friend, or  
  not recognising a family member?   
- Have you ever said hello to someone you thought you knew, and then it turned out it was  
  someone else?   
- When you make one of these mistakes, do you worry about what the other person might  
  think? 
- Do you tell them about your vision problem? 
 
• Do you try to use other information about people to help recognise who they are, like their  
  hairstyle, or the way they walk, or their voice? 
- How often do these things actually work, so you can tell who the person is even if you  
  can't recognise the face? 
 
• Have you changed your behaviour? 
- Do you tend to wait for others to speak first because you can’t recognise them? 
- Do you wait for others to get closer to you, or move yourself closer to them to work out  
  who they are? 
- Do you smile at everyone to avoid offending people because you can’t tell whether   
  you know them or not? 
 
• Are you sometimes unable to see other people’s facial expressions, like whether they are 
looking happy, sad, angry, or bored? 
- Have you made mistakes understanding how someone is feeling, like thinking they are  
  happy and only later realising they are sad? 
- Do you ever have no idea how others are responding to you, such as if they like you or  
  not, or if they are enjoying your conversation or they are bored?   
- Do you sometimes fail to pick up on jokes because you can't see facial expressions? 
 
• Do you try to use other information to help work out what people are feeling, like their tone  
  of voice, or their body language? 
- How often do these things actually work, so you can tell how a person is feeling even if  
  you can't see their face? 
 
• Do you ever have trouble making eye contact with people, or telling whether someone is  
  looking at you? 
 
• Do you find it takes more concentration or mental effort to follow a conversation, because  
  you can't see faces properly? 
 
• If you lip read, do you find it hard to understand what people are saying because of  
  problems seeing their mouth? 
 
• Do you find it particularly hard to follow what is going on when you are in a group?  
- Why? Is it partly because sometimes you aren't sure who everyone is? 
- It is partly because you can't see everyone's expressions or where they are looking? 
113 
 
 
• Do these difficulties make it harder for you to fully engage in conversations so instead you  
  sit quietly in social situations? 
 
• Have problems seeing faces made social situations harder, or less rewarding? 
- Does it make it harder to join in, and to feel you are fully part of the group? 
- Does it mean you miss out sometimes, like missing out on talking to a friend because  
  you couldn't see them at the back of the room and you didn’t know they were there? 
- Are you worried others will think badly of you if you make mistakes, or accidentally 
  ignore them? 
 
• Do you ever just want to avoid social situations? 
 
 
How would you like others to help? 
  
[Replace 'Mary' below with actual name of the person with AMD]. 
 
• Would it be helpful if people introduce themselves when they approach, so you know who  
  they are, like saying: ‘Hi [Mary], it's Karen’ ? 
 
• In group settings, would it be helpful if everyone says the name of the person they are  
  speaking to each time, like: ‘John, who do you think will win this weekend?’ and ‘[Mary],  
  how about you?’  
 
• Would it be helpful if I said the names of people to you, like: ‘Here comes Bob’, or ‘David  
  Smith is sitting at the back of the room with his wife’ ? 
 
• Would you like me to tell you nicely if you've made a mistake, like laugh and say ‘Actually  
  that is Bob but he looks like David’.   
- Would you want me to say this in front of the other person, or when we are alone later? 
 
• Would you like me to tell you if someone is looking particularly emotional, like saying: ‘Jill  
  looks upset, she's crying’. Or help you interpret people's expressions, like saying: ‘I know  
  you might think the doctor was a bit annoyed, but actually I think we was joking because he  
  was smiling’.  
 
• Would you like me to explain your problems with faces to other people, so you don't have 
  do it all the time, or so they know you don't mean to be rude if you ignore them? 
- Who would you like me to explain to? 
- Who don't you want me to say anything to? 
- Would you rather explain yourself? 
 
• Do you have any other ideas for things I, or other people, could do to help? 
 
• Is there anything people currently do that doesn’t help (including me!), and you would like 
  them to stop doing? 
 
 
Version 25 June 2018 
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3.4.8.2 Supplement S2: Full vision assessment information, including rationale for 
ranking patients' functional vision based on best-eye BCVA 
 Twenty of the 21 patients underwent a full vision assessment in a clinical setting at 
the Australian National University (approximately 90 minutes per patient; same payment and 
ethics/consent arrangements as for the interview part of the study). Visual acuity was 
assessed monocularly using Best Corrected Visual Acuity (BCVA) and Low Contrast Visual 
Acuity (LCVA) using a retro-illuminated logMAR chart mounted on a stand conforming to 
the ETDRS standard format [1]. Other tests were used to diagnose AMD type, and stage 
using the Age-Related Eye Disease Study (AREDS system) [2], and to exclude other visual 
disorders. These included: examination of the anterior segment of the eye using slit-lamp 
biomicroscopy; instilling Oxybuprocaine Hydrochloride 0.4% eye drops to anesthetise the 
eyes to measure intraocular pressure using Goldmann applanation tonometry and to measure 
central corneal thickness using a Pachmate (DGH Technology Inc., Exton, PA); 10-2 
frequency doubling technology (FDT) threshold using Humphrey Matrix (Carl Zeiss 
Meditec, Inc., Dublin, CA). After the visual field test both eyes were dilated with 
Tropicamide 1% and Phenylephrine 2.5% and the following tests were done: Optical 
Coherence Tomography (OCT) Spectralis (Heidelberg Engineering, Heidelberg, Germany) of 
the retina (posterior-pole) and the peripapillary retinal nerve fibre layer (pRNFL); scan was 
done to measure the thickness of the RNFL surrounding the optic nerve and fundus auto-
fluorescence images were also acquired; Fundus photography was performed using a Canon 
CR-2 (Canon Inc. Medical Equipment Group, Tokyo, Japan) digital non-mydriatic camera to 
get an image of the fovea, the macula and the optic nerve. 
 Table S1 shows BVCA, LCVA, AMD type, and AREDS stage for each eye 
separately. 
 In terms of ranking (and then grouping) our patients by severity of vision loss, we 
used best-eye BCVA. Empirical justification for this — rather than, for example, using 
LCVA or acuity information from the poorer eye — was as follows.  
 First, consider low-contrast visual acuity (LCVA), still from the best eye. Whichever 
was the patients' best eye by BCVA was also their best eye by LCVA. Best-eye LCVA was 
extremely highly correlated with best-eye BCVA (r = .93), indicating no statistical potential 
of LCVA to explain any additional variance in functional vision. Consistent with this, Table 
S2a shows that best-eye LCVA correlations with everyday visual function (on the National 
Eye Institute Visual Function Questionnaire, NEIVFQ [3]) were no higher than best-eye 
BCVA correlations, for any of the full-scale NEIVFQ-25 nor the two individual items 
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relevant to face perception (A6 and Q11); indeed, LCVA correlations were slightly lower. 
Further, a stepwise regression predicting NEIVFQ-25 entering BCVA first followed by 
LCVA showed no independent effect of LCVA (on entering LCVA, F change (1, 18) =.264 
p=.614, with R square change indicating only 1.1 % of variance was explained by LCVA). 
 Second, consider the other eye. Recall that the other eye also has AMD, but with 
lower acuity. Worst-eye BCVA was largely uncorrelated with best-eye BCVA in our sample 
(r = .28), meaning there is statistical potential for worst-eye BCVA to explain additional 
variance in functional vision. However, analysis discounted this possibility. Table S2a shows 
bivariate correlations with everyday functional vision (the NEIVFQ measures) were all 
nonsignificant. More importantly, stepwise regression predicting NEIVFQ-25 entering 
BCVA first followed by LCVA showed no independent effect of LCVA (on entering LCVA, 
F change (1, 18) =.786 p=.387, with R square change indicating only 3.3 % of variance was 
explained by worse-eye acuity). Additionally, note that worst-eye acuity showed only weak 
correlations with psychological wellbeing measures (Table S2b). 
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Table S1. Detailed vision information for both eyes (bold indicates strongest eye). 
Patient code 
(from Table 1)  
Eye Visual Acuity 1 
 
Diagnosis 
 
Visual Acuity 
Repeated test 2 
AREDS 
Stage 4 
 BCVA LCVA  BCVA LCVA  
P1 L 6/240 6/240 Wet AMD   4 
 R 6/7.5 6/15 Dry AMD   4 
P2 L 6/9.5 6/19 Wet AMD 6/12 6/24 4 
 R 6/120 6/190 End-stage AMD 6/120 6/200 4 
P3 L 6/15 6/60 Dry AMD   4 
 R 6/12 6/30 Dry AMD   4 
P4 L CF <6/240 End-stage AMD   4 
 R 6/12 6/19 Wet AMD   4 
P5 L 6/15 6/38 Wet AMD 6/12 6/19 4 
 R 6/190 <6/240 Wet AMD 6/240 <6/2405 4 
P6 L 6/95 6/120 End-stage AMD   4 
 R 6/15 6/30 Wet AMD   4 
P7 L 6/15 6/60 Dry AMD   4 
 R 6/95 6/240 Dry AMD   4 
P8 L CF <6/240 Wet AMD   4 
 R 6/15 6/60 Early AMD   3 
P9  L 6/24 6/38 Early AMD   3 
 R 6/19 6/30 Wet AMD   4 
P10 L 6/30 6/60 Dry AMD   4 
 R 6/19 6/48 Dry AMD   4 
P11 L 6/19 6/48 Wet AMD   4 
 R 6/190 <6/240 End-stage AMD   4 
P12 L 6/24 6/38 Early AMD   3 
 R 6/95 6/120 End-stage AMD   4 
P13 L 6/24 6/60 Wet AMD 6/24 6/60 4 
 R CF <6/240 End-stage AMD CF <6/240 4 
P14 L 6/190 <6/240 End-stage AMD   4 
 R 6/38 6/48 Wet AMD   4 
P15 L 6/38 6/60 Wet AMD   4 
 R CF <6/240 End-stage AMD   4 
P16 L 6/60 6/95 Dry AMD   4 
 R 6/95 6/120 Dry AMD   4 
P17 3 L 3/60 - Wet AMD   - 
 R <6/60** - Wet AMD   - 
P18 L 6/150 6/240 Dry AMD   4 
 R 6/75 6/150 Dry AMD   4 
P19 L 6/75 6/120 Wet AMD   6/24 6/48 4 
 R 6/240 <6/240 End-stage AMD 6/240 <6/240 4 
P20 L 6/75 6/190 Wet AMD   4 
 R HM <6/240 End-stage AMD   4 
P21 L 6/190 <6/240 End-stage AMD   4 
 R 6/240 <6/240 End-stage AMD   4 
Notes:  
1 BCVA = best corrected visual acuity (high contrast), LCVA = low contrast visual acuity; CF = counting 
fingers, HM = hand movements. LCVA results with <6/240 indicates the patient could not read all letters on the 
largest line of the LCVA chart. L = left eye (i.e., OS, ocular sinister), R = right eye (i.e., OD, oculus dextrus). 
2 For the 4 patients with more than 6 months between interviews, vision testing was repeated close in time to 
Interview 2. Note diagnosis and AREDS stage was unchanged at the second vision assessment. 
3 P17 did not have a vision assessment at ANU. Visual acuity (BCVA only) was reported by ophthalmologist.  
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4 AREDS = Age-related Eye Disease Study [2]. AREDS stages are based on anatomy of the central 6mm of the 
retina. Stage 1 = Early AMD, small drusen. Stage 2 = Early AMD, intermediate drusen. Stage 3 = Early AMD, 
large drusen. Stage 4 = Active exudative AMD, CNV (choroidal neovascularisation)/Wet AMD; or End-stage 
Dry AMD/sub-foveal GA (geographic atrophy). For AREDS Stages 1 to 3 it is expected visual acuity would be 
close to normal; for Stage 4 acuity can vary from normal to <6/60 (e.g., depending on treatment).  
 
Table S2. Correlations (r) between different possible acuity measures and everyday 
visual function and psychological wellbeing.   
 Acuity measure used as predictor 
  
Dependent measures 
Best-eye 
BCVA 
Best-eye 
LCVA 
Worst-eye 
BCVA 
a. Everyday visual function      
 NEIVFQ-25 -.47* -.36 -.39 
 NEIVFQ-25 A6   -.58**      -.55** -.33 
 NEIVFQ-25 Q11 -.48*  -.45 -.44 
b. Psychological wellbeing     
 Anxiety (GAI)    .44*    .49*   .10 
 Depression (GDS) .12  .23 -.08 
 MacDQoL -.41 -.39 -.23 
Notes: 
* p < 0.05 (2 tailed) ** p < .001(2-tailed). Correlations performed with acuity scores in LogMAR. See main text 
Table 2 for dependent measure details. Patient P17 did not have a vision assessment; her ophthalmologist 
reported her BCVA was <6/60, however 6/60 or logMAR +1.0 was entered into the correlation. P17 did not 
have a LCVA score; a score of 6/120 or logMAR +1.3 was entered into the correlation (which is her expected 
LCVA score based on her BCVA score). NEIVFQ [3], GAI [4], GDS [5], MacDQoL [6].    
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3.4.8.3 Supplement S3: Interview 1 initial questions (asked of all participants) 
 
1. Visual problems associated with AMD: 
 
Interviewer: The first question I am going to ask you is about the visual problems you have 
due to AMD.  The question is: How much does AMD affect your vision?  
You will be asked to answer this question using one of the four following options; not at all, 
mildly e.g., sometimes, moderately, e.g., most of the time or severely e.g., all of the time.  
 
Interviewer: Now I would like you to think about how your vision problems have affected 
particular areas of your life and particular everyday tasks. Which areas or tasks have been 
made harder because of AMD?  
 
Interviewer: Now think about how much these have affected your quality of life, that is, how 
good or bad you feel your life to be. For you, Which area or task problem has MOST 
reduced your quality of life? Which has had the LEAST effect? What about the others 
in the middle?  
 
2. Problems seeing people’s faces with AMD: 
 
Interviewer: Now I am going to ask you if you have any problems seeing people’s faces.   
The question is: Has AMD made it harder for you to see people’s faces? You will be asked 
to answer this question using one of the four following options in the same way as last time; 
not at all, mildly e.g., sometimes, moderately, e.g., most of the time or severely e.g., all of the 
time. Can you give examples of how AMD has made it harder for you to see people’s 
faces? 
Some prompts if needed: 
• What particular problems do you have with faces? (e.g., what types of things can or 
can’t you see in faces anymore?).  
 • How has this affected your interactions with other people?  
 • Has it affected how much you socialise with other people? 
 
Interviewer: The next question is: How important is seeing other people’s faces to you?  
To answer this question you will be asked to use one of the four following options: not 
important, low importance, medium importance and high importance.   
 
Interviewer: The next questions are to find out if your problems with seeing faces has 
reduced your quality of life, that is reduced how good your life is. How much have your 
problems with seeing faces reduced your quality of life? (Can you give me some 
examples?) How much does this upset, bother or frustrate you? How much do your 
problems with seeing faces upset, bother or frustrate you compared to your problems with 
other visual tasks (e.g., driving, reading)? 
 
3. Identity: Problems recognising other people from their faces, and psychosocial 
consequences: 
 
Interviewer: Now I'm going to ask you specifically about one particular type of task we 
often do with faces, which is recognising who other people are. This might include, for 
example, recognising that a person is your son, or one of friends, or someone you used to 
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know from work (even though you have forgotten their name, this is not about 
remembering someone’s name, but whether you recognise a person by their face). It also 
includes just recognising whether you have seen a person before or not, e.g., if there is a 
person shopping at your supermarket today, you can tell if you have seen that person before 
or not (from their face, not their clothes etc.). 
 
The question is: Has AMD made it harder for you to recognise people from their face?  
You will be asked to answer this question using one of the four following options; not at all, 
mildly e.g., sometimes, moderately, e.g., most of the time or severely e.g., all of the time.  
 
Interviewer: You will be asked again about the importance of this task, that is: How 
important is recognising people from their face to you? You will be asked to answer that 
question using one of the four following options: not important, low importance, medium 
importance and high importance.   
 
Interviewer: 
• If AMD has made it hard to recognise people from their face, can you give me some 
examples?  
• Are some people's faces easier or harder for you to recognise than others? Do you 
know why? (kids? other age groups? distinguishing features? immediate family?) 
• Are there situations/places in which you find it easier or harder to recognise people's 
faces? 
• Do you find you fail to recognise people you do know? Give examples [false negatives] 
• Do you ever think you recognise someone who you don't actually know? Give examples 
[false positives] 
• Do problems like these make you upset, or embarrassed, or do they bother or frustrate 
you? How much? Can you give some examples? 
• Did it affect the other person? If so, how? (did it upset, embarrass, or annoy them) 
• Have any of the problems you have talked about changed the way you deal with other 
people? 
• Have they made you less willing to have social interactions, or to go out? 
• Have any of the problems you have talked about affected your confidence? 
• Overall, how much have problems in recognising other people from their face affected 
your quality of life?   
 
Interviewer: The next questions are related to whether you seek help with recognising 
other people from their face and what other strategies you might use to do this for 
yourself. 
If AMD has made it hard for you to recognise people's faces: 
 Do you notice people around you help you to recognise other people? In what 
way? e.g., do you ask for their help? i.e., you partner whispers you the name of a 
person as they walk up to you, or they might say "Hi Bob....", or introduce some 
identifying information into the conversation. 
 If no help is available from someone else, do you have particular strategies that 
you use to help get around the problem? e.g., recognising a person by the hair or 
the way they walk, or clothes, or their height/weight. 
 How effective do you find these strategies? 
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4. Problems recognising other people's facial expressions, and psychosocial 
consequences: 
 
Interviewer: Now I'm going to ask you some questions about another type of task we often 
do with faces, which is to recognise other peoples' facial expressions and from that their 
emotions (i.e., what they are feeling). This includes, for example, recognising that someone is 
smiling or frowning, and using their facial expressions to know when someone is happy, or 
sad, or angry, or bored, or in pain. Has AMD impacted your ability to see a person’s facial 
expressions? Again you will be asked to answer this question using one of the four following 
options; not at all, mildly e.g., sometimes, moderately, e.g., most of the time or severely e.g., 
all of the time.  
 
Interviewer: You will be asked again about the importance of this task. 
How important is it for you to be able to see a person’s facial expressions? not important, 
low importance, medium importance, high importance? 
 
Interviewer: 
• If AMD has made it hard to see a person’s facial expressions, can you give me some 
examples?  
• Are some facial expressions easier or harder for you to see than others? Do you know 
why? (smiling can see flash of teeth, surprise mouth is open etc.) 
• Are there situations/places in which you find it easier or harder to see facial 
expressions? 
• Is it easier for you to see facial expressions on a person you know really well compared 
to a stranger? Do you know why? 
• Does not being able to see a person’s facial expressions make you upset, or 
embarrassed, or does this bother or frustrate you? How much? Can you give some 
examples? 
• Have you had situations where not being able to see a person’s facial expressions 
affected the other person? If so, how? (did it upset, embarrass, or annoy them) 
• Have your problems seeing a person’s facial expressions changed the way you deal 
with other people? 
• Have they made you less willing to have social interactions, or to go out? 
• Have any of the problems you have talked about affected your confidence? 
• Overall, how much have problems in seeing a person’s facial expressions affected your 
quality of life?   
 
Interviewer: The next questions are related to whether you seek help with seeing facial 
expressions and what other strategies you might use to do this for yourself. 
If AMD has made it hard for you to see a person’s facial expressions: 
 Do you notice people around you help you to see facial expressions or to realise 
how someone is feeling? In what way? e.g., do you ask for their help? i.e., you 
partner whispers you that Bob is looking sad, or say something aloud in conversation 
e.g., “Hi Bob. You are looking a bit down today”. 
 If no help is available from someone else, do you have particular strategies that 
you use to help get around the problem? e.g., looking for flashes of teeth to indicate 
smiling, listening to the tone of the person’s voice, asking them how they are feeling 
today.  
 How effective do you find these strategies? 
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5. Relative importance of recognising facial expression and facial identity: 
 
Interviewer: Which is most important to you about face recognition: recognising who 
people are; or recognising their expressions? You have three options: 
a) recognising who they are 
b) recognising their expressions 
c) both are equally important. 
 
6. Visual face cues to speech: 
 
Interviewer: Now I'm going ask you some questions about whether you think your problems 
with seeing faces have affected your ability to follow other people's speech, and to follow 
conversations. 
• Do you find it harder to follow face-to-face conversations than you did before your 
AMD really started affecting your vision? 
• Do you know if your hearing itself might be a problem as well? 
• Do you think your ability to follow face-to-face conversations has been affected more 
than your ability to hear people's speech well on the phone? If so why? 
(e.g., because the speech itself seems less clear or less easy to understand what words people 
are saying than it used to?; because I find it harder to follow their emotions?; following 
conversational norms: because you don't know who is going to speak next, you don't when 
someone is about finish talking?).  
 
7. Willingness to use technology to improve face recognition: 
 
Interviewer: I am now going to talk about the last topic in today’s interview: the use of 
technology to help your ability to recognise faces. We won't be able to improve your vision 
itself, but the idea is to try to show you faces using technology in such a way that they 
become a bit easier for you to recognise. This technology doesn't exist at the moment, but we 
are trying to develop it, and as a first step we are asking you about what you think might be 
most useful and practical to you. 
 
Watching the TV 
First we're going to talk about TV. Do you find faces and their emotions hard to recognise 
on TV?  
 
The type of thing we want to try is to see whether we can make the faces on TV easier for 
people with AMD to see and recognise, by enhancing the picture in some way. There are 
various different ways we might try to change the picture to make the faces easier -- we won't 
try to explain the details to you now because it is very technical. We also don't know yet 
whether these changes to the picture would actually work (i.e., help you) -- that's what the 
rest of our project 1 will be about finding out. 
 
 
 
                                                 
1 Here, the "rest of the project" refers to other studies, not included in the present article, which involved 
testing whether image enhancement via face caricaturing could improve patients' identity/expression 
recognition. 
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But our question at this stage is whether: If we WERE able to make the faces on TV easier 
for you to recognise, how helpful would that be to you? not at all helpful, a little bit 
helpful, e.g., sometimes, somewhat helpful, e.g., most of the time, very helpful, e.g., all of the 
time. Can you provide more information about your answer? 
 
In real life 
Now I’m going to talk about real life rather than TV.  
Here, we are talking about: 
(a) taking photos or video of real people you are talking to or seeing at the time,  
(b) using some kind of device with a screen to show you those pictures so that they are bigger 
than in real life, and  
(c) enhancing the face pictures to make them easier to see and recognise in the same way as 
we would be trying for TV.  
 
Let's go through some practical examples to make it clearer what this might mean and how it 
might work. 
 
A. iPad / tablet computer 
[Show the iPad, held in crook of arm, with full-size face on it].  
Interviewer: The idea is that you would have a camera on your glasses and the face pictures 
would be shown on the iPad, which is a little computer.  
You would press a button you are holding, or is in your pocket, to tell it when you see a face 
that you wanted expanded up and the iPad would expand and enhance the face pictures for 
you to look at, which we think should make them easier to recognise. There wouldn't be any 
wires or noise. Hold it to one side or the other (to use your peripheral vision; get them to try 
both sides). 
 
Do you think this sort of set up might be useful to you in everyday life? Would it work 
practically? If not, what's wrong with it? (Holding other things; expense) 
 
How enthusiastic/interested would you be about trying this type of set up in your 
everyday life? (if we can eventually get it to work) 
 Not at all interested, mildly interested, moderately interested, very interested.  
 
B. Smartphone   
[Show the smart phone with full size face, held up close-ish to participant’s face so the image 
is large].  
Interviewer: Using the smartphone will be similar to the iPad or tablet computer, but you use 
a smaller screen (phone) held closer to your eyes, rather than a bigger screen (iPad) held in 
the crook of your arm. 
 
Do you think this sort of set up might be useful to you in everyday life? Would it work 
practically? If not, what's wrong with it? (Holding other things) 
 
How enthusiastic/interested would you be about trying this type of set up in your 
everyday life? (if we can eventually get it to work) 
 Not at all interested, mildly interested, moderately interested, very interested. 
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C. Smart Glasses 
A researcher at The University of Oxford has recently developed special glasses that can be 
used to display pictures on the glasses themselves, without you needing to hold anything. 
Again, the glasses have a built-in camera, and can expand and enhance the pictures. You 
would press a button to control whether you want it to show you an expanded face or whether 
you want to switch it off so you can see through your glasses as normal. 
[Show picture of smart glasses prototype]. 
 
Do you think this sort of set up might be useful to you in everyday life? Would it work 
practically? If not, what's wrong with it?  
 
How enthusiastic/interested would you be about trying this type of set up in your 
everyday life? Not at all interested, mildly interested, moderately interested, very interested. 
 
D. Comparison 
From the options we have discussed; iPad, Smartphone, glasses, which do you think 
would be most practical for you? Why? 
 
Do you currently use an iPad or smart phone device? 
 
E. Is computer naming enough?  
All of these methods use a little computer of some sort to help, but also use your brain to 
do/process the actual recognition of the face.  
Would it be at all useful to you if a computer was able itself to work out who a person is 
and tell you than name somehow aloud?  
e.g. say their name in your ear?  
If so, would that be all you would want, or would important things still be missing for 
you? e.g. would it still be important to you to be able to recognise the face yourself.  (NB. 
Wouldn't work for expression). 
 
F. Websites e.g., news, internet, Facebook etc.  
Like TV, would it be useful if we could enhance face pictures on the internet? e.g., new 
websites, Facebook etc.  
 
G. Other suggestions 
Do you have any other suggestions related to technology or a device that could help you to 
see faces better? 
 
Are there any comments or questions you have about what we have discussed today? 
 
  
124 
 
3.4.8.4 Supplement S4: Interview 1 example of different follow-up questions to initial 
questions, arising from different patient responses 
The way in which the participant responded to the initial interview questions was not 
uniform, and the follow-up questions and discussion was based on each participant’s 
individual response. The two examples below demonstrate the richness of responses and 
variability across participants: in response to the same question, P9 discussed the appearance 
of faces to her, whereas P16 talked about the impact of his poor face recognition on social 
interactions, the strategies he uses to recognise others, and variability in how well he can see.  
• P9 was asked ‘Can you provide examples of how AMD has made it harder for you to 
see people’s faces?’ to which she replied: ‘You mean how do I perceive them?’ She continued 
by explaining ‘Well, their features are kind of deformed, jumbled’. The interviewer linked 
P9’s reports of facial distortions to her previous reports of facial blur, then saying: ‘That’s 
really interesting, it’s not just the blur, it’s actually the way the face is configured’ to which 
P9 replied: ‘It is, yes’. 
• Another patient (P16) was asked the same original question: ‘Can you provide 
examples of how AMD has made it harder for you to see people’s faces?’. He replied: ‘I can 
meet people down the street that I have known for fifty, sixty years … they can pass me within 
arms-length and they speak to me and I can’t see who it is’.  The interviewer followed up 
with ‘How does that make you feel?’. P16 said ‘Not good, sometimes I, if there are people 
coming towards me I can pick their walk, and listen, sometimes I know their talk, you know’. 
The interviewer followed up the information about non-face strategies with: ‘So you can use 
strategies like walking and their voice, talking’ to which P16 replied ‘Yes, the vision is 
different from time to time … sometimes I can see and sometimes I can’t see anything.’ 
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3.4.8.5 Supplement S5: Relative importance of face perception domain compared to 
domains currently included in the MacDQoL 
 In the first section of Interview 1, before any questions about faces had been asked 
(see Supplement S3), we asked patients “What areas or tasks have been made harder because 
of your AMD?”. This question format was deliberately open ended, and early in the 
interview, to obtain information about what areas/tasks came to patients' minds without prior 
leading questions about any particular domains. Table S3 lists the full set of responses from 
each patient, in the order they raised each area/task. Table S4 summarises the percentage of 
patients spontaneously mentioning face perception (bold responses from Table S3) as 
compared to percentage of patients spontaneously mentioning 10 domains currently on the 
MacDQoL [6]. Note this table codes only for MacDQoL domains which we would 
reasonably be expected to be elicited by our "areas or tasks" question format: more abstract 
domains (e.g., 'closest personal relationships') were not mentioned by any patients but we do 
not take that as meaningful given the question format would not be expected to elicit these 
domains.  
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Table S3. Individual patient responses to interview question “What areas or tasks have 
been made harder because of your AMD?”, with face-related responses highlighted.  
Patient code What areas or tasks have been made harder because of your AMD? 
P1 Reading, cutting up food, cooking, eating, dressing, hair, walking 
P2 Shopping, reading 
P3 Reading, identifying people at a distance, TV, walking, computer, driving, close 
work e.g., knitting, home duties e.g., pouring things, cooking 
P4 Making a cup of tea, walking (especially steps/changes in height), reading, 
knitting, TV, going to the theatre, recognising people when walking down the 
street, shopping 
P5 Everything, dressing, cooking, cutting vegetables 
P6 Everything, domestic duties, filing, crosswords 
P7 Reading, recognising someone across the room, telephone numbers, gardening, 
sewing 
P8 Walking around, reading, cooking, cleaning, driving  
P9 Reading, quilting, beading 
P10 Driving, recognising people in a crowd at a distance, reading 
P11 Writing, computer, identifying people, driving 
P12 Reading, watching TV because can’t see people very clearly, sewing 
P13 Reading, computer, gardening, sewing, recognising people 
P14 Work (practicing pharmacy), driving, reading, working with tools e.g., machinery 
P15 Reading, needle work, close work, seeing the ballet 
P16 Getting around/walking, reading, shopping, driving 
P17 Reading, cooking, craft, knitting, playing DVDs, ironing, driving, TV 
P18 Reading, close work e.g., sewing, cooking, cutting, gardening, home duties e.g., 
ironing, cleaning, things with electricity, driving, crossing streets 
P19 Reading, writing, knitting, using my hands 
P20 Recognising people, looking at fine things e.g., microwave, odd jobs at home, 
reading, driving  
P21 Painting, reading a clock, seeing colour, knitting, crocheting, tasks around home 
e.g., dealing with electricity/powerpoints 
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Table S4. Percentage of patients spontaneously mentioning face perception as compared 
to 10 domains currently on the MacDQoL [6]. 
Domain (all except faces currently 
included in MacDQoL) 
No of patients % of patients 
(N=21) 
Interests/Free time activities (reading, TV, radio, hobbies) 20 95 
Household tasks  16 76 
Get out and about (foot, car, bus, train) 11 52 
Faces 8 38 
Personal affairs (letters, bills, etc.) 3 14 
Shopping 3 14 
Physical appearance (clothes, grooming) 2 10 
Enjoy meals 1 5 
Independence 0 0 
Do things for others 0 0 
Mishaps or lose things 0 0 
Notes: 
Some domains in the MacDQoL [6] provide specific examples e.g., Interests/Free time activities (reading, TV, 
radio, hobbies), whereas other domains e.g., household tasks, does not provide examples.  We categorised 
patients’ responses in Table S3 into the most suitable MacDQoL domain e.g., for household tasks included 
cooking, gardening and use of powerpoints.   
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3.4.8.6 Supplement S6:  Interview 2 results for patient endorsement of content included in 
Faces and Social Life in AMD Information Sheet 
Table S5 indicates the degree to which, in Interview 2, patients endorsed the inclusion 
of particular concepts in our Faces and Social Life in AMD Information Sheet. The table 
includes only statements for which the key information was eventually included in the 
Information Sheet. The final wording in the sheet may have been simplified or shortened as 
compared to statement listed in table. 
Note Table S5 does not list all statements that patients were asked to consider. Some 
additional statements were excluded from the final information sheet because patient 
responses indicated the statements were poorly or confusingly worded (i.e., the patients 
couldn't understand them), or had too much information (and therefore it was not certain 
which part of the statement patients were endorsing). Further, some additional statements had 
included draft information about severity of AMD (along the lines, for example, that patients 
with less severe AMD would have no trouble seeing faces/expressions, or be fine seeing them 
close-up) which in fact turned out to be inaccurate once we had analysed the full interview 
data from all participants. Another observation from patients' responses was that the 
information sheet should be kept purely to dealing with issues related to faces and social 
interactions: we found that any statements including any mention of other aspects of AMD 
(e.g., either medical details, or other aspects of vision loss such as driving) distracted patients 
by making them think the information sheet was about these topics as well, or AMD more 
broadly, and thus should include extensive other information about AMD (which is well-
covered by existing AMD public information sheets). We also included three open ended 
questions about whether patients had other points they thought would be good to include, but 
these did not elicit any additional information. 
In Table S5, where total patient numbers do not equal 19 (the number who 
participated in Interview 2), this is because one or more patients: did not provide specific 
feedback about the statement (e.g., they described their own experience or were distracted by 
components of the question that were not relevant for present purposes, e.g., reading and 
driving); said they couldn’t comment because they did not have personal experience 
regarding the statement; or were not asked the question (due to fatigue, being distracted or 
they did not endorse a previous relevant statement).   
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Table S5. Patient Endorsement of Including Particular Statements in the Information Sheet.   
 
Statement read to patients 
# patients 
endorsing 
Faces and social interactions  
People living with AMD can have problems with faces. This includes recognising who other people are, and 
also with seeing their facial expressions. 
18/18 
There is a lot of variation across the visual abilities of AMD patients.... Some find bright light useful ... whereas 
others are sensitive to bright light. [Full statement included additional material on other topics; patient 
transcripts have been used to extract specific endorsement of information about variability.] 
10/16 
Some people with AMD may appear disengaged in social situations, this may be because they cannot see who is 
in a room. 
15/15 
People with AMD 1 may also be unable to see a person’s facial expressions i.e., whether someone looks happy, 
sad or bored.  Because they cannot see facial expressions, they might miss social cues.  For example, someone 
might be looking bored but the person with AMD can’t see this so they keep on talking, or a person might be 
just having a joke and is smiling when they say something, but the person with AMD takes it seriously. 
15/16 
Do you think it would be helpful to let others know that social situations can be tricky because of vision loss in 
AMD? ['Yes' responses] 
10/11  
Where a person with AMD has trouble with faces this can lead to a variety of difficulties in social settings.  For 
example, people may feel less confident in social situations and they may also feel frustrated or  
embarrassed that they cannot recognise people from their face. These feelings can impact how a person with 
AMD behaves in social situations which may include becoming less interactive and engaged and more passive. 
For example, they might wait for people to come to them rather than approaching other people in the room. It 
could also include waiting for other people to speak first, before they speak. 
18/18  
Vision loss in AMD can affect a person’s confidence in social situations 18/19 
What can be done to help?  
So, what can be done to help? First, there are some strategies a person with AMD might try out by themselves 
to help with recognising people. Strategies that might be helpful to try include: waiting until the other person 
speaks and recognising their voice; or trying to recognise the person from distinctive clothing, or their hair, or 
their body shape because these things don’t require such fine vision as recognising their face. Be aware, 
however, that these strategies do not always work, e.g., the other person may not speak, or they might have 
changed their appearance in some way (like their hairstyle or lost weight), or they may wear similar clothing to 
lots of other people. 
19/19 
For recognising expressions, strategies that the person with AMD might find helpful to try include: listening to 
tone of voice, noticing body language and context e.g., is another person engaging with others or sitting alone?  
Be aware, however, that these strategies do not always work e.g., people may not be open about the way they 
feel and behave in a way that does not indicate their emotions, and vision loss in AMD will make it difficult to 
pick up subtle cues from the facial expressions that indicate a person’s true emotions. 
18/18 
There are also strategies people around the person with AMD — such as family members, friends, and carers — 
can try when they are having trouble seeing faces. These strategies involve giving the person extra information 
to help them identify who people are, and what their expressions are showing; e.g., you could: 
    - Say “Hi Bob” to identify a person aloud as they approach, or provide other clues about the person such  
      as “How did the trip to the coast with Mary go last week?” 
    - Whisper the name of a person approaching  
    - Identify out loud familiar people sitting around the room that are too far away for the person with              
      AMD to recognise. For example, “Aunty Jo is sitting at the back of the room with her husband”.  This  
      may encourage the person with AMD to move around a room and be more engaged in social situations  
      if they know who is present. 
    - For facial expressions and mood, say “Uncle Bruce is looking down today” or “Bob is sitting on his  
      own and he looks tired” or “Joan had a big smile on her face when she said that, I think she is having a  
      joke with you”. 
19/19 
Others don’t understand/ concerns about faking it   
The fact that AMD is invisible to other people can be difficult and confusing.  For example, others can see you 
doing some visual tasks (walking around) and they might forget you cannot do other visual tasks (read and see 
faces).  Do you think explaining this to others might help? ['Yes' responses] 
19/19 
Because of these inconsistencies across visual tasks, other people may think a person with AMD is faking their 
vision loss (or people with AMD might worry that others might think this).  Do you think explaining this to 
others might help?  ['Yes' responses] 
14/14 
Notes: 1 Wording originally said "with moderate AMD" but patients endorsed the statement for all levels of 
vision loss.  
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Chapter 4: Development of the Face Perception and Social 
Interactions in AMD (FPSI_AMD) Questionnaire   
 
4.1 Background 
The qualitative study presented in Chapter 3 provided evidence of the types of face 
perception and psychosocial difficulties experienced by AMD patients. However, it did not 
examine the frequency at which the types of face perception difficulties occur, either in 
individual patients nor (with any degree of accuracy given our small sample size) averaged 
across patients. This chapter presents a new Face Perception and Social Interactions in AMD 
Questionnaire (FPSI_AMD; refer to section 4.4) designed to be used to quantify face and 
social problems in AMD (and potentially other low vision disorders) based on the findings of 
Chapter 3. There are many research questions of scientific interest that can be addressed only 
with access to such quantitative information, thus supporting the development of the 
FPSI_AMD. Here I will describe the questionnaire and propose some potential uses for it. 
Testing of the questionnaire was beyond the scope of this thesis. Further investigation is 
required to determine the useability of this measure (i.e., structure, wording and length when 
administered on older adults with vision loss), as well as evaluation of the psychometric 
properties, including validity and reliability and Rasch analysis to determine the 
dimensionality, discriminant ability and item difficulty of the questionnaire (similar to the 
analysis conducted on the MacDQoL by Finger et al., 2012).   
 
4.2 Design and structure of the FPSI_AMD Questionnaire 
The FPSI_AMD questionnaire is a quantitative measure that includes questions that 
cover the different domains we assessed in the qualitative study (Chapter 3) and it is 
organised into 5 sections. Part 1 “Seeing faces” asks about the importance of seeing faces to 
gauge the potential impact of reduced face perception on the individual participant as 
proposed by Mitchell and Bradley (2004). Part 1 also covers problems with perceiving faces 
(including identity, expression, eye gaze, and facial speech, making mistakes, use of non-face 
recognition strategies, face perception ability prior to AMD and hearing loss). Part 2 “What 
do faces look like to you?” covers blurring, distortions, other visual experiences and 
variability in vision. Part 3 “How much do other people understand?” includes telling others, 
worrying that others think you are faking, and others not understanding vision loss. Part 4 
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“Social situations” asks about social interaction difficulties related to impaired face 
perception, confidence and quality of life. Finally, Part 5 “What can other people do to help?” 
covers practical strategies for patients and people around them that might make social 
situations easier. 
 The instructions for the FPSI_AMD questionnaire specify the questions are designed 
to be read aloud to the patient by a family member, friend or carer. The aim of the 
questionnaire is to gain quantitative data on the frequency and severity of the various 
problems that occur in everyday life in AMD. The instructions also emphasise the variability 
in vision across AMD patients, that is, every person’s experience with AMD is different. 
Finally, the instructions state “there are no right or wrong answers” to encourage participants 
to respond based on their current personal experience of AMD.  
 Most questions in the FPSI-AMD questionnaire ask participants about the occurrence 
of an experience (e.g., "How often does AMD make it hard for you to recognise someone by 
their face?”) with responses on a 4-point scale (0 = never; 1 = sometimes; 2 = often; and 3 = 
almost always). The 4-point likert scale was chosen to obtain good variability across 
responses without overwhelming older adult participants with too many options. The 
response “almost always” was chosen rather than “always” as most occurrences are unlikely 
to occur always unless the vision loss due to AMD is very severe (e.g., because a face might 
be recognisable very close up, if not further away). When dichotomous responses were more 
appropriate, yes/no responses were used e.g., to the question “Do family and close friends 
know about your vision loss” and in Part 5 asking if particular strategies would be helpful in 
social situations. In Part 4 patients were asked to rate the severity of their difficulties (0 = not 
at all; 1 = mildly; 2 = moderately; 3 = severely) e.g., to respond to the question “how much 
[has their problems seeing faces and difficulties in social situations caused by AMD] reduced 
your confidence?”. Open-ended questions are also included to allow patients to describe in 
their own words their experience of face perception with AMD and to determine if areas have 
been missed and further questions could be developed.     
The wording on the FPSI_AMD as demonstrated here focuses specifically on AMD, 
but with minor wording changes, that is, inserting the specific low vision disorder, the FPSI 
will be suitable for other forms of macular degeneration, or indeed more broadly for 
assessing problems with face perception and social interactions in any low vision disorder. 
We request that if researchers use the questionnaire in other low vision disorders, that they 
make an appropriate variation to the questionnaire name (e.g., FPSI_RP for a retinitis 
pigmentosa version, or FPSI_CAT for a cataract version). There is also no requirement that 
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the full questionnaire be administered: for example, the sections (or individual questions) on 
exactly what faces look like to patients, and on exactly what alternative strategies they use, 
will be of relevance only to certain types of research projects, and might well be omitted in 
projects focussing on, say, quality of life issues. The FPSI will be made freely available to 
researchers, on the proviso that this thesis is cited as its source in any publications arising 
from use of the FPSI_AMD questionnaire or variants. 
 
4.3 Proposed uses of the FPSI_AMD 
The quantitative FPSI_AMD questionnaire will allow future studies to address 
questions of scientific interest that are beyond those that can be addressed with qualitative 
research. Examples include: determining with reliability the proportion of AMD patients who 
experience particular face perception or social interaction problems (this requires testing a 
much larger sample size than is feasible with a qualitative study); testing statistically whether 
certain social interaction problems increase in severity as vision loss worsens (i.e., comparing 
low versus moderate versus severe-vision loss groups); testing whether certain problems 
might be improved by a technological intervention (e.g., image enhancement); testing 
whether certain face perception problems (e.g., percept of blur versus distortions) might be 
associated with, say, different types of AMD (wet versus dry) or other aspects of AMD 
progression (e.g., whether acuity is supported by a small island within an otherwise severely 
damaged fovea, versus by using peripheral vision only). The FPSI_AMD questionnaire could 
also be used to test large sample sizes to accurately determine rates of certain types of social 
interaction difficulties, or to statistically evaluate their association with other measures such 
as vision loss severity or patients' depression levels. It could also be used to address the 
effectiveness of potential interventions such as face image enhancement via smart glasses, by 
providing pre-versus-post intervention scores for everyday social interaction problems and 
quality of life. 
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4.4 The Face Perception and Social Interactions in AMD (FPSI_AMD) 
Questionnaire 
 
• This questionnaire can be used by people with Age-related Macular Degeneration (AMD) 
to help explain to your family, friends, and carers, exactly how AMD has affected your ability 
to see faces, and how this affects you in social situations. 
• It is designed for people whose vision loss means they experience some trouble seeing 
faces properly in everyday life. 
• One way to use the questionnaire is for the family member, friend, or carer to read the 
question out loud, and use this as a springboard to start a conversation.  
• Every person's experience with AMD is different. There are no right or wrong answers. 
Also, if your AMD has got worse over time, you might find that the answers you give now are 
not the same as they would have been when you were first diagnosed, or may not be the 
same in the future.  
 
The questions are about your personal experience of AMD at the moment. 
 
 
PART 1: Seeing faces 
 
How important is seeing faces to you? 
 
Not important  Low importance    Medium importance  High importance 
 
1. How often does AMD make it hard for you to see faces properly when they are at a 
distance e.g., on the far side of the room? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
2. How often does AMD make it hard for you to see faces properly when they are close up to 
you e.g., 1-2 metres away when having a conversation? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
3. How often does AMD make it hard for you to see facial expressions e.g., whether 
someone is looking happy, angry, bored, etc.? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
4. How often does AMD make it hard for you to recognise someone by their face?  
 
0 1 2 3 
Never Sometimes Often Almost always 
 
5. How often do you fail to recognise someone you know well, e.g., you might walk straight 
past an old friend, or not realise the woman standing next to you is your neighbour? 
 
0 1 2 3 
Never Sometimes Often Almost always 
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6. How often do you recognise someone you don't actually know, e.g., say hello to someone 
and then realise it isn’t who you thought it was? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
7. How often did you make these types of mistakes in recognising people before you had 
AMD? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
8. How often do you try to use other, non-facial information about people's appearance to 
recognise them, e.g., the way they walk, their distinctive body shape, hair or clothing? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
9. How often does using other information to recognise someone not work e.g., you thought 
you recognised a person by their walk and then realised you were wrong?  
  
0 1 2 3 
Never Sometimes Often Almost always 
 
10. How often do you use a person’s voice to recognise them?  
 
0 1 2 3 
Never Sometimes Often Almost always 
 
11. How often do you use a person’s tone of voice or other sounds (laughing, crying) to work 
out how they are feeling?  
  
0 1 2 3 
Never Sometimes Often Almost always 
 
12. How often do you use a person’s body language to work out how they are feeling?  
 
0 1 2 3 
Never Sometimes Often Almost always 
 
13. How often does AMD make it hard for you to see where other people are looking e.g., 
whether they are looking at you or not? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
14. How often does AMD make it hard for you to see a person’s mouth clearly and 
understand what they are saying?  
 
0 1 2 3 
Never Sometimes Often Almost always 
 
15. Do you have hearing loss? 
 
No    Mild   Moderate   Severe 
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PART 2: What do faces look like to you? 
 
1. How blurred do faces look to you?  
 
 0  Not blurred at all   
 1  Blurred in the distance but OK close up 
 2  Quite blurred even close up (1-2 metres away) 
3  So blurred that even close up (1-2 metres away) the eyes, nose and mouth are  
    not clear, blurred or fuzzy blobs 
 
2. How often do faces look distorted to you? 
‘Distorted’ includes the face looking twisted or a weird shape, parts of the face moving 
around and/or parts of the face disappearing. 
 
0 1 2 3 
Never Sometimes Often Almost always 
  
3. How often do you see a black 'blob' in the centre of your vision? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
4. How often do you see other visual experiences that affect your ability to see faces, e.g., 
flecks, movement, hallucinations (seeing things that you know aren’t there) feeling like you 
are looking through a screen, etc? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
Describe these visual experiences and how they make faces look like to you:  
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
5. Does your ability to see faces vary with different lighting conditions? 
 
 0    No, it's always pretty much the same 
 1    Yes, different light makes me see faces better or worse  
 
If Yes, what lighting works best for you? 
  
Low light  Bright light   Medium light   It changes at different times 
  
6. Does your ability to see faces vary with other factors e.g., time of day; whether you've 
recently had an injection; etc.? 
 
0 No   
1    Yes  
 
If Yes, describe this: 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
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7. Overall, describe how faces look to you: 
 
___________________________________________________________________ 
 
___________________________________________________________________ 
 
 
PART 3: How much do other people understand? 
 
1. Some people tell others about their vision loss and others like to keep it private:  
 
a. Do family and close friends know about your vision loss?     
 
0    No     
1    Yes 
 
b. Do you tell other people you aren't as close to, e.g., people you haven't seen for a while, 
neighbours, workmates, nurses who help care for you, other residents in your nursing 
home? 
  0    No, never 
  1    Sometimes (e.g., if I make a mistake and don't recognise them) 
  2    Yes, I'm happy to tell anyone 
 
If you tell other people about your vision loss (you have answered Yes in Q1a above): 
 
2. AMD can lead to difficulty with lots of visual tasks, for example reading or driving. How 
often do you tell others specifically about how AMD affects your ability to see faces?  
 
0 1 2 3 
Never Sometimes Often Almost always 
 
3. How often do you worry that other people might think you are faking it? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
4. How often do you worry other people don’t understand that you do have a vision problem 
(e.g., because you can do some visual tasks like see well enough to walk around)? 
 
0 1 2 3 
Never Sometimes Often Almost always 
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PART 4: Social situations 
 
1. Imagine another person is walking towards you or standing next to you, and you are not 
sure who they are. How often do you: 
 
a. Wait for the person to speak first because you can't recognise them by their face? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
b. Wait for the person to get closer to you, or move yourself closer to them, to help you 
work out who they are? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
c. Smile at everyone to avoid offending them because you can't see whether you know 
them or not? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
2. Now think about actually making a mistake, such as saying "Hello Bill" to someone you 
thought was Bill but it turns out you've actually never met, or ignoring someone you do know 
because you didn't recognise them. When this happens, how often do you: 
  
       a. Worry that they might think you are rude or judge you?  
 
0 1 2 3 
Never Sometimes Often Almost always 
 
       b. Feel frustrated? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
       c. Feel embarrassed? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
       d. Apologise?  
 
0 1 2 3 
Never Sometimes Often Almost always 
 
       e. Have a laugh about it or make a joke? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
      f. Tell them you have vision loss?  
 
0 1 2 3 
Never Sometimes Often Almost always 
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3. Some people with AMD say they sometimes miss important information about how other 
people feel. For example, because you can't see expressions clearly, you might not realise 
when something you said hurt someone's feelings. Or, you might not realise when the 
person you are telling a story to has got bored, and it is time to change the topic of 
conversation. Thinking about these types of examples: 
 
How often do you worry that you miss important information about how other people feel?  
 
0 1 2 3 
Never Sometimes Often Almost always 
 
4. Some people with AMD say they find it hard to follow conversations properly. This can 
happen for lots of different reasons, including because you are unsure who people are, or 
you can't see their expressions so you are slow to pick up the jokes, or you don't realise 
when someone is talking to you because you can't see that they are making eye contact with 
you. Thinking about all these sorts of things: 
 
a. How often does AMD make it hard for you to properly follow a conversation when 
you are one-on-one with another person?  
 
0 1 2 3 
Never Sometimes Often Almost always 
 
b. How often does AMD make it hard for you to properly follow what is going on when 
you are in a group (e.g., 5 or more people)? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
Do you watch TV? 
 
  0    No 
 1    Yes  
 
a. If you watch TV, how often do you have problems seeing faces and their 
expressions on TV? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
b. How often does AMD make it hard for you to properly follow what is going on 
between the characters in TV shows: 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
6. In a room or social event with lots of people, do you sometimes find out later that there 
were people there you knew, and that you would have liked to talk to, but you didn't 
recognise them and so didn't know they were there?  
 
0 1 2 3 
Never Sometimes Often Almost always 
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7. Now think about all the things you've already told me, about problems seeing faces and 
difficulties in social situations caused by AMD.  
 
How often have these things: 
 
     a. Made social situations harder? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
     b. Made social situations less rewarding? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
     c. Made you go quiet or withdraw in a group? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
d. Made you avoid or be less enthusiastic about having social interactions with other 
people? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
e. Made you feel like you couldn’t join in? 
 
0 1 2 3 
Never Sometimes Often Almost always 
 
f. Made you feel like you weren’t part of the crowd or group? 
 
0 1 2 3 
Never Sometimes Often Almost always 
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8. Keep thinking about all the things you've told me about problems seeing faces and 
difficulties in social situations caused by AMD.   
 
How much have these: 
 
 a. Changed your personality so you are less outgoing? 
 
0 1 2 3 
Not at all Mildly Moderately Severely 
 
b. Made you feel the following: "I won't let AMD take my social life away from me, 
and I have to actively fight against it to keep up a good social life"? 
 
0 1 2 3 
Not at all Mildly Moderately Severely 
 
     c. Reduced your confidence? 
 
0 1 2 3 
Not at all Mildly Moderately Severely 
 
     d. Reduced your quality of life? 
 
0 1 2 3 
Not at all Mildly Moderately Severely 
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PART 5: What can other people do to help? 
 
I'm going to read out a list of things which other people might try, to help make social 
situations easier for you. Which of these things do you think would be useful to you (or are 
already useful to you if some people around you do them already)? 
 
1. It is useful for people to introduce themselves when they approach you: ‘Hi Mary, it's 
Karen’. 
    Yes    No 
 
2. If someone is coming towards you, say their name: ‘Here come's Bob’. 
     
    Yes    No 
 
3. When I join a group, or go into a room with a group of people in it, tell me the names of 
any people I know in the room, and point out where they are, so I don't miss any friends. 
 
    Yes    No 
 
4. In group conversations, use the name of the person you are speaking to each time: ‘John, 
who do you think will win this weekend?’ and ‘Mary, how about you?’   
     
    Yes    No 
 
5. Tell me if someone is looking particularly emotional ‘Jill is crying, I wonder what has 
happened’. 
    Yes    No 
 
6. Tell me nicely if I've made mistake: Laugh and say ‘Actually I think the doctor was joking’ 
or ‘that is Bob, he looks a lot like John’. 
   
    Yes    No 
 
7. Explain about my vision problems to other people, so I don't have to do it all the time, and 
so they know I don't mean to be rude. 
    
    Yes    No 
 
8. Is there anything people currently do that doesn’t help? 
 
___________________________________________________________________ 
 
 
9. Is there anything else others can do to help? 
 
___________________________________________________________________ 
 
10. Is there anything else about face perception you would like to include that we have 
missed in this questionnaire? 
 
___________________________________________________________________ 
 
Thank you for participating in this questionnaire 
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Chapter 5: Improving face identity perception in age-related 
macular degeneration via caricaturing  
 
5.1 Chapter overview   
Chapter 3 demonstrated that face perception is important to AMD patients and poor 
face perception can result in impaired social interactions and reduced quality of life. In 
previous studies image enhancement methods including magnification and spatial frequency 
manipulations have been used to improve face perception. This chapter investigates for the 
first time in people living with AMD whether caricaturing, a method that exaggerates face 
shape information, enhances face identity perception. Of particular interest was if 
caricaturing does help improve face identity perception are the benefits found across all 
levels of vision loss due to AMD, and how does the size of the mild-vision-loss improvement 
in AMD patients compare to previous studies with normal vision young adults (shown 
blurred images to simulate a key feature of AMD).  
 
5.2 Publication status  
This manuscript has been published as follows: 
 
Lane, J., Rohan, E. M. F, Sabeti, F., Essex, R. W., Maddess, T., Barnes, N., He, X., Robbins,  
R. A., Gradden, T., & McKone, E. (2018). Improving face identity perception in age-
related macular degeneration via caricaturing. Scientific Reports, 8:15205. 
doi:10.1038/s41598-018-33543-3   
  
5.3 Author contributions  
AMD patient project: 
 Lane and McKone proposed the project design with advice from Barnes and He. 
 Lane and McKone prepared the ethics documentation and obtained ethics approval. 
 Lane and Gradden programmed the experiment and conducted preliminary data 
extraction. 
 Lane recruited all patients with the assistance of Essex.  
 Lane tested all patients for the experiment and administered demographic 
questionnaire. 
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 Rohan performed all vision assessments and consulted with Essex, Sabeti and 
Maddess regarding diagnosis. 
Young adults with normal-vision project (described in Supplementary Materials:  
 McKone proposed the project design with advice from Barnes and He. 
 Robbins programmed the experiment, tested younger adults and performed 
preliminary data extraction.  
Preparation of manuscript for publication:  
 Lane and McKone performed statistical analyses.  
 Lane produced the figures with editing from McKone. 
 Lane drafted the manuscript. 
 Lane and McKone together refined the paper, with detailed editing provided by 
McKone and general content comments and editing by Maddess, Essex, Sabeti, 
Barnes and He.  
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5.4 Published manuscript: Improving face identity perception in age-
related macular degeneration via caricaturing  
147 
 
 
  
148 
 
  
149 
 
  
150 
 
  
151 
 
  
152 
 
  
153 
 
  
154 
 
  
155 
 
  
156 
 
 
 
 
  
157 
 
5.5 Supplementary materials  
 
5.5.1 Supplement S1: More detailed vision information, for both eyes 
 A more complete vision assessment was conducted for 9 of the 12 patients—covering 
14 of the 19 tested eyes—to assess low contrast visual acuity (LCVA) and obtain more 
detailed retinal information including diagnosis of AMD stage1. Full vision testing involved a 
90 minute session (which was in addition to the 2-6 hours of face-experiment testing), and 
was conducted at the Australian National University. Travel reimbursement and 
ethics/consent was as for the main experiment. 
 Vision data are shown in Supplementary Table S1. LCVA was measured using a 
retro-illuminated logMAR chart mounted on a stand conforming to the ETDRS format. 
Anterior segment of the eye was examined using slit-lamp biomicroscopy, instilling 
Oxybuprocaine Hydrochloride 0.4% eye drops to anesthetise the eyes to measure intraocular 
pressure using Goldmann applanation tonometry and to measure central corneal thickness 
using a Pachmate (DGH Technology Inc., Exton, PA). Patients were tested on 10-2 frequency 
doubling technology (FDT) threshold using Humphrey Matrix (Carl Zeiss Meditec, Inc., 
Dublin, CA). After the visual field test both eyes were dilated with Tropicamide 1% and 
Phenylephrine 2.5% and the following tests were done: Optical Coherence Tomography 
(OCT) Spectralis (Heidelberg Engineering, Heidelberg, Germany) of the retina (posterior-
pole) and the peripapillary retinal nerve fibre layer (pRNFL); scan to measure the thickness 
of the RNFL surrounding the optic nerve; fundus auto-fluorescence images were acquired, 
with fundus photography performed using a Canon CR-2 (Canon Inc. Medical Equipment 
Group, Tokyo, Japan) digital non-mydriatic camera to get an image of the fovea, the macula 
and the optic nerve. AREDS stages are based on anatomy of the central 6mm of the retina 
(Stage 1 = Early AMD, small drusen; 2 = Early AMD, intermediate drusen; 3 = Early AMD, 
large drusen; 4 = covers active exudative, choroidal neovascularisation for Wet AMD, and 
end-stage Dry AMD/sub-foveal geographic atrophy. For Stages 1-3 visual acuity is usually 
close to normal; for Stage 4, acuity can vary widely between normal and <6/60 (legally 
blind), e.g., depending on treatment (for Wet AMD).  
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Supplementary Table S1. Patient vision information for both eyes. 
Patient 
code 
Eye code 
(left or 
right) 
Visual Acuity 
BCVA                LCVA 
Diagnosis 
AMD type 
AREDS 
Stage 
Pa E1 (L) 6/6-2# 6/12 Wet AMD 2 
 n/a (R) 6/190 <6/240 Corneal scar, amblyopia/No AMD n/a 
Pb  E2 (R) 6/7.5 – Wet AMD – 
 E14 (L) 6/30 – Wet AMD – 
Pc E3 (L) 6/9.5 6/19 Wet AMD 4 
 E17 (R) 6/120 6/190 End-stage AMD/Dry 4 
Pd E4 (R) 6/9.5 6/24 Wet AMD 4 
 E13 (L) 6/24 6/75 Wet AMD 4 
Pe E5 (L) 6/9.5 6/30 Wet AMD 4 
 n/a (R) 6/7.5 6/12 Vitrectomy/No AMD n/a 
Pf E6 (R) 6/12 6/30 Wet AMD 4 
 E15 (L) 6/60 6/120 Wet AMD 4 
Pg  E7 (L) 6/12 – Wet AMD – 
 n/a (R) 6/6 – No AMD n/a 
Ph E8 (L) 6/15 6/38 Wet AMD 4 
  n/a (R) 6/190 <6/240 Wet AMD 4 
Pi  E9 (R) 6/15 – Wet AMD – 
 E18 (L) <6/360 – Wet AMD – 
Pj E10 (R) 6/19 6/30 Wet AMD 4 
 E11 (L) 6/24 6/38 Early AMD/Dry  3 
Pk E12 (L) 6/24 6/60 Wet AMD 4 
 E19 (R) <6/360 <6/240 End-stage AMD/Dry   4 
Pl E16 (L) 6/75 6/120 Wet AMD 4 
  n/a (R) 6/240 <6/240 End-stage AMD/Dry 4 
Notes: LCVA = low contrast visual acuity; LCVA <6/240 indicates the patient could not read all letters on the 
largest line of the LCVA chart. LCVA correlated very highly with BCVA (r=.96 for 14 eyes with LCVA 
scores). Patients Pb, Pg and Pi did not have a vision assessment at the ANU; BCVA and diagnosis were 
provided by their ophthalmologist. Patients Ph and Pl had AMD in their weaker eye, making the eye eligible for 
the study, but with this eye reported they could not see the faces well enough to rate them (e.g., because images 
were too blurred and/or they could not see major parts of the face) and therefore this eye was not tested. n/a = 
eye not tested or not eligible. For additional notes see Table 1. 
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5.5.2 Supplement S2: Dissimilarity Rating Task Instructions  
 
Key sections from the Experimenter Script: 
FIRST EYE TO BE TESTED (weaker eye if both tested)  
• You will be looking at faces on the computer screen and making some decisions about 
them.  Place the participant 40 cm from the screen. You are free to move your head around 
when you are looking at the screen, if you find that moving the location of your head helps 
you see the faces more clearly. Please don’t move your face forward, closer to the screen.  If I 
notice you are moving forward during the experiment, I will place you back to the correct 
position. 
• At any time during the experiment if you need to move, stand up, stretch or have a break 
please let me know. Also, if you are finding the task tiring, or straining on your eyes, let me 
know and we can take a break. Check the participant is in a comfortable position e.g. chair 
height etc. 
• You will see images like this one (image of task on the computer screen) that have four 
photos of one person on the left side of the screen, a line down the middle, and four photos of 
a different person on the right side of the screen.  You can see here on the left side of the 
screen (point), there are four different photos. These are all photos of one person that are 
taken at four different angles so you can get an overall look at that person’s face. Here on the 
right side of the screen (point) is another person, again with four photos taken at four 
different angles so you can get an overall look at that person’s face. Does that make sense?  
• I’ll be showing you different pairs of people on each trial and what I want you to do is tell 
me how different the two people look to you, on a 9-point scale ranging from “Most 
similar” to “Most different” by choosing a number between 1 and 9 (point to hard copy of 
scale below the computer screen). 
• We would like you to make your judgment based on each person’s face, not just what a 
particular photograph of them looks like.  So please try to focus on how different the two 
people appear to you, rather than on how different some superficial aspect of the images 
appears e.g., the size of the photo, lighting in the photo or the colour tone of the photo. 
• You need to select a number between 1 and 9 and say it out loud and I will enter your 
response on the keyboard. 
• When you rate how different the two faces on the computer screen look, you need to make 
your judgments based on how different the faces look relative to each other within the set of 
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faces.  For example, you would respond with the number 1 if you thought the two male faces 
on the screen are the MOST SIMILAR compared to the male faces that you saw in that block 
of male faces. 
• Or if you were comparing female faces, you would press the number 9 if you thought the 
two female faces on the screen are the MOST DIFFERENT compared to the female faces 
that you saw in that block of female faces. 
• For each eye you will be presented with four blocks of faces, two blocks of female faces 
and two blocks of male faces. 
• In the first block of the experiment you will be using your weaker eye and your stronger eye 
will be covered with an eye patch.  This will be reversed in the second block.   
• Please cover your stronger eye now so you are only using your weaker eye. 
Your eye may take a little time to adjust. Wait for participant to say their weaker eye has 
adjusted.  
• Please use the full range of the 1 to 9 scale so we can see the range of differences between 
the faces within the set. The next slide will show you some of the male/female faces you will 
see in the male/female block and how much the male/female faces vary. 
• To help you get an idea of the task and work out how you might use the rating scale, here is 
a slide that has six different male/female faces that you will see during the experiment.  Here 
you can see the variation in the different faces you will see. As you might be able to see, the 
faces are all adults, all young, all white Caucasian and don’t vary much in hairstyle because 
we have hidden most of their hair. Can you see the faces on the screen?  Can you tell that the 
photos are all of different people? 
• Looking at these faces, can you point to two faces that look MOST SIMILAR TO EACH 
OTHER WITHIN THESE MALE/FEMALE FACES? Using the rating scale (pointing to it) 
what number on the rating scale might you give if you saw those two faces come up together 
during the experiment? (Should say they would respond with a low number, e.g., 1 or 2) 
• Looking at these faces, can you point to two faces that look MOST DIFFERENT FROM 
EACH OTHER WITHIN THESE MALE/FEMALE FACES? Using the rating scale (pointing 
to it) what number on the rating scale might you give if you saw those two faces come up 
together during the experiment? (Should say they would respond with a high number, e.g., 8 
or 9) 
• Can you point to two faces that you think would fall in the MIDDLE of the scale (e.g., you 
would respond to with a 4, 5 or 6)?. 
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• Do you have any questions about the experiment? Please get comfortable (check seating 
position). Let me know when you are ready to begin the experiment. 
• Between blocks have a break e.g., stretch, tea/coffee etc. 
 
IF SECOND EYE TO BE TESTED (which would be the stronger of the two) 
• The task you have to do is exactly the same as before, however this time you will be using 
your stronger eye and your weaker eye will be covered with an eye patch. 
• Like before, your task in this block is to indicate how different the two people’s faces look 
on a 9-point scale ranging from “1 = Most similar” to “9 = Most different” within the set of 
faces.   
• The only difference in this block is that you may find the way you use the scale is different 
because you are using your stronger eye. For example, you may notice the differences 
between the faces within a set more easily now because you can see the differences more 
clearly.  This is to be expected.  
• You need to completely change how you assign the scale numbers compared to the first half 
of the experiment.  Base your judgment on the way the faces look to you now, not as they did 
with your weaker eye. 
• Again, your task is to rate how different the faces look and make your judgments based on 
how different the faces look relative to each other within the set of faces   
e.g., 1 = “most similar within this set of males”.  The next slide will show you some of the 
male/female faces you will see in the male/female block and how much the male/female faces 
vary. 
• Please cover your weaker eye now so you are only using your stronger eye. Your eye may 
take a little time to adjust. 
• Rest of instructions as for first eye. 
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5.5.3 Supplement S3: Interpretation of proportion-of-variance-explained 
effect size measures in individual-eye analysis  
As noted in the main-text Methods, effect size measures such as eta-squared mean 
something quite different in our individual-eye analysis (i.e., specifically proportion of 
across-item-variance explained), as compared to the more common situation where scores are 
averaged over participants (i.e., proportion of across-participant-variance explained).  
The logic behind the usual interpretation of effect size measures is that the type of 
variance being explained is meaningful — that is, in the case of analysis averaging over 
participants, the standard argument is that variation between different people is meaningful 
and that one wishes to explain this. Thus, for example, saying that sex explains 4% of 
variance in mathematics test scores would be interpreted as meaningful evidence of a small 
effect (i.e., because it would indicate that the mean difference between males and females 
was small compared to the overall variability in peoples' maths ability).  
However, in our case of individual-eye analysis, effect size measures (eta-squared) 
describe the proportion of variance in ratings for different items (i.e., specifically, the 
different face pairings) that can be explained by caricaturing. In absolute terms, this is not a 
meaningful measure. For example, if we find that 8% of variance in a person's face-pair 
dissimilarity ratings can be attributed to caricaturing, the 8% value per se is meaningless: had 
we selected a different set of 26 faces, or paired them up differently (e.g., so that some pairs 
were more different, or less different, in appearance than within our current pairings), then 
we could have obtained a completely different value (i.e., simply because the variance value 
will change, not the actual caricature impact). 
This limits the usefulness of effect size measures in our design to relative 
comparisons where the items are identical across the situations compared. For example, it is 
valid to ask whether the statistical effect size correlates with acuity for the 14 eyes tested on 
an identical item set (i.e., the 14 eyes tested on all four blocks and thus all 72 face pairs). 
These 14 eyes are listed in Table S2, and show a significant correlation between greater 
vision loss (acuity coded as logMAR) and reduced proportion of across-item-variance 
explained by caricaturing, r = –.572, p = .033. Note the table and correlation calculation 
excludes the 5 eyes for which not all items were tested (e.g., they may have completed only 
the female-face blocks and not the male-face blocks, see Methods); this is because variance 
across a smaller set of items cannot be validly compared to variance across a different, larger 
set of items. 
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Table S2. Effect size: Eta-squared for the linear trend on the caricature effect (for the 
14 eyes tested on all 72 items) against acuity.  
Eye Patient  Acuity 
(BCVA) 
Acuity expressed 
as logMAR 
Linear trend 
partial eta-sq 
E1 Pa 6/6-2 0.04 .311 
E2 Pb 6/7.5 0.1 .314 
E3 Pc  6/9.5 0.2  .228  
E5 Pe 6/9.5 0.2 .164 
E6 Pf 6/12 0.3 .071 
E7 Pg 6/12 0.3 .211 
E8 Ph 6/15 0.4 .067 
E10 Pj 6/19 0.5 .000 
E11 Pj 6/24 0.6 .001 
E12 Pk 6/24 0.6 .097 
E13 Pd  6/24 0.6 .255 
E16 Pl 6/75 1.1 .055 
E17 Pc  6/120 1.3 .024 
E19 Pk      <6/360  1.8 .063 
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5.5.4 Supplement S4: Comparison of mild-vision-loss AMD patients to 
previous experiments in normal-vision young adults 
 As described in main text Results, we compared the amount of caricature 
improvement (difference between rating for 60% Caricature and rating for Veridical faces) in 
the mild-vision-loss AMD patient group to caricature improvements in the same rating task in 
three previous experiments that used young adults with normal vision. Means for Veridical 
and 60% Caricature separately from these experiments are shown in Supplementary Table 
S3. Also, key features and publication details of these previous experiments are: 
• Study 1. Experiment 1 of Irons et al. (2014). This experiment used a subset of 20 of the 
present 26 faces. It also tested conditions not reported here (with trials intermixed with the 
reported conditions), including intermediate 20% and 40% caricature strengths, and 3 blur 
levels; data in Table S3 are for high resolution (i.e., unblurred) faces. The published 
experiment reported data for N=12 participants; we also later tested an additional N=10 
participants on exactly the same experiment. All participants were Caucasian (same race as 
the face stimuli, and AMD patients). 
• Study 2. Experiment 1 of Irons et al. (2017). This experiment used a subset of 20 of the 
present 26 faces. It also tested conditions not reported here (with trials intermixed with the 
reported conditions), including an intermediate 40% caricature strength, and a bionic eye 
simulation condition (40x40 phosphene grid); the published data in Table S3 are for high 
resolution faces. All participants were Caucasian. 
• Study 3. Experiment 1 of McKone et al. (submitted). This experiment used all 26 of the 
present faces (paired exactly as here, i.e., grouped into same set of 7 and 6 of each sex). It 
also tested conditions not reported here (with trials intermixed with the reported conditions), 
including 2 blur levels and a condition where caricatures were made using fewer landmark 
points; data in Table S3 are for high resolution (i.e., unblurred) faces and for the same 147-
point caricatures as used for the AMD patients. All participants were Caucasian. 
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Table S3. AMD patients and previous studies of young adults with normal vision. 
 Veridical 60% 
Caricature 
Improvement 
(60%-V) 
Study & participants N Mean SEM Mean SEM Mean SEM 
Present study, mild-vision-loss AMD patients 9 7.112 .276 7.626 .235 .504 .063 
Young adults Study 1 [Irons et al. 2014] 12 6.408 .169 6.667 .185 .504 .090 
   - additional participants on same experiment 10 6.110 .344 6.425 .315 .558 .139 
Young adults Study 2 [Irons et al. 2017] 20 6.109 .257 6.793 .235 .684 .120 
Young adults Study 3 [McKone et al.]  20 5.358 .158 6.057 .122 .699 .085 
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Chapter 6: Caricaturing improves recognition of low intensity 
facial expressions in age-related macular degeneration 
 
6.1 Chapter overview   
Following on from Chapter 5, where for the first time it was demonstrated that 
caricaturing can improve face identity discrimination in people living with mild to severe 
vision loss due to AMD, this Chapter investigates whether caricaturing can improve face 
expression recognition in AMD. Of particular interest whether caricaturing improves 
expression recognition for low intensity expressions where performance is poorest and where 
the greatest benefits of caricaturing might be seen. Other questions of interest included, if 
caricaturing does improve expression recognition, is it effective across AMD severity levels, 
what caricature strength is most effective, and does the improvement provide a practical 
benefit to AMD patients in the real-world.    
This Chapter is methodologically different from Chapter 5 in that the rating task used 
in the identity experiment was reliable enough to examine data from individual eyes. The 
measure used in this experiment was accuracy of recognition, and this does not produce 
reliable enough data to be used at the individual level and is instead averaged over groups.  
 
6.2 Publication status  
This manuscript is to be submitted. 
 
Lane, J., Mazlin, J., Irons, J., Rohan, E. M. F, Sabeti, F., Essex, R. W., Maddess, T.,  
 Robbins, R. A., Gradden, T., Dawel, A., Smithson, M., Barnes, N., He, X., Crookes,  
K., & McKone, E. Caricaturing improves recognition of low intensity facial 
expressions in age-related macular degeneration. To be submitted.  
  
6.3 Author contributions  
AMD patient project: 
 Lane and McKone proposed the project design. 
 Lane and McKone prepared the ethics documentation and obtained ethics approval. 
 Lane, Gradden and Robbins programmed the experiment and conducted preliminary 
data extraction. 
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 Lane recruited all patients with the assistance of Essex.  
 Lane tested all patients for the experiment and administered demographic 
questionnaire. 
 Rohan performed all vision assessments and consulted with Essex, Sabeti and 
Maddess regarding diagnosis. 
Young adults with normal-vision project (described in Supplementary Materials, plus pilot 
study mentioned in Method section):  
 McKone proposed the project design. 
 McKone, Gradden, Irons, Mazlin and Dawel created and prepared stimulus set, used 
initially in young adults, and then by Lane with the AMD patient study. 
 Gradden, Smithson, Barnes, He, Lane and McKone conducted and analysed the pilot 
study used to determine the number of trials needed to provide statistical power for 
AMD-affected eyes. 
 Mazlin, Dawel, Irons and McKone conducted young adult experiment to obtain 
intensity ratings and determine normal-vision expression recognition accuracy for 
stimulus set used in AMD experiment.  
Preparation of the manuscript for publication: 
 Lane and McKone performed statistical analyses.  
 Lane produced the figures with editing from McKone. 
 Lane drafted the manuscript. 
 Lane and McKone together refined the paper, with some comments and editing 
provided by all co-authors.  
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6.4 To be submitted manuscript: Caricaturing improves recognition of low 
intensity facial expressions in age-related macular degeneration 
 
6.4.1 Abstract 
Purpose. Patients with age-related macular degeneration (AMD) can have difficulty 
recognising facial expressions. Here, we provide the first test of whether this can be 
improved by caricaturing, a shape-based image enhancement method targeted at mid- 
to high-level cortical vision, which physically exaggerates the facial expression. We 
also examine whether caricature benefits vary with initial expression intensity, the size 
of the benefit at the optimal exaggeration strength, and effects of vision loss severity. 
Methods. We monocularly tested 19 AMD-affected eyes (from 12 patients aged 67-
94 years), selected to cover a wide range of vision loss (acuities from 6/7.5 to poorer 
than 6/360). In a 6-alternative recognition task (anger, disgust, fear, happy, sad, 
surprise), we crossed 4 caricature strengths (0, 40, 80, 100% exaggeration) with 3 
intensity levels (low, medium, high, based on ratings from normal-vision young 
adults).  
Results. For low intensity expressions, patients' recognition was initially poor (48% 
correct), and was improved significantly by caricaturing. At the optimal exaggeration 
strength of 80%, the size of the benefit was approximately 6%, and was seen in eyes 
with mild vision loss (+5.1% improvement, P=0.036) as well as in eyes with moderate 
to severe vision loss (+6.5% improvement, P=0.017). For medium and high intensity 
expressions, recognition was good even without caricaturing (≥75% correct where 
normal vision = 85%), in the context that our faces were large.  
Conclusions. We conclude caricaturing offers a potentially useful technique for 
improving recognition of facial expressions in AMD, particularly for low intensity 
expressions where performance is naturally poor. 
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6.4.2 Introduction  
Age-related macular degeneration (AMD) is the most common incurable eye 
condition in the developed world.1,2 Progressive damage to the retina impairs central vision. 
Patients perceive blur, distortion and/or missing parts.3 Many aspects of face perception are 
impaired, including facial expression recognition.4-6   
Inability to recognise others' emotions from their expressions can result in significant 
difficulties in everyday social interactions.7 Thus, it is important to develop techniques that 
have the potential to improve patient recognition ability. The general concept behind image 
enhancement is to alter facial images in such a way that they are easier for the patient to 
perceive.8 
To date, only one expression enhancement technique has been tried, namely 
magnification. Making the face larger5,6 improves AMD patients' expression recognition, 
although not to age-matched control levels even for images sized 21° or 44°, equivalent to 
seeing a real person's head 24–53 cm away.5 
In the present study, we focus on caricaturing (Figure 1) as a potential additional 
technique. Theoretically, magnification is targeted at improving early-stage visual processing 
(e.g., retina to V1). Caricaturing, in contrast, is targeted at improving later-stage coding of 
face shape, in mid- and high-level visual areas. This includes regions of inferotemporal 
cortex sensitive to facial expression (e.g., superior temporal sulcus, fusiform gyrus),9 plus 
areas sensitive to general shape information (e.g., V4, Lateral Occipital Complex).10-12 In 
low-resolution vision, caricaturing has been shown to improve performance for face identity 
recognition across blurred faces,13,14 prosthetic vision simulation,15 and AMD patients (Lane, 
et al., 2018 under review). Here, we provide the first test in a low-vision context of whether 
caricaturing may also be useful for improving poor recognition of facial expression. 
For expression, caricaturing involves exaggerating the ways in which a particular 
expression (e.g., happy) differs physically from the same individual displaying a neutral 
expression.16 To make a caricature (Figure 1), multiple landmark points are assigned to the 
expressive version of the face (the original expression, referred to as the Veridical image), 
and the matching locations are marked in the relaxed, neutral version. Morphing software is 
then used to exaggerate the differences between landmark locations. This exaggeration can be 
performed to differing degrees, resulting in different caricature strengths (Figure 2). 
We tested caricaturing as a plausible method for improving poor expression 
recognition in AMD because it is known to improve expression perception in normal-vision 
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observers. In young adults, this includes evidence that caricaturing can: improve speed of 
naming the expression; increase ratings of "how much" of the target emotion the face is 
displaying; and sometimes improve recognition accuracy if accuracy is not already close to 
maximum for the Veridical images.16-19 Caricaturing also improves accuracy in older adults, 
at the younger end of the AMD-relevant age range (mean age mid-60s).20,21  
We also examined whether any caricature-related improvements in AMD patients 
might be modulated by the intensity of the original expression. Previous AMD expression 
studies have not discussed intensity.4-6 Two of these papers, however, used stimuli from a 
database22 containing expressions that are typically of high intensity,23,24 similar to the 
surprise and disgust examples in Figure 2. In contrast, real-world expressions have varying 
intensity levels23,25 and AMD patients' everyday social interactions would commonly include 
exposure to subtler cues to others' emotions, such as the low-intensity sad face example in 
Figure 2. Low intensity expressions contain only small physical changes from a neutral 
expression. Thus, AMD patients' low-resolution vision is likely to result in particularly poor 
recognition, compared to recognition of the larger physical changes present in a more intense 
version of an emotion. 
The size of the caricature advantage could then vary with initial expression intensity, 
for two reasons. First, methodologically, if high intensity Veridical expressions were already 
recognised well in AMD (e.g., for faces magnified to a large size), there may be little room 
for further accuracy improvement with caricaturing16 (note reaction time may improve, but 
measuring reaction time is not feasible in AMD patients). Second, high intensity Veridical 
expressions are already quite physically exaggerated, and so caricaturing could potentially 
push these into looking "weird". Too much exaggeration can make expressions look less 
“face-like”18 and increase their perceived strangeness26, which could potentially impair 
expression recognition. More broadly, this also predicts there will be a maximally effective 
caricature strength, beyond which caricatures will become too extreme to further improve 
recognition.  
In a task requiring recognition of the six 'basic expressions' (anger, happy, sad, fear, 
disgust, surprise),27 our study design crossed four caricature strengths (Figure 2) with three 
intensities of the Veridical expression (low, medium, and high, based on ratings of the stimuli 
by normal-vision young adult observers). Our core research question was whether 
caricaturing can improve expression recognition at intensities for which recognition is poor. 
Other issues we examined were: How does intensity affect recognition of Veridical 
expressions? What caricature strength is most effective? What is the size of the caricature 
172 
 
improvement, and is this large enough to be of functional value to patients? And, for what 
range of vision loss is caricaturing effective? This last question is important because it 
addresses whether caricaturing might be useful, say, only to patients with mild vision loss 
who can potentially still see larger faces with some degree of clarity, or whether its value 
might also extend to patients with more severe vision loss including even those who are 
legally blind. 
 
6.4.3 Methods 
6.4.3.1 Patients and eyes  
 Participants were 12 patients (8 females; age Mean = 81.4 years, range 67-94), 
diagnosed by a qualified ophthalmologist as having AMD in at least one eye. To be eligible, 
patients had to be Caucasian to match the race of the face stimuli, and display no evidence of 
dementia (including demonstrating good ability to comprehend task instructions).  
Recruitment targeted eyes covering the full range of vision loss severity (Table 1). 
Best Corrected Visual Acuity (BCVA) ranged from 6/7.5 to poorer than 6/360. We analyse 
the 19 individual eyes, tested monocularly, which met inclusion criteria. The first inclusion 
criterion was that the eye had to have AMD, and no other diagnoses; note clinically 
nonsignificant visual opacity was allowed. Additionally, there were separate inclusion criteria 
applied at the top and bottom end of vision ability. Given that image enhancement technology 
is of interest only where ability is poorer than normal vision, at the top end, we included only 
eyes with relevant functional vision loss. This was defined as having BCVA worse than 6/6 
and expression recognition performance (for Veridical faces) below normal-vision levels. At 
the bottom end, we did not test any eyes where vision was so poor that the patient reported 
they could not see the face stimuli. Supplement S1 provides additional details. 
Recruitment was via: The Canberra Hospital Department of Ophthalmology and 
private ophthalmologist’s rooms using a study brochure and/or personal approach whilst 
patients were waiting for their consultation; radio interview promoting the study; and letter 
sent to all local-area AMD patients on the Macular Disease Foundation Australia mailing list.  
Duration of participation was 2-6 hours for the expression recognition experiment 
(time to test a single eye ranged from 1-4 hours), plus 1.5 hours for vision assessment. 
Individual sessions were < 2 hours, to minimise fatigue. Patients were reimbursed for travel. 
Participants gave informed written consent after explanation of the nature and possible 
consequences of the study. Research methods adhered to the Declaration of Helsinki and 
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were approved by the Australian National University and ACT Health Human Research 
Ethics Committees. 
 
TABLE 1. The 19 AMD-affected eyes meeting inclusion criteria, ordered by severity of 
vision loss (best corrected visual acuity), and corresponding patient information.  
 
* L = left eye (i.e., OS, ocular sinister), R = right eye (i.e., OD, oculus dextrus). 
† BCVA measured by qualified orthoptist using a retro-illuminated logMAR chart 
conforming to the Early Treatment Diabetic Retinopathy Study (ETDRS) standard format. 
Cut-off values for vision loss categories from ICD-10 criteria30: mild = BCVA 6/6 to 6/18; 
moderate = poorer than 6/18 to 6/60; severe = poorer than 6/60. For context, in Australia 
worse than 6/12 binocular vision results in loss of standard drivers' license, and 6/60 or worse 
is legally blind. 
‡ Seven patients had two eyes meeting inclusion criteria; five (Pb, Pd, Pe, Pk, Ph) had only 
one. Supplement S1 gives more complete vision data, including for eyes not meeting 
inclusion criteria. M = male, F = female.  
  
Eye code * 
(& left or right eye) 
Visual acuity 
(BCVA) † 
Diagnosis 
 AMD type 
Patient  
code ‡ 
(sex, age) 
Mild vision loss    
E1 (R) 6/7.5 Early AMD Pa (M, 86) 
E2 (L) 6/7.5 Wet AMD Pb (M, 72) 
E3 (L) 6/7.5 Wet AMD Pc (M, 81) 
E4 (L) 6/9.5 Dry AMD Pd (F, 79) 
E5 (L) 6/9.5 Wet AMD Pa 
E6 (R) 6/12 Wet AMD Pe (F, 70) 
E7 (L) 6/12 Wet AMD Pf (F, 78) 
E8 (L) 6/12 Wet AMD Pg (F, 93) 
E9 (R) 6/12 Dry AMD Ph (F, 86) 
Moderate vision loss    
E10 (R) 6/19 Dry AMD Pi (M, 79) 
E11 (L) 6/24 Dry AMD Pj (F, 92) 
E12 (L) 6/24 Wet AMD Pk (F, 94) 
E13 (L) 6/24 Wet AMD Pl (F, 67) 
E14 (R) 6/30 Wet AMD Pc 
E15 (L) 6/30 Dry AMD Pi 
Severe vision loss    
E16 (R) 6/95 End-stage AMD Pj 
E17 (R) 6/120 End-stage AMD Pg 
E18 (R) 6/240 Wet AMD Pf 
E19 (R) <6/360   End-stage AMD Pl 
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6.4.3.2 Stimuli 
Veridical expression faces, and corresponding Neutral faces needed to make 
caricatures. Veridical and corresponding Neutral images were taken from four databases: 
Karolinska Directed Emotional Faces (KDEF),29 NimStim,22 McLellan28 and Gur.31 The 
Veridical expressions were 82 colour front-view photographs, showing anger (14 images), 
disgust (13), fear (11), happiness (14), sadness (20), or surprise (10). Images came from a 
total of 48 Caucasian young adults (24 females, 24 males). Selection of items (and uneven 
number across emotions) was based on meeting multiple inclusion criteria: good quality 
photographs; availability of neutral-expression reference image showing the same person; 
availability of matched mouth-position across Veridical and Neutral (e.g., for mouth-open 
anger we required a mouth-open Neutral because using mouth-closed introduces morphing 
artefacts into the caricatures); good labelling accuracy (as provided in the original database 
articles); and covering a range of expression intensities.  
 Validation of Veridical face set: Intensity ratings and effective maximum recognition 
accuracy in normal vision. Supplement S2 provides details of experiments in normal vision 
observers (25 young adults) used to validate and describe our stimuli. Results confirmed our 
Veridical expressions were well recognised, and showed the effective maximum expression 
recognition accuracy for the stimulus set was 85% correct; note 100% is not expected, even 
in normal vision, because some expressions such as fear are intrinsically less-well 
recognised.24 Intensity ratings from the normal-vision observers were used to rank order the 
82 faces and divide them into low, medium, and high intensity sets (Table 2).  
 Expression caricaturing. Caricatures were created using Abrosoft Fantamorph 5.3.0. 
Multiple landmark points were manually placed on each Veridical image (Figure 1B), tracing 
out the shape of all major features (eyes, nose, mouth, eyebrows, hairline, face outline 
including cheek and chin shape), plus any extra expression-related lines. For particular 
images, extra lines could include: wrinkle lines across the top of the nose if these were visible 
in a disgust face; or upward curving lines in the forehead between the eyes in sad. Matching 
locations were then marked on the corresponding Neutral-expression image. For major 
features, this is straightforward (i.e., a marker dot at left corner of smiling mouth is paired 
with a marker dot at left corner of neutral mouth). For the extra expression-related lines, the 
lines often disappear in Neutral; we marked the paired location as being our best visual 
estimate of where the expressive-face location would relax to in the neutral expression. 
Where the individual person had additional distinguishing features (e.g., moles visible in both 
the Veridical and the Neutral version), some were also marked to match locations of the same 
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piece of skin across the expressive and neutral versions. Final number of landmark points was 
approximately 140-230 points per face (varying with different expressions and different 
individual models). 
 Caricatures were then extracted from Fantamorph, at 0% (Veridical), 40%, 80% and 
100% strengths, where 100% indicates a doubling of the differences between Veridical and 
Neutral landmark point locations. Shape information was caricatured (in morphing-software 
language, caricaturing was applied only to warp and not fade functions); this is because, in 
the real world, patients would see faces varying in lighting, and caricaturing non-shape 
information exaggerates lighting information that is irrelevant to expression recognition. 
Supplement S3 gives extra caricaturing details.   
 
TABLE 2. Properties of low, medium and high intensity face subsets. 
 
Intensity 
Intensity rating  
for Veridical * 
 
Number of face items 
category M(SD) [range] Total Anger Happy Sad Surprise Fear Disgust 
Low 3.34(0.84) [1.92-4.76] 27 8 2 10 1 2 4 
Medium 5.74(0.48) [4.80-6.36] 27 2 6 4 7 5 3 
High 7.09(0.58) [6.40-8.36] 28 4 6 6 2 4 6 
* Intensity rating task was: "How intense does this emotional expression look to you?", with 
response scale running from 1="weak" to 9 = "strong". 
 
6.4.3.3 Procedure 
On each trial, the face appeared at screen centre for 5 seconds. Patients were asked 
“What emotion is being expressed by this face?”, with options in large print on a card under 
the screen (anger, disgust, fear, happy, sad, surprise). Patients responded verbally. The 
experimenter entered the response. Interval between trials was 300 ms.  
Target viewing distance was 40 cm, making face images 17.1° vertical x 15° 
horizontal, equivalent to viewing a real-world person from 58 cm away; calculation uses the 
fact that average real head size is 22 cm.32,33 Patients wore their best glasses for screen 
viewing. Free viewing was used (i.e., no chin rest or fixation), to match real-world behaviour: 
patients were allowed to place faces in their best retinal position for viewing by moving their 
head sideways or up/down.  
Eyes were tested monocularly (with patch over the other eye). Where a patient had 
two eligible eyes, the stronger was tested first. For a given eye, a minimum of 328 trials (82 
images x 4 caricature levels, presented intermixed and in random order) were tested (Run A). 
Where patients were willing and fast enough to make it feasible to continue (14 eyes), the 
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328 trials were repeated (Run B; with scores averaged over the two runs). The decision to use 
two runs where possible was based on statistical analysis of a pilot experiment using young 
adults shown blurred faces, which implied as many trials per patient as possible would be 
valuable to give error bars small enough to test reliably for caricature effects with small 
numbers of eyes (e.g., as needed to support analysis of subsets of eyes in specific vision loss 
categories).   
Before the experimental trials began, the task was explained to participants using 
binocular vision. All instructions were verbal. Supplement S4 details computer equipment, 
task instructions, and the practice phase.  
 
6.4.4 Results 
6.4.4.1 Caricature effects across all 4 caricature strengths (0 to 100%) 
 Table 3A presents mean expression recognition accuracy across all eyes. This 
demonstrates that, with the relatively large face size we used, recognition of medium and 
high intensity expressions was quite good, at 75% and 78% correct respectively for Veridical 
faces (where normal vision performance is 85% correct, see Supplement S2, and chance is 
only 17%). Our primary interest concerning caricaturing was thus whether caricaturing could 
improve performance where it was initially poor, that is, for low intensity expressions (48% 
correct).  
 Two-way repeated measures ANOVA (4 caricature levels x 3 expression intensities) 
confirmed a main effect of intensity, F(2,36)=99.202, MSE=146.697, p<.001, and also 
showed a main effect of caricature level, F(3,54)=3.299, MSE=25.59, p=.027. Of more 
interest is that there was a significant interaction between expression intensity and the linear 
trend on caricature, F(1,18)=5.34, MSE=196.587, p=.033. This indicates caricature 
improvements varied significantly with intensity category. Additionally, the caricature effect 
had a quadratic component when all four caricature strengths were included, F(1,18)=5.265, 
MSE=10.062, p=.034. Table 3A shows this reflected a pattern in which accuracy improved up 
to 80% caricature strength, and then worsened with more extreme caricatures. This tendency 
was present for all three intensity levels, and the drop between 80% and 100% strength was 
significant when averaged across intensity, t(18)=2.36, p=.030.  
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6.4.4.2 Caricaturing up to 80% strength: size of the low-intensity improvement, and effects 
of vision loss severity  
 Figure 3A plots accuracy up to the most effective caricature strength of 80%. For low 
intensity expressions, the figure illustrates the initial poor performance for Veridical, together 
with a significant caricature improvement (linear trend across 0, 40, 80% caricature strengths, 
F(1,18)=15.607, MSE=19.741, p=.001). The size of this improvement was 5.8%, calculated 
as the increase in accuracy from Veridical to 80% caricature strength (Table 3A). For 
medium and high intensity expressions, the figure illustrates the good initial accuracy, 
together with a lack of any further accuracy increase with caricaturing (no linear trend for 
medium F(1,18)=.229, MSE=34.598, p=.638, or high F(1,18)=.128, MSE=22.837, p=.725).  
Figure 3A includes all eyes, covering the full range of visual acuity. We next 
examined whether low-intensity-expression caricaturing benefits might be limited to only 
eyes with mild vision loss, or whether caricaturing was also useful for more severe vision 
loss. Eyes were split into two subgroups (Figure 3B): 9 eyes with mild vision loss (acuities 
6/7.5 to 6/12); and 10 eyes with moderate or severe vision loss (acuities 6/19 to <6/360). 
Note it was not feasible statistically to analyse a severe-only subgroup (i.e., in the legally 
blind range of <6/60) due to having only 4 eyes in this category. For mild vision loss, results 
revealed a significant caricature improvement (linear trend across 0, 40, 80% caricature 
strength, F(1,8)=6.345, MSE=13.384, p=.036), the size of which was 5.1% (Table 3B). For 
moderate-and-severe vision loss, results also revealed a significant caricature improvement 
(linear trend across 0, 40, 80% caricature strength, F(1,9)=8.58, MSE=24.120, p=.017), the 
size of which was 6.5% (Table 3C). Thus, the low-intensity caricaturing benefit was no 
weaker for moderate-and-severe vision loss than for mild vision loss. Indeed, it was possibly 
slightly stronger (although not significantly so: two-way ANOVA showed no interaction 
between vision loss subgroup and caricature level, F(1,17)=.041, MSE=.20.987, p=.843. 
A final analysis confirmed findings were not due to any carryover effect from the first 
eye tested to the second eye. Results for the 12 first-tested eyes (Table 3D) showed a 
significant caricature improvement for low intensity expressions (linear trend across the 0, 
40, 80 caricature levels, F(1,11)=10.533, MSE=13.614, p=.008), the size of which was 5.9%.  
Overall, results indicated the size of the caricature effect for low intensity expressions 
to be approximately a 6% improvement in accuracy, regardless of whether we analyse all 
eyes or subsets of eyes.  
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TABLE 3. Caricature effects on expression recognition accuracy (% correct choice as 
anger, fear, happy, surprise, sad or disgust) in AMD patients as a function of Veridical-
expression intensity, expressed as Mean(SE). 
 Caricature strength condition  
Participant/eye group 0% 
(Veridical) 
40% 80% 100% Caricature 
improvement 
(80%–Veridical) 
A. AMD patients (n=19 eyes)       
All intensities 67.2(2.2) 68.6(2.7) 69.6(2.7) 67.1(2.4) 2.4(.79), p=.007 
Low intensity 48.3(3.3) 53.2(3.4) 54.2(3.5) 52.7(3.7) 5.8(1.5), p=.001 
Medium intensity 74.9(1.8) 75.2(2.6) 75.7(2.0) 72.5(2.2) 0.9(1.8), p=.638 
High intensity 78.1(2.8) 77.0(2.7) 78.7(3.2) 75.7(2.5) 0.6(1.6), p=.725 
B. Mild vision loss (n=9 eyes)      
All intensities 69.6(2.7) 71.8(3.3) 71.1(3.9) 68.6(3.3) 1.5(1.4), p=.317 
Low intensity 53.1(3.9) 55.4(4.1) 58.2(4.8) 56.6(5.2) 5.1(2.0), p=.036 
Medium intensity 78.0(1.6) 80.7(3.4) 75.5(3.3) 73.5(3.2) -2.5(2.5), p=.354 
High intensity 77.4(3.5) 79.2(3.3) 79.2(4.8) 75.4(3.4) 1.8(2.5), p=.502 
C. Moderate+severe vision loss (n=10 
eyes) 
     
All intensities 65.1(3.5) 65.7(4.1) 68.4(3.8) 65.7(3.5) 3.2(.79), p=.003 
Low intensity 44.1(5.0) 51.3(5.5) 50.6(5.1) 49.3(5.2) 6.5(2.2), p=.017 
Medium intensity 72.0(2.9) 70.4(3.2) 75.9(2.5) 71.7(3.1) 3.9(2.4), p=.135 
High intensity 78.8(4.4) 75.0(4.3) 78.2(4.6) 75.9(3.9) -.05(2.0), p=.794 
D. First-tested eyes (n=12 eyes) *      
All intensities 68.1(3.1) 70.3(3.3) 69.8(3.8) 66.5(3.2) 1.7(1.1), p=.160 
Low intensity 49.8(3.9) 53.2(4.0) 55.7(4.6) 53.2(4.8) 5.9(1.8), p=.008 
Medium intensity 76.7(2.6) 78.7(3.1) 75.3(2.9) 71.6(3.1) -1.4(2.5), p=.583 
High intensity 77.5(3.7) 78.6(3.4) 78.1(4.5) 74.4(3.1) 0.6(2.0), p=.772 
Notes:  
* The 12 first-tested eyes (of the 19 analysed for caricature effects) comprise a combination 
of the only eye tested from 5 patients, and the first eye tested (which was the stronger eye) 
for 7 patients.  
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FIGURE 1. Expression caricaturing.  (A) Example of our caricaturing of a happy 
expression. Neutral and Veridical images from McLellan database28 and published with 
permission from Tracey McLellan. (B) Location of the landmark points (green dots) we 
used to make the caricature. 
  
A. Example of our expression caricaturing: 
Neutral expression Veridical expression 
uncaricatured, original photo 
Caricatured expression 
80% strength 
Neutral Veridical 
B. Landmark point locations used to make the caricature: 
Step 1. Major 
features traced 
out (eyes, 
mouth, etc) 
Step 3. 
Distinguishing 
marks (freckles) 
visible in both 
expressive and 
relaxed images 
marked (eg. help 
to code how 
upper cheeks get 
raised closer to 
eye in happy) 
Step 2. Extra 
expression 
lines (eg. eye 
crinkles, cheek 
folds) marked 
in Veridical 
first, then 
matching 
position where 
that location 
would relax to 
in Neutral face 
visually 
estimated 
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FIGURE 2. Example expression stimuli, selected to illustrate: the caricature strengths we 
tested; the six expressions we tested27; and a range of expression intensities for the 
original face. Numbers in parentheses give the mean intensity rating for the Veridical 
image, on scale of 1 = “weak”, 9 = “strong”. Veridical images from McLellan28 (sad, 
F009; angry, F004) and KDEF databases29 (fear, AF16; happy, AM23; surprise, AM11; 
disgust, AF12).   
Veridical 
0% caricature 
40% 
caricature 
80% 
caricature 
100% 
caricature 
Low 
(2.0) 
Intensity category 
& rating (/9) for 
Veridical image 
Low 
(3.6) 
Medium 
(5.9) 
Medium 
(6.2) 
High 
(6.9) 
High 
(7.2) 
Sad 
Anger 
Fear 
Happy 
Surprise 
Disgust 
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FIGURE 3. Caricature effects on expression recognition in AMD patients. (A) Caricature 
effects for all AMD-affected eyes (after excluding two with ceiling performance), split by 
intensity of the Veridical expression. (B) Caricature effects for low intensity expressions split 
by vision loss category, showing that the caricature improvement for eyes with moderate-
and-severe vision loss (BCVA 6/19 to <6/360) was at least as large as that for mild vision 
loss eyes (BCVA 6/7.5 to 6/12). Data plotted up to the most effective caricature strength 
(80%). p = significance value for linear trend across the three caricature levels shown. Error 
bars show the repeated-measures equivalent of ± 1SEM. Effective maximum performance for 
this stimulus set determined from normal-vision observers (Supplement S2). 
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6.4.5 Discussion 
Our key finding is that for low intensity expressions — where patients' expression 
recognition was initially poor — recognition accuracy was significantly improved by 
caricaturing. At the most effective caricature strength (80% exaggeration), the size of the 
caricature improvement was approximately 6%. Importantly, caricaturing was as effective in 
moderate-to-severe vision loss as it was in only mild vision loss. This indicates caricaturing is 
of potential benefit across a wide range of AMD patients of different residual visual acuities. 
We also found intensity substantially affected patients' recognition of the original 
facial expressions. Accuracy was much poorer for low-intensity expressions than for medium 
and high intensity expressions. This is as predicted by the fact that lower intensity 
expressions have the least physical difference from neutral, and small physical differences 
will be hardest to see in AMD. Concerning the fact that recognition of medium and high 
intensity expressions was rather good (≥ 75% even in moderate-to-severe vision loss patients, 
Table 3C), note this was for large face stimuli , equivalent to a person viewed from 58 cm; 
even medium and high intensity expressions would be expected to be more poorly recognised 
if small or far away.  
Our 6-expression task is more demanding than in previous AMD studies, which used 
simultaneous odd-one-out6 or 3-alternative neutral/happy/angry tasks4,5. Even recognising the 
6 'basic expressions',27  however, is only the minimum in terms of everyday-life requirements 
for expression and emotion perception. Other social signals sent by facial expressions can 
include "I'm bored with your conversation", "She's flirting" (see Reading the Mind in the 
Eyes test34), the difference between mouldy-food 'physical disgust' and contempt, or whether 
your grandchild is genuinely sad or merely pretending.34 All these signals involve small facial 
differences, implying AMD patients are likely to misperceive them. We suggest caricaturing 
may improve recognition, noting that both our present results, and our previous studies of 
simulated low-vision,13,14 show that caricaturing tends to be most effective where 
performance is initially poor. 
A key issue concerns the size of the caricature benefit. Our 6% improvement in 
expression recognition accuracy is large enough to be of some practical benefit to patients. At 
the same time, however, 6% is only a modest improvement. Thus, rather than viewing 
caricaturing as a fix-all image enhancement procedure, we see it as one of a series of additive 
enhancements that could be co-applied to facial images. This idea is bolstered by the fact that 
enhancements derive theoretically from independent stages of the visual processing stream, 
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either mid/high-level vision via caricaturing, or low-level vision in the case of 
magnification5,6 (and also increasing the contrast of certain spatial frequencies, as has been 
applied in AMD for face identity36).  
One practical limitation of current caricaturing techniques is that they can be applied 
only to static images. Static images are of course experienced by patients (e.g. photographs 
on websites), and thus improving expression recognition even of static expression images is 
beneficial. However, improving patients' real-time social interactions with other people 
would require caricaturing dynamic expressions. This requires technical advances within 
computer science. While caricaturing itself is a solved problem,37 automated assignment of 
enough landmark points to make an accurate expression caricature is not. With manual 
assignment (as also used in all previous caricaturing studies16-18), we could accurately locate 
140-230 landmark points per face. However, automatic assignment of landmark points in 
faces is currently restricted to a smaller number of points, e.g. 68 points in close-to-real time, 
across changes in viewpoint, and allowing for partial occlusion of the face such as the hand 
coming up to scratch the nose.38 Moreover, current auto-assigned locations fail to trace out 
face regions relevant specifically to expression (e.g., wrinkles across the nose in disgust). An 
additional challenge is developing methods to extract a neutral expression image from the 
video stream to caricature away from (automatic expression recognition remains difficult 
even in constrained stimulus environments).39 
Only shape information was caricatured in this study. This was because, in the real 
world, patients would see faces across various lighting conditions and it is likely caricaturing 
will exaggerate colour information that is not relevant for expression recognition. For 
example, a neutral face in red ambient lighting may appear angry if the colour of this face 
was exaggerated. Whilst Benitez-Quiroz, Srinivasan and Martinez40 have shown colour 
information is important in emotion decoding, future computer science research would need 
to develop technology that can differentiate useful from misleading colour and lighting 
information, and allow caricaturing only of the former. If such technology becomes available, 
then it is likely that caricaturing expression-informative colour information in the face, as 
well as shape, may further improve recognition compared to shape-only (e.g., 41-42).  
In the long-term, our aim in exploring image enhancement procedures in AMD is to 
determine experimentally which image manipulations actually improve behavioural 
performance, and then to implement these manipulations on an easy-to-use patient platform 
so that the patient can, for example, select a face from the full visual scene to track, and view 
it enhanced on their computer (e.g., caricatured and magnified when video-conferencing with 
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family) or smart glasses (in real-world social interactions). These methods are also likely to 
be effective in other low-vision disorders, noting that the success of caricaturing derives 
theoretically from cortical-level face coding and has nothing to do with the specifics of the 
retinal damage in any one particular low-vision condition.  
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6.4.7 Supplementary Materials 
Supplement S1:  Additional details on patients and eyes: Inclusion criteria, excluded 
eyes, and more detailed vision testing. 
 Supplement S2:  Normal vision experiments: Recognition accuracy, caricature effects,  
    intensity ratings.  
Supplement S3:  Stimuli — Additional details concerning caricaturing. 
Supplement S4:  Additional procedure details for expression recognition task in AMD 
patients. 
  Supplement S5:  References for Supplementary Materials.  
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6.4.7.1 Supplement S1: Additional details on patients and eyes: Inclusion criteria, excluded 
eyes, and more detailed vision testing 
Inclusion criteria and excluded eyes  
 Table S1 shows vision data for included and excluded eyes. As shown, we originally 
recruited 13 patients, however one patient (Px) failed to meet inclusion criteria for either eye, 
leaving the 12 patients whose demographics are described in the main-text Methods. Of the 
total of 26 eyes originally available: 1 eye was excluded due to not having AMD; 3 eyes were 
excluded due to having vision too poor to allow testing on the face recognition task (i.e., the 
patient reported they could not see the faces on the screen); and 3 eyes were excluded due to 
having vision that was too good, and thus having no need for image-enhancement 
technology.  
 These "too good" eyes all had AMD based on diagnosis of the retina, but 
demonstrated no relevant functional vision loss. One had acuity at or above normal vision 
levels, with BCVA = 6/4.8. Two had mild deficits in acuity (Patient Px’s right eye with 
BCVA = 6/7.5; and Patient Pd’s right eye with BCVA = 6/9.5) but performed at normal-
vision levels in the expression recognition task. Normal-vision performance was defined as 
85% correct for Veridical faces. Supplement S2 shows 85% was the mean accuracy for our 
stimulus set in young adults with normal vision. (Note normal-vision performance is not 
expected to be 100%1,2 some expressions such as happy attain close to 100% recognition in 
normal vision, but other expressions such as fear and disgust are much less reliably 
recognised, e.g., 50% for fear across five databases).1 The eyes we deleted scored 83% and 
85% correct, averaged across the 82 Veridical face stimuli. The next-best-performing eye 
scored 79% correct, which we considered far enough below normal-vision performance to be 
retained.  
 
Detailed vision testing 
 Patients were given a complete vision assessment lasting 1.5 hrs. They gave informed 
written consent after explanation of the nature and possible consequences of this assessment. 
Research methods adhered to the Declaration of Helsinki and were approved by the 
Australian National University (ANU) and ACT Health Human Research Ethics Committees. 
 Table S1 includes LCVA and AREDS3 score. LCVA was measured using a retro-
illuminated logMAR chart mounted on a stand conforming to the ETDRS format. AREDS 
stages3 are based on anatomy of the central 6mm of the retina (Stage 1 = Early AMD, small 
drusen; 2 = Early AMD, intermediate drusen; 3 = Early AMD, large drusen; 4 = covers active 
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exudative, choroidal neovascularisation for Wet AMD, and end-stage Dry AMD/sub-foveal 
geographic atrophy). For Stages 1-3 visual acuity is usually close to normal; for Stage 4, 
acuity can vary widely between normal and <6/60 (legally blind), e.g., depending on 
treatment (for Wet AMD).   
 Anterior segment of the eye was examined using slit-lamp biomicroscopy, instilling 
Oxybuprocaine Hydrochloride 0.4% eye drops to anesthetise the eyes to measure intraocular 
pressure using Goldmann applanation tonometry and to measure central corneal thickness 
using a Pachmate (DGH Technology Inc., Exton, PA). Patients were tested on 10-2 frequency 
doubling technology (FDT) threshold using Humphrey Matrix (Carl Zeiss Meditec, Inc., 
Dublin, CA). After the visual field test both eyes were dilated with Tropicamide 1% and 
Phenylephrine 2.5% and the following tests were done: Optical Coherence Tomography 
(OCT) Spectralis (Heidelberg Engineering, Heidelberg, Germany) of the retina (posterior-
pole) and the peripapillary retinal nerve fibre layer (pRNFL); scan to measure the thickness 
of the RNFL surrounding the optic nerve; fundus auto-fluorescence images were acquired, 
with fundus photography performed using a Canon CR-2 (Canon Inc. Medical Equipment 
Group, Tokyo, Japan) digital non-mydriatic camera to get an image of the fovea, the macula 
and the optic nerve. 
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Supplementary Table S1. Participant vision information for both eyes. 
Patient 
Code 
Eye code * (& left 
or right) 
Visual Acuity 
BCVA        LCVA† 
Diagnosis 
AMD type 
AREDS Stage 
Pa E1 (R) 6/7.5 6/7.5 Early AMD 3 
 E5 (L) 6/9.5 6/30 Wet AMD 4 
Pb E2 (L) 6/7.5 – Wet AMD 4 
 – (R) <6/360 <6/240 Corneal scar, 
amblyopia/No AMD 
n/a 
Pc E3 (L) 6/7.5 6/24 Wet AMD 4 
 E14 (R) 6/30 6/38 Wet AMD 4 
Pd E4 (L) 6/9.5 6/24 Dry AMD 4 
 – (R) 6/9.5 6/19 Dry AMD 4 
Pe E6 (R) 6/12 6/19 Wet AMD 4 
 – (L) <6/360 <6/240 End-stage AMD 4 
Pf E7 (L) 6/12 6/19 Wet AMD 4 
 E18 (R) 6/240 <6/240 Wet AMD 4 
Pg E8 (L) 6/12 6/24 Wet AMD 4 
 E17 (R) 6/120 6/200 End-stage AMD/Dry 4 
Ph E9 (R) 6/12 6/30 Dry AMD 4 
 – (L) 6/15 6/60 Dry AMD 4 
Pi E10 (R) 6/19 6/48 Dry AMD 4 
 E15 (L) 6/30 6/60 Dry AMD 4 
Pj E11 (L) 6/24 6/38 Dry AMD 3 
 E16 (R) 6/95 6/120 End-stage AMD/Dry 4 
Pk E12 (L) 6/24 6/48 Wet AMD 4 
 – (R) 6/240 <6/240 End-stage AMD/Dry 4 
Pl E13 (L) 6/24 6/60 Wet AMD 4 
 E19 (R) <6/360 <6/240 End-stage AMD/Dry 4 
Px – (L) 6/4.8 6/9.5 Dry AMD 3 
 – (R) 6/7.5 6/9.5 Wet AMD 4 
* Eyes marked with "–" were not eligible for inclusion in the study (see Supplement 1). Eyes 
given codes (E1, E2 etc.) met inclusion criteria, and are numbered the same as in Table 1 of 
main text.   
† LCVA = low contrast visual acuity; LCVA <6/240 indicates the patient could not read all 
letters on the largest line of the LCVA chart; BCVA <6/360 indicates the patient is counting 
fingers only. LCVA correlated very highly with BCVA (r = .95 for the 19 AMD-affected 
eyes meeting study inclusion criteria).  
 
  
193 
 
6.4.7.2 Supplement S2: Normal vision experiments: Recognition accuracy, caricature 
effects, intensity ratings  
 We report here results of experiments in normal-vision participants that are relevant to 
various aspects of analysing the AMD patient study. The same group of young adults (N=25) 
participated in two experiments: One experiment obtained intensity ratings (providing data 
relevant to stimulus validation); the other tested expression recognition accuracy for our 
stimulus set (providing data relevant to stimulus validation, eye exclusion at the top end of 
vision ability, effective maximum recognition accuracy for this stimulus set, and normal-
vision caricature effects with high initial accuracy).  
 
Participants (normal vision) 
 Participants were 25 young adults with normal or corrected-to-normal vision (all 
Caucasian; 17 female, 8 male; age Mean = 21.8 years, SD = 4.1, range 18-38). Recruitment 
was via advertisement to the student community at the Australian National University. 
Participants received course credit or were paid $15 per hour. Duration was approximately 1 
hour per participant. Visual acuity was assessed using a high-contrast ETDRS acuity chart, 
wearing correction if relevant; acuity was tested binocularly (to match binocular viewing 
used for the recognition and intensity rating tasks), and at a distance of 2 feet/60 cm (to match 
screen viewing distance for the experimental tasks). Participants gave informed written 
consent after explanation of the nature and possible consequences of the study. The research 
methods adhered to the Declaration of Helsinki and were approved by the Australian 
National University Human Research Ethics Committee. 
 Each participant completed both experiments, with intensity ratings done second. 
 
Expression Recognition Experiment: Recognition accuracy, caricature effects 
Methods 
 The normal-vision young adults performed the same task as the AMD patients, i.e., 
forced-choice recognition between the 6 basic emotions. The stimuli were the same used with 
AMD patients. The general procedure was as for the AMD patients (see main text Method), 
with the following minor differences. Each of the 82 expressions was shown once in each of 
the 4 caricature levels (0=Veridical, 40, 80 and 100% caricature), in a different random order 
for each participant, but with no second run. Viewing distance was 60 cm, and faces were 
12.7° x 7.6° (note this size is easily large enough for good performance in normal-vision 
observers).4,5 Each face was displayed until response, and participants entered their own 
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responses via the keyboard. Viewing was binocular. Note the data reported here were part of 
a larger study that, in addition to the high-resolution images of relevance here, also tested a 
lower-resolution bionic-eye simulation; the bionic eye simulation results are being prepared 
for independent publication.  
 
Results 
 Table S2 shows recognition accuracy in the normal vision young adult observers. 
Several points are of note. 
 Beginning with Veridical Faces, recognition accuracy was very good, at 85% correct 
(where 17% correct is chance). This validates our choice of Veridical faces. A suitable 
stimulus set for studying impaired recognition in AMD requires good recognition in normal 
vision, and our 85% correct is on par with normal-vision recognition accuracy in "gold 
standard" expression stimulus sets. Note accuracy of 100% is not expected due to the fact that 
some emotions (most notably fear) are never recognised more than moderately accurately 
even in the best stimulus sets.1,2 
 This normal-vision accuracy of 85% was also used in our eye exclusion criteria (see 
Supplement 1). Additionally, it provides the effective maximum performance towards which 
we would be aiming to improve recognition accuracy in AMD via caricaturing (e.g., as used 
in Figure 3). 
 Table S2 also shows caricature effects in normal-vision observers. Previous studies in 
young adults have found that, with accuracy as high as 85% (in a task where chance is only 
17%), further improvements in expression recognition with caricaturing are typically not 
observed on accuracy (but only on other measures such as reaction time, which cannot be 
easily assessed in AMD patients).6 Our results replicated this finding. Two-way repeated 
measures ANOVA (4 caricature levels x 3 expression intensities) found a main effect of 
intensity, F(2,48)=48.276, MSE=147.56, p<.001. However, there was no main effect of 
caricature level when all intensities were combined (as in previous normal-vision observer 
studies), F(3,72)=.070, MSE=19.470, p=.976, and also no significant caricature improvement 
for any expression intensity considered individually (Table S2).  
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Supplementary Table S2. Normal vision recognition of our stimulus set, showing M(SE) 
from N=25 young adults.  
 Caricature strength condition  
 0% 
(Veridical) 
40% 80% 100% Caricature 
improvement 
(80%-Veridical)  
All intensities (all 82 faces) 84.6(1.1) 84.9(1.1) 84.7(1.0) 84.6(1.1) 0.1(0.8), p=.95 
Low intensity 73.4(1.6) 74.4(1.9) 75.9(1.9) 76.1(1.6) 2.5(1.4), p=.09 
Medium intensity 89.3(1.5) 90.7(1.3) 88.6(1.5) 88.1(1.4) -0.7(1.1), p=.50 
High intensity 91.1(1.3) 89.6(1.7) 89.4(1.7) 89.4(1.4) -1.7(1.0), p=.11 
 
Intensity rating experiment 
Methods 
To allow us to split the Veridical faces into low, medium and high intensity subsets, 
the young adult participants provided intensity ratings for the 82 Veridical (i.e., 
uncaricatured) expression stimuli. The Veridical faces were shown one a time until response, 
in a different random order for each participant. The task question was "How intense does 
this emotional expression look to you?" and the response scale (shown on the screen) was a 
9-point scale running from 1 ("weak") to 9 ("strong").  
 
Results 
 For each Veridical face item, intensity ratings were averaged across the 25 
participants. The face items were then rank ordered from lowest to highest mean intensity 
rating, and divided into the lowest, middle and highest third. Properties of the resulting low, 
medium, and high intensity sets are described in main text Table 2. 
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6.4.7.3 Supplement S3: Stimuli — Additional details concerning caricaturing 
 For expressions displaying teeth, these were often not visible in open-mouthed 
Neutral versions. We thus matched landmark locations based on the inside line of the lips, 
with no landmarks around the teeth. This results in exaggeration of the size of the teeth in the 
caricatures, while keeping the proportions of tooth size to size of gap between the lips (see 
happy example in Figure 2A). We judged this to be the best way to caricature the apparent 
strength of the emotion displayed; also note that the alternative of not caricaturing the teeth at 
all (i.e., keeping them the same size as in the Veridical version) often led to a very peculiar 
appearance (e.g., an impression of tiny teeth in a huge mouth, for anger expressions with a 
gap between top and bottom teeth). 
 We did not test caricatures stronger than 100% because these regularly showed 
morphing artefacts. 
 Faces were placed on a standard-sized black background and images cropped to show 
the region from chin to approximately the hairline (see examples in Figure 2), using Adobe 
Photoshop Elements 12 software. 
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6.4.7.4 Supplement S4: Additional procedure details for expression recognition task in 
AMD patients 
 For the binocular practice phase, patients were shown six practice trials presented 
without a time restriction, and were given feedback on whether their response was correct. 
These showed faces not used in the main experiment, and showed one of each expression (all 
veridical). The practice trials were then repeated with the restricted presentation time (5 
seconds per face). 
 For the real experiment, patients were warned that the number of expressions would 
not be equal between each of the six emotions, and also to ignore the identity of the face (i.e., 
they would see a variety of different people, but each person may not display all of the 
emotions). They were also informed that similar to real-life, some of the faces are very 
expressive and their emotions may be easier to recognise, whereas other faces will be less 
expressive and may be harder to recognise and so patients should not be concerned if they 
could not recognise all or many of the expressions. No mention of caricaturing or image 
manipulation was made. 
 Stimuli were presented on an Apple iMac computer (screen size 68.5cm, resolution = 
2560 x 1440 pixels) running OS X, using SuperLab 4.5 software. Patients were monitored for 
fatigue or discomfort, and offered regular breaks. 
 
The following script contains the instructions given to AMD patients: 
 
Show the instruction slides with BOTH eyes 
• You will be looking at faces on the computer screen with one eye only and will make some 
decisions about them. Place the participant 40 cm from the screen. You are free to move your 
head around when looking at the screen, especially if you find that moving your head helps 
you see the faces more clearly. Please don’t move your face forward, closer to the screen. If I 
notice you are moving forward during the experiment, I will place you back in the correct 
position. 
• At any time during the experiment if you need to move, stand up, stretch or have a break 
please let me know. Also, if you are finding the task tiring, or straining on your eyes, let me 
know and we can take a break. Check the participant is in a comfortable position e.g. chair 
height etc. 
 
 
198 
 
• During the experiment you will see faces on the screen that will have one of six possible 
emotions. I will ask you: What emotion is being expressed by this face? and you can 
choose from anger, disgust, fear, happy, sad and surprise (point to large-text list of emotions 
on card below the computer screen).  
• Here are some examples of faces on the screen and I want you to tell me what emotion is 
being expressed by each face choosing between anger, disgust, fear, happy, sad and surprise.  
Present the example slides of the six different emotions and ask participants “What emotion 
is being expressed by this face; from anger, disgust, fear, happy, sad and surprise?”, wait for 
the patient to respond (there is no time restriction for slide presentation), then tell the 
participant what the emotion on each slide is “e.g., you are correct/incorrect, this face is 
expressing anger”. 
• Ask the participant if they can remember what the six emotions are to check they can 
remember them all and present the slide with the six emotions table as a reminder. 
• Now we are going to see what the experiment looks like. This time when you see the face 
on the screen you are going to say the emotion being expressed on the face out loud and I will 
enter your response into the keyboard. This time the face will only be presented on the screen 
for 5 seconds and then disappear. You can make your choice after the face has gone away 
from the screen, however it is recommended you try to choose one of the six facial 
expressions as quickly and accurately as you can, you don’t have to wait the 5 seconds to 
decide. 
• Here are some examples of faces being presented on the screen for 5 seconds. Like the last 
practice, you need to tell me what emotion is being expressed by each face choosing between 
anger, disgust, fear, happy, sad and surprise. Present the time restricted example slides of the 
six different emotions and ask participants “What emotion is being expressed by this face; 
from anger, disgust, fear, happy, sad and surprise?”, wait for the patient to respond, then tell 
the participant what the emotion on each slide is “e.g., you are correct/incorrect, this face is 
expressing disgust”. 
• During the experiment, the number of expressions you see will not be equal between each 
of the six emotions, so don’t feel like you need to say each emotion an equal amount of times.  
• Some of the people you see in the experiment may be expressing different emotions during 
the experiment and each person may not display all of the emotions, so base your response on 
the emotion you can see and not on the specific person.  
• You might notice that the intensity of emotions across the faces varies. This is similar to 
real-life, for example, some people are very expressive and it is easy to recognise their 
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emotions, whereas other people are much less expressive and therefore it is less obvious 
which emotion that person is expressing. That is normal, so just try to choose the emotion on 
each face. 
• We will be measuring your accuracy during the experiment, so try to recognise the emotion 
on each face as best as you can. 
• In the first block of the experiment you will be using your stronger eye and your weaker eye 
will be covered by an eye patch. This will be reversed in the second block. 
• Do you have any questions? Do you feel comfortable with what the task involves? Would 
you like to see the introduction/practice slides again? 
• We will have a break (tea/coffee) half way through the experiment, but if you need a break 
at any time, please let me know. 
 
FIRST EYE TO BE TESTED (stronger eye if both eyes tested) 
• Please cover your weaker eye now with the eye patch so you are only using your stronger 
eye. Your eye might take a little time to adjust. Wait for one minute. 
• Remove the eye patch when completed and have a break. 
 
IF A SECOND EYE IS BEING TESTED (on a different day)...  
• Instructions and practice as for the first eye.  
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Chapter 7: General discussion 
 
7.1 Chapter overview 
This final chapter summarises and discusses the main findings of the research in this 
thesis. As each individual chapter of the thesis has been written as a stand-alone paper with 
its own discussion, this final chapter will provide a general discussion of the thesis as a 
whole. 
This thesis had two main approaches to attempt to improve the quality of life for 
people living with AMD. The first approach was to determine whether problems with face 
perception negatively impact social interactions and quality of life in AMD. The qualitative 
interviews in Chapter 3 revealed that face perception is important to people living with AMD, 
and reduced face perception can negatively impact social interactions and quality of life 
across all levels of vision loss in AMD. Based on these findings, we developed three new 
community resources for AMD patients, family, friends, carers and health professionals 
intended to improve awareness, understanding and empathy related to the everyday problems 
associated with poor face perception in AMD. 
The second approach was to investigate whether caricaturing, a face enhancement 
method, can improve face perception in AMD. Two experimental studies found that 
caricaturing improves both face identity discrimination and face expression recognition in 
low intensity expressions in patients with mild, moderate and severe vision loss due to AMD.   
 Addressing the two main approaches used to improve the quality of life in people 
living with AMD in this thesis, this chapter will summarise the findings, discuss the 
implications, and explore open questions and future research directions. Finally, the broader 
implication of the findings for other low vision disorders will be discussed.  
 
7.2 Understanding the impact of reduced face perception on social 
interactions and quality of life in AMD 
7.2.1 Summary of outcomes from this thesis and implications 
This thesis presents the first study to comprehensively examine the impact of reduced 
face perception on social interactions and quality of life in AMD (Chapter 3).  The qualitative 
study demonstrated that reduced face perception in AMD can result in difficulties in social 
situations including making mistakes recognising others, misinterpreting social interactions, 
missing out, not being able to join in, and fear of offending others by appearing to ignore 
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them. Patients also reported a lack of understanding by others regarding how AMD affects 
vision and face perception which resulted in others thinking they were faking their vision 
loss. These difficulties often contributed to social withdrawal, reduced confidence and quality 
of life in AMD patients. The conclusion of this paper was therefore, face perception problems 
in AMD can negatively impact social interactions and quality of life. Moreover, contrary to 
previous assumptions, we found that these outcomes were not restricted to severe AMD, that 
is, patients with mild vision loss reported qualitatively similar difficulties as those with severe 
vision loss.  
Chapter 3 provides the first direct evidence that poor face perception is an important 
concern for people living with AMD. Because of a lack of previous research and 
understanding of the importance of face perception in AMD patients, there are very limited 
resources available on face perception difficulties to AMD patients and their family, friends 
and carers. There are no existing resources that address the impact of poor face perception on 
social interactions and quality of life. The findings from the qualitative interviews (Chapter 3) 
directly lead to the development of new ‘Faces and Social Life in AMD’ community 
resources which included a brochure, information sheet and conversation starter. These 
resources were designed to improve awareness and understanding of the impact of reduced 
face perception in AMD on social interactions and quality of life, which are intended to 
increase empathy for people living with AMD and enable others to provide practical help in 
social interactions.  
These community resources were also intended to help patients with AMD understand 
their own problems with faces. One factor which might have contributed to the lack of 
understanding of the consequences of poor face perception in AMD is the finding that adults 
in general have low insight into their face recognition abilities (Palermo et al., 2016). In 
Chapter 3 we asked AMD patients about their everyday face perception, and many would 
initially say they had few problems seeing faces, however when asked very specific 
questions, they reported many difficulties seeing faces. This may seem counter-intuitive as 
you might expect a person with progressive vision loss would notice their everyday 
functioning deteriorating, however it seems in our AMD patients, this was not the case, 
perhaps due to the development of strategies used to compensate for vision loss as AMD 
progresses. This lack of insight is further demonstrated by the low correlation in AMD 
patients between self-reported difficulty in face perception and performance in face 
recognition tasks (r = 0.13 for identity and r = 0.05 for expression) (Tejeria, Harper, Artes & 
Dickinson, 2002). The community resources we developed will enable AMD patients to 
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consider how they perceive faces which could potentially improve their insight and help them 
understand their vision loss and the impact their reduced face perception has on their quality 
of life.  
 
7.2.2 Open questions and future directions 
The research in Chapter 3 has shown that the importance of face perception 
difficulties to everyday life in AMD is higher than has been implicitly assumed previously, 
including in quality of life research and in community information websites. More research is 
required to further understand the impact of poor face perception in AMD. The most pressing 
future directions and open questions are discussed below. 
 
7.2.2.1 The complexities of quality of life research   
Quality of life research is complex because the components of this construct are often 
multifaceted, overlapping and interconnected. For example, reduced face perception can 
contribute to social withdrawal, reduced confidence and feeling anxious about making 
mistakes or appearing rude. Social withdrawal can contribute to low mood, low energy and 
low motivation, which in turn reduces social interactions and confidence. Therefore, when 
measuring reduced social interactions, it is difficult to separate which components are related 
to poor face perception, low mood, or both. Alternatively, reduced social interactions may be 
due to other factors associated with ageing including poor health, loss of driver’s licence and 
independence, reduced mobility, and death of friends and family. Future research that focuses 
on understanding and disentangling factors and confounds associated with quality of life will 
assist in designing more effective and targeted interventions.   
 
7.2.2.2 Increasing the amount of research data on the impact of poor face perception  
Previous research on the impact of reduced face perception has been very limited and 
only two previous studies have examined the impact of AMD on social interactions (Wang & 
Boerner, 2008; Owsley et al., 2006). Chapter 3 demonstrated that reduced face perception is 
important across all AMD severity levels, and highlighted the importance of including face 
perception as a domain or item in measures that examine the impact of AMD on patients’ 
quality of life like the Macular Degeneration Quality of Life questionnaire (MacDQoL; 
Mitchell & Bradley, 2004). The MacDQoL is a widely used tool designed to measure change 
in quality of life due to AMD, and currently it does not include any questions about face 
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perception. By not including questions about faces the results of Chapter 3 suggest it is 
missing a domain that can have a big impact on quality of life in AMD. The findings from 
this thesis also indicated that the wording of current questions related to face perception in 
other questionnaires could be improved. For example, the National Eye Institute Visual 
Functioning Questionnaire (NEI-VFQ; Mangione et al., 2001) includes the question “Because 
of your eyesight, how much difficulty do you have seeing how people react to things you 
say?”. This question may be too broad (i.e., relates to all types of responses including facial 
expressions and body language), or poorly worded as one third of the AMD patients in our 
study reported they cannot see how others react e.g., responded with “how would I know?”. 
Future research examining quality of life and visual functioning in AMD should include 
questions about the importance of face perception, how face perception is affected, and the 
impact of reduced face perception on social interactions and quality of life in measures.  
To aid future research on face perception in AMD, we developed the Face Perception 
and Social Interactions in AMD (FPSI_AMD) quantitative questionnaire which has five 
sections including: seeing faces, what do faces look like to you, how much do other people 
understand, social situations, and what can other people do to help (Chapter 4). In the first 
instance, the useability (structure, wording, length etc.) and psychometric properties of this 
measure need to be evaluated. Once reliable and valid, this tool will assist with ongoing 
research investigating the impact of reduced face perception on social interactions and quality 
of life in AMD. Examples of potential research questions include determining if certain face 
perception problems are associated with different types of AMD, and what proportion of 
AMD patients experience specific face perception or social interaction problems. 
Importantly, the FPSI_AMD could also be used to evaluate the effectiveness of interventions 
designed to improve face perception, social interactions and quality of life in AMD such as 
the community resources and caricaturing proposed by this thesis.  
 
7.2.2.3 New community resources 
In the qualitative study we interviewed AMD patients asking them about their face 
perception, social interactions and quality of life. This data was used to develop new 
community resources. The aim of these resources was to improve patient and community 
awareness and understanding, which may also lead to increased empathy. Practical strategies 
were included in the resources to empower AMD patients and those around them to actively 
engage in behaviours that assist with maintaining social engagement and interactions. Finally, 
the conversation starter was designed to guide a family member, friend or carer through 
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questions they can ask the person living with AMD, to gain a better understanding of that 
particular person's day-to-day social experiences, and how the family member/friend/carer 
can best help them. 
The effectiveness of these resources is as yet untested. Future research is needed to 
investigate whether these resources work as intended. One approach might be to use the 
FPSI_AMD questionnaire once it has been validated. For example, before a new community 
resource is introduced into an aged care facility, AMD patients could complete the 
FPSI_AMD questionnaire as a baseline measure. The resources could then be introduced and 
disseminated to AMD patients, family, friends, carers and aged care facility staff and after a 
suitable time-frame (e.g., allowing time for the implementation of practical tips and possible 
increase in insight and empathy), the FPSI_AMD questionnaire could be readministered and 
responses pre/post intervention compared. A delayed follow-up measure could also examine 
the longevity of the intervention outcomes.  
Other future research questions include investigating: attitudes towards the resources, 
rate and pattern of uptake (e.g., whether people look at one or multiple resources), if the 
resources improve awareness, understanding, empathy and quality of life, if the practical tips 
are implemented or lead to behavioural changes (i.e., for the AMD patient and others around 
them), and if behavioural changes occur, how long they persist. 
 
7.2.2.4 Increasing awareness of how AMD affects vision   
Patients’ descriptions in the qualitative study (see also Taylor, Edwards, Binns and 
Crabb, 2018) suggest current depictions of how AMD affects vision on macular disease 
information websites (see Figure 2.3.1 in Chapter 2) are inaccurate (e.g., very few patients 
experienced a central scotoma), and too simplistic (e.g., patients often report concurrent 
symptoms including  blur, distortions and missing parts). One approach to obtain accurate 
depictions of AMD would be to ask patients with normal vision in one eye and AMD in their 
other eye to look at a normal face image with their AMD-affected eye, and describe how well 
their experience is matched by potential illustrations of AMD vision shown to their 
unaffected eye. Another area for future work is to examine the types of distortions 
experienced by AMD patients to determine if they are qualitatively similar or different across 
different objects e.g., faces vs. other objects.  
It is important to have accurate depictions of AMD to increase understanding of how 
AMD affects vision and the heterogeneity of the disease, which may lead to an improvement 
in empathy, acceptance and quality of social interactions. Research using the FPSI_AMD 
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questionnaire will provide more data on AMD patients’ visual experiences, including whether 
there are differences between wet or dry AMD. This information can be used to develop more 
accurate representations of how AMD affects vision on relevant websites.   
 
7.2.3 Conclusion 
This thesis has shown for the first time that poor face perception in AMD contributes 
to reduced social interactions, confidence and quality of life. We developed new community 
resources that were designed to increase awareness and understanding and improve social 
interactions and quality of life in AMD patients. The qualitative research also contributed to 
the development of the Face Perception and Social Interactions in AMD (FPSI_AMD) 
quantitative questionnaire. Future research is required to examine the impact and 
effectiveness of the community resources and evaluate the validity of the FPSI_AMD.   
 
7.3 Improving face perception in AMD via caricaturing 
The second part of this thesis focused on examining if caricaturing, a face 
enhancement technique that exaggerates face shape information, can improve face perception 
in AMD patients. Both face identity discrimination (Chapter 5) and face expression 
recognition performance (Chapter 6) were examined. 
 
7.3.1 Summary of outcomes from this thesis and implications 
The experimental studies in this thesis showed for the first time that caricaturing 
improved face perception in AMD patients for both identity discrimination and face 
expression recognition for low intensity expressions. The effects of caricaturing were 
observed across all levels of vision loss from mild to severe. The size of caricaturing benefit 
seen in AMD patients (5-10% improvement in face identity discrimination and expression 
recognition) was similar to that seen in young adults with normal vision in both high 
resolution images, and in conditions of simulated AMD (Irons et al., 2014; Irons et al., 2017; 
McKone, Robbins, He & Barnes, (in press)). Importantly, a 5-10% improvement in face 
perception would have practical value in the real-world for AMD patients. However, the gain 
in performance provided by caricaturing would not be enough to return patients’ performance 
to the level of older adults without vision loss. Possible ways to address this shortfall are 
discussed in the following section.   
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7.3.2 Open questions and future directions  
The findings in Chapter 5 and Chapter 6 indicate caricaturing improves face 
perception in AMD patients. There are limitations to our current understanding of 
caricaturing which are discussed below with suggestions to overcome these limitations and 
some suggestions for the practical implementation of caricaturing as a face perception 
enhancement technique. 
 
7.3.2.1 How might caricaturing be implemented in the real-world? 
The results of our laboratory studies suggest identity and expression caricaturing of 
faces would be beneficial to AMD patients in their everyday lives and social interactions. 
However, conversion of caricaturing from the laboratory into AMD patients’ everyday lives, 
will require advancements in technology and the resolution of some limitations of the current 
caricaturing procedure. The advancement of this technology will require a collaborative effort 
from computer scientists, engineers, face perception experts, vision scientists and clinical 
psychologists.  
 To be genuinely helpful to AMD patients, the long term aim is to have real-time 
caricaturing of both face identity and expression. One potential implementation could be a 
system that allows a patient to take a photo of a face in their environment and manipulate it 
via caricaturing either on a screen (e.g., computer or iPad) or on smart glasses (glasses worn 
on the patients’ eyes like normal glasses, but the lenses can have images presented on the 
inside). Another approach could be to caricature faces in the environment simultaneously and 
automatically in real-time directly through the smart glasses without requiring any specific 
hands-on interaction from the patient. This second approach might be particularly helpful for 
AMD patients with mobility issues (e.g., they use a walking aid and therefore a hands-free 
device would be more practical), or for AMD patients who do not feel competent with 
interactive technology (i.e., have never used an iPad or similar devices).  
One practical limitation associated with the caricaturing procedure is the allocation of 
landmark points on each stimulus face. In this thesis landmark points were manually placed 
on each face which was very labour intensive and time consuming (similar to Benson, 
Campbell, Harris, Frank & Tovee, 1999; Calder, Young, Rowland & Perrett, 1997; Irons et 
al., 2014). To caricature face identity we manually placed up to 150 points on each face, and 
up to 230 landmark points for caricaturing face expression. McKone et al. (in press) tested 
software for face identity caricaturing that automatically assigned 68 landmark points to 
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faces. This automatic method produced a significant caricature improvement in identity 
discrimination that was approximately 50% as effective as caricatures made using the 
standard method of manually assigning 147-point (McKone et al., in press). Computer 
scientists are working to develop automatic caricaturing e.g., Su, Duan, Wang, Lee and Lai 
(2014) and future research is required to optimise the effectiveness of such software.   
A second practical limitation associated with the caricaturing procedure is the creation of 
reference faces. To caricature face identity, we used average reference faces that were 
matched on age, race and sex to the face being caricatured. The creation of the average face 
requires placing landmark points on approximately 50 individual faces of the same age, sex, 
race and viewpoint before morphing the faces together. To avoid this time-consuming 
process, the development of a ‘universal average face’ that averages thousands of faces of 
different age, gender and race could be used as a prototypical average face. Alternatively, a 
database of average faces from specific subgroups could be created (e.g., a female middle-
aged Caucasian prototype, a male young adult Asian prototype etc.) and used as an average 
reference face as required to caricature face identity. Research could determine the 
effectiveness and utility of the different types of average faces by comparing the caricature 
benefits (e.g., is there a meaningful advantage in using a subgroup specific average face 
versus a universal average face). Support for this work has come from research showing 
perceptual norms for different gender and race faces (Jaquet, Rhodes & Hayward, 2008; 
Rhodes et al. 2004).  
When caricaturing face expression, a neutral reference face of each target face is 
required. In the real-world, the manual allocation of landmark points for each person an 
AMD patient interacts with would be impossible. Similar to face identity, the creation of a 
‘universal neutral face’ or subgroup prototypes could be used as a neutral reference face. To 
go one step further, the development of a ‘universal face’ that could be used for both identity 
and expression caricaturing would reduce the time and effort demands of the caricaturing 
procedure. However, whilst the use of a universal face will assist with simplification of the 
caricaturing procedure, this approach will not exploit optimal performance, particularly for 
expression where there are individual differences in how people express emotions (e.g., 
Kaufmann & Schweinberger, 2004).  
In our experiments, we only caricatured the face shape information and not the colour 
information of the faces. In face identity recognition, research has shown caricaturing the 
reflectance of faces (which includes colour, luminance, hue, pigmentation, texture and 
saturation of pixels) improves recognition of familiar faces, whereas caricaturing shape 
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information facilitates the rejection of unfamiliar faces (Itz, Golle, Luttmann, Schweinberger 
& Kaufmann, 2017; Itz, Schweinberger & Kaufmann, 2016; Itz, Schweinberger, Schulz & 
Kaufmann, 2014; Lee & Perrett, 2000). More recent research by Benitez-Quiroz, Srinivasan 
and Martinez (2018) showed emotion can be decoded via colour information in the face, 
independent of muscle movement. Future caricaturing research would benefit from 
investigating the effectiveness of caricaturing shape and shape+colour information, 
particularly to examine if this combined enhancement might further improve AMD patients’ 
face recognition. However, whilst caricaturing face colour information may benefit face 
perception in the laboratory, translating this method to benefit AMD patients’ in everyday life 
has many challenges. In the laboratory, face stimuli are created under optimal lighting 
conditions to minimise differences in ambient lighting and other lighting and reflectance 
artefacts (e.g., using white light and lighting at various angles to avoiding shadowing). In the 
real-world, lighting conditions are complex and includes the presence of ambient light, 
reflectance from other objects onto the face and shadowing. Therefore, to exaggerate face 
colour information in the real-world, technology would need to detect colour information 
specific to the face and exaggerate it, whilst removing any other non-face colour or 
reflectance information before caricaturing. Otherwise, a normally pale face which happens 
to have an orange hue due to ambient lighting from a sunset will, after caricaturing, have a 
coloured face similar to that of Donald Trump. This inaccurate reflectance would presumably 
reduce rather than improve identity recognition.    
 
7.3.2.2 Caricaturing dynamic faces: Can it be done? Does it help? 
 All previous studies have used static images to investigate caricature effects in both 
face identity (e.g., Benson & Perrett, 1991; Lee, Byatt & Rhodes, 2000; Valentine, 1991); 
and face expression (e.g., Benson et al., 1999; Calder et al., 1997; Calder et al., 2000).  
Understanding caricature effects on static face images can have application in the real-world 
as we frequently encounter static face images in everyday life for example, when viewing 
photos both as hardcopy (e.g., newspapers, magazines), and online (e.g., social media). 
However, most faces we encounter are dynamic. No research has examined caricaturing for 
dynamic faces even in normal vision. Therefore, there is an open question as to whether 
caricaturing improves identity and expression recognition in dynamic faces, in general and in 
AMD specifically.  
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Technological advances are required to test this question. Computer scientists are 
working to caricature dynamic face images for both face identity and face expression (e.g., 
Theobald et al., 2009), however this technology is still in development. There are many 
potential challenges to caricaturing dynamic face images especially for expression. For 
example, facial expressions can be fleeting (e.g., 0.5 seconds for smile; Frank, Ekman & 
Friesen, 1993) therefore it might be difficult for the software to keep pace with changes in 
expression. Further, exaggerating every expression that flashes across a person’s face might 
be unhelpful in a social situation. It might be necessary for the software to distinguish which 
expressions are socially important (i.e., to get the general gist of a person’s emotional state 
based on their expressions), rather than exaggerating every changing expression as it occurs.  
 
7.3.2.3 Caricaturing research should use a range of expression intensities  
Caricaturing has been investigated as a method for improving expression recognition 
in other patient groups including fronto-temporal dementia (Kumfor et al., 2011; Kumfor, 
Irish, Hodges, & Piguet, 2013) and Down Syndrome (Cebula, Wishart, Willis & Pitcairn, 
2017). These studies, in line with the original demonstration of expression caricaturing 
effects in typical young adult participants, have largely used face stimuli with high intensity 
expressions (e.g., Calder et al., 1997 used the Pictures of Facial Affect database; Ekman & 
Friesen, 1976, and Kumfor et al., 2011, 2013 used the Facial Expressions of Emotion – 
Stimuli and Tests (FEEST) database; Young, Perrett, Calder, Sprengelmeyer & Ekman, 2002 
In Chapter 6 we examined the effectiveness of caricaturing faces with low, medium and high 
intensity expressions. We demonstrated that, in AMD, caricaturing did not significantly 
improve expression recognition in medium and high intensity expressions as recognition 
accuracy of veridical faces was already at a high performance level. Our results suggest that 
caricaturing is of greatest benefit for low intensity facial expressions. It is an open question 
whether this finding applies to other patient groups. In order to best investigate the usefulness 
of expression caricaturing future studies should include a range of facial expression 
intensities. 
 
7.3.2.4 Can caricaturing improve recognition of “other” facial expressions?    
In this thesis, as in all previous research on caricaturing of expressions (e.g., Calder et 
al., 1997, 2000), we focused on Ekman’s (1993) six basic expressions (happy, sad, disgust, 
fear, angry, surprise). However, in our everyday lives we experience a diverse and complex 
range of more subtle, nuanced expressions (e.g., boredom, doubt, contempt). It would 
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potentially be beneficial to AMD patients to also improve recognition of these “other” 
expressions. Caricaturing might also work to improve recognition of these expressions but 
this is as yet untested even in normal vision. 
 
7.3.2.5 Does caricaturing improve genuine expressions?  
A final potential limitation associated with currently available face expression stimuli 
used in caricaturing research is the majority of expressions are posed rather than genuine. For 
example, in the Pictures of Facial Affect (PoFA; Ekman & Friesen, 1976) actors were asked 
to perform specific facial movements, and for the Karolinska Directed Emotional Faces 
(KDEF; Lundqvist, Flykt & Öhman, 1998) and the Gur database (Gur et al., 2002), actors 
were given instructions on how to pose each expression.  
It is important to be able to distinguish between genuine and posed (or faked) 
expressions to accurately interpret social interactions with others e.g., whether someone is 
genuinely happy to see you or smiling to be polite, or whether a child is genuinely sad or is 
faking sadness to seek attention (Dawel et al., 2017; Dawel, Wright, Dumbleton & McKone, 
(in press)).  
Future research is required to examine if AMD patients are able to discriminate 
between posed and genuine expressions. Also in both normal vision and AMD, it is unknown 
if caricaturing benefits are seen for genuine expressions, and if they are found, how the 
caricaturing benefits compare in genuine versus posed expressions.  
 
7.3.2.6 What is the optimum level of caricature? 
An important consideration for the practical implementation of caricaturing in the 
real-world is what level of caricaturing produces the greatest benefit for patients. For both 
identity and expression extreme caricaturing results in morphing artefacts this imposes an 
upper limit on the amount of caricaturing possible. Previous research has indicated that for 
expression too much exaggeration can make faces look strange (Mäkäräinen, Kätsyri & 
Takala, 2014) and less face-like (Calder et al., 2000). In our identity study (Chapter 5), the 
most effective caricature level matched the maximum level we used. For the expression study 
(Chapter 6), the most effective caricature strength was 80%, and expression recognition 
performance decreased between the 80% and 100% exaggeration levels.  
It would perhaps be expected that individual AMD patients would have a preferred 
caricaturing level based on their vision loss, but also on external situational factors including 
lighting, proximity, familiarity of the person they are interacting with, and expression 
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intensity. Future research could test this assumption and future technology could include a 
mechanism that allows individual AMD patients to manipulate their preferred caricature level 
to get optimal face perception enhancement. For example, this might allow patients to 
increase the caricature level when they are interacting with someone who is not particularly 
expressive and reduce the caricature level for people who are highly expressive. 
Alternatively, this approach could assist with cues to facial speech in a noisy group situation 
as compared to a one-on-one interaction.  
 
7.3.2.7 Monocular versus binocular viewing 
During testing, AMD patients in our experiments viewed the face stimuli monocularly 
due to the differences in the diagnosis, stage and visual acuity across both eyes. If AMD 
patients performed the experiments binocularly, it is most likely they would preferentially use 
input from their best eye and largely ignore input from their poorer eye (Asper, Crewther, 
Crewther, 2000; Evans, 2007). It is unlikely the size of the caricature improvement would 
change if AMD patients’ were tested binocularly. Studies from our laboratory have shown 
that when young adults viewed the same stimuli binocularly under conditions of simulated 
AMD with varying levels of blur (Irons et al., 2014; Dawel, Wong et al., (in press)), the 
amount of caricature improvement was similar to that seen in AMD patients with monocular 
viewing (i.e., 5-10% improvement in recognition accuracy). Future experiments could 
examine the effect of caricaturing on face perception in AMD patients when viewing faces 
binocularly and their best-eye monocularly, to determine if there are any differences across 
viewing conditions. Future technology that is binocular e.g., smart-glasses will need to 
accommodate the differential vision loss and symptoms in each eye, and may need to correct 
the perceived image when a breakthrough in attention occurs in the weaker eye.  
 
7.3.2.8 Caricaturing of other face information 
If automatic real-time caricaturing can be developed, this technology could potentially 
simultaneously exaggerate all face shape information including identity, expression, facial 
cues to speech and eye gaze. Exaggerating facial cues to speech is likely to be useful for 
AMD patients’ speech perception particularly in noisy environments or for patients with 
hearing loss. However, no studies to date have used caricaturing as a method to exaggerate 
facial cues to speech even in normal vision, which is likely related to the current 
technological barriers associated with caricaturing dynamic face movements.  
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Conversely, caricaturing of eye gaze information is likely to be detrimental to AMD 
patients’ perception of gaze as it would look like a person is looking away from their point of 
fixation, rather than directly at it. For example, when a person is using a left-oriented eye 
gaze to make eye contact with an AMD patient, if this eye gaze is exaggerated, it will appear 
to the AMD patient that the person is looking to the left of them and not directly at them. This 
would be inaccurate and confusing and likely would impair social interactions. Therefore, 
caricaturing technology would need to be designed to simultaneously exaggerate identity, 
expression and facial cues to speech, but not eye gaze.  
 
7.3.2.9 Combining caricaturing with other face enhancement techniques 
This thesis has demonstrated that caricaturing can improve face perception (identity 
discrimination and expression recognition) in AMD patients by approximately 5-10%. This 
amount of improvement has practical value in the real-world, however it is not enough to 
reach recognition performance achieved prior to the onset of AMD, or to match performance 
of age-matched controls without AMD. Other enhancement methods have been found to be 
similarly helpful but inadequate (e.g., magnification, Johnson, Woods-Fry & Wittich, 2017).  
It is likely a combination of enhancement methods will achieve the greatest total benefit to 
AMD patients’ functional vision. For example, combining caricaturing (targeting mid-and-
high level visual processing areas) with magnification and/or spatial frequency manipulations 
(targeting early-stage visual processing areas) may provide an additive improvement in face 
enhancement compared to when each method is used alone. This prediction requires 
empirical testing.  
 
7.3.2.10 Does caricaturing improve quality of life 
The overall aim of this thesis was to examine potential ways to improve social 
interactions and quality of life in people living with AMD. We have shown that caricaturing 
can improve face perception in AMD in the laboratory. Once technology has been developed 
to implement caricaturing in the daily lives of people with AMD the effectiveness of the 
intervention, or combination of interventions, can be examined via the FPSI_AMD. For 
example, the FPSI_AMD can be administered pre- and post-implementation of face 
enhancement technologies (i.e., smart glasses with caricaturing and magnification software) 
to examine if the intervention improves face perception, social interactions and quality of life 
in AMD patients. 
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7.3.3 Conclusion 
For the first time, caricaturing has been shown to improve face identity discrimination 
and face expression recognition for low intensity faces in AMD patients across all levels of 
vision loss. However, before caricaturing can be successfully implemented in the real-world 
some technological advancements are required including: software that automatically 
allocates landmark points (based on a database of reference faces), development of an 
appropriate reference norm/s, software that can enhance face identity, face expression and, 
potentially, facial speech cues automatically in real-time both for static and dynamic faces, 
and technology that allows AMD patients’ to manipulate their preferred caricature level 
based on their vision and environment.  When such technology is introduced, the use of a pre- 
and post-intervention measure (i.e., the FPSI_AMD in Chapter 4) will assist to determine if 
the technology, both alone and in conjunction with other enhancement methods, improves 
face perception, and if the benefits from the technology contributes to an improvement in the 
social interactions, confidence and quality of life of AMD patients.  
 
7.4 Potential implications for other low vision disorders 
The findings of this thesis have implications beyond AMD. Australia’s older 
population is growing (with 3.7 million Australians aged 65 and above in 2016, which is 
expected to increase to 8.7 million in 2056; AIHW, 2016). Consequently, the prevalence of 
age-related low vision disorders, including AMD will continue to increase. Despite the 
differences across low vision disorders (e.g., how the eye is affected and resulting 
symptoms), theoretically associated face perception difficulties have the same origin; that is, 
visual processing areas of the cortex involved in face perception are not receiving adequate 
visual information. Therefore, the findings from this thesis have potential implications for 
other low vision disorders. 
This research has shown the effects of poor face perception on social interactions and 
quality of life in AMD (a vision disorder), are qualitatively similar to that seen in 
prosopagnosia (a cortical disorder; Yardley, McDermott, Pisarski, Duchaine & Nakayama, 
2008). Therefore, it is highly likely similar qualitative outcomes will occur in other low 
vision disorders (e.g., Best disease, Stargart disease, glaucoma and diabetic retinopathy). If 
this is the case, the new community resources and quantitative measure we developed for 
AMD patients could be adapted under consultation with vision experts to suit specific low 
vision disorders. For example, patients with glaucoma can experience blurred vision, missing 
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parts, dark patches, peripheral vision loss and light sensitivity problems (Crabb, Smith, Glen, 
Burton & Garway-Heath, 2013; Hu et al., 2014). A revised information sheet and/or 
quantitative questionnaire could be developed to be specific for glaucoma (e.g., the 
FPSI_Glaucoma). Alternatively, more generalised community resources could be developed 
that are appropriate across all severe low vision disorders rather than being specifically 
designed for one eye condition e.g., a Faces and Social Life in Low Vision Disorders 
brochure and information sheet.   
Regarding the improvement of face perception in other low vision disorders, it has 
been demonstrated across multiple studies that caricaturing produces a similar caricature 
advantage for face identity perception in young adults viewing blurred faces (Irons et al., 
2014), AMD patients with mild-to-severe vision loss due to AMD (Chapter 5), and in young 
adults viewing simulations of the bionic eye which present a very impoverished image (Irons 
et al., 2017). Studies indicate caricaturing can enhance face identity perception across 
conditions that are perceptually very different (e.g., in blur and bionic eye simulation as 
depicted in Figure 7.4B and 7.4D). It is likely that caricaturing can enhance face identity 
perception across other low vision disorders as this enhancement method targets mid-and-
high level visual processing areas of face perception, not the specific dysfunction of a 
particular low vision disorder (e.g., damage to the retina in AMD). However, this prediction 
needs to be examined in future research.  
 
A. B. C. D. 
    
Figure 7.4 Demonstration of the caricature effect under different low-vision and 
impoverished image conditions. A. High-resolution veridical (unaltered) face. Enhancement 
of face with 60% exaggeration in: B. Blurred face simulation where blurring is a common 
symptom of many low vision disorders. C. Simulated AMD with blur, a scotoma and 
distortion. D. Bionic eye simulation.    
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7.5 Overall conclusion 
This PhD research has examined potential means to improve the quality of life for 
people living with AMD. This has been achieved by providing a greater understanding of the 
importance and impact of reduced face perception on social interactions and quality of life in 
AMD. New community resources were developed to share this knowledge. It is hoped that 
these resources will improve understanding of the face processing difficulties and associated 
social consequences in AMD in patients’ family, friends, carers and health professionals and 
the patients themselves. Greater understanding can potentially increase empathy for people 
living with AMD, and allow others to provide suitable practical help to assist with social 
interactions, and decrease the likelihood of others taking offence (e.g., if the person with 
AMD appears to ignore them or misunderstand their social cues). Also, from these findings 
we developed a quantitative measure, the FPSI_AMD, which, once validated, can be used in 
future research investigating the impact of reduced face perception on social interactions and 
quality of life in AMD.  
The second approach to improve quality of life in AMD patients’ in this thesis was to 
improve their ability to perceive faces via caricaturing. For both face identity discrimination 
and face expression recognition, caricaturing provided an improvement that has practical 
value in the real-world. Strategies were identified to convert caricaturing from the laboratory 
into the everyday life of AMD patients’ and people with other low vision disorders. Overall, 
this thesis has contributed to understanding the impact of reduced face perception in AMD, 
and developed methods to potentially improve social interactions and quality of life in people 
living with age-related macular degeneration.   
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